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Epidemiological studies have shown that high consumption of fruits and 
vegetables is associated with reduced risk of cancer. Phytochemicals, mainly 
phenolics and flavonoids, have been suggested to be responsible for these health 
benefits. However, the molecular mechanisms of the anticancer effects of fruits and 
vegetables are not fully understood.   
Fourteen grape varieties were analyzed for the profiles of total phenolics, total 
flavonoids, and trans-resveratrol. Phytochemicals in those grapes have potent 
antioxidant and antiproliferative activities. In addition, thirteen grape varieties and 
fourteen common phytochemicals were evaluated for their ability to induce 
mammalian phase II detoxification enzyme – quinone reductase. Grape 
phytochemicals had strong activity in quinone reductase induction and potent 
antiproliferative activities toward Hepa1c1c7 cells. These results support the 
hypothesis that phytochemicals prevent cancer by acting as free radical scavengers 
and/or inducers of phase II detoxifying enzymes in the initiation stage, and/or as cell 
proliferation suppressors in the promotion/progression stages. 
Combinations of selected fruits and phytochemicals were studied for their 
antioxidant activity, antiproliferative activity, and induction of quinone reductase. The 
combination of apple extracts and quercetin 3-β-D-glucoside (Q3G) exhibited more 
potent antiproliferative activity when compared to the apple extracts and Q3G alone. 
The combination of grape extracts and quercetin, genistein, and resveratrol showed  
higher induction activity of quinone reductase than grape extracts and phytochemicals 
alone.  
In conclusion, we have demonstrated that the additive and synergistic effects 
of phytochemicals in fruits are responsible for their potent antioxidant activity, 
antiproliferative activity, and phase II detoxifying enzyme induction activity, and that 
the health benefit of a diet rich
 in fruits is attributed to the complex mixture
 of 
phytochemicals and their interactions present in those foods. 
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CHAPTER ONE 
 
                                    LITERATURE REVIEW 
 
1.1. Introduction 
Cardiovascular diseases and cancer are the leading causes of death in the 
United States and the most industrialized countries. Both diseases are thought to be 
partially the result of oxidative stress, which can damage biomolecules. Based on the 
American Cancer Society (ACS) estimation, in 2007 a total of 1,444,920 new cancer 
cases are expected in the United States, and 559,650 Americans are expected to die of 
cancer, more than 1,500 people a day (American Cancer Society, 2007). Cancer is the 
second most common cause of death in the US, exceeded only by heart disease. In the 
US, cancer accounts for 1 of every 4 deaths. The three leading cancer types among 
new cancer cases are cancers of the genital system, with 33% prostate cancers in male 
and 31% breast cancers in female, followed by about 13% cancers of lung and 
bronchus, and about 11% cancers of colon and rectum. Diet ranks second only to 
smoking as a leading contributor to cancer incidence and mortality. Data suggest that 
as much as one third (range 20-42%) of all cancer deaths in the United States could be 
avoidable by dietary modification (Doll and Peto, 1981; Willett, 1995).  
 
The federal government’s 2005 Dietary Guidelines for Americans provides 
advice on healthy food choices for
 the population over the age of two and about how a 
proper diet can promote health and reduce the risk of major chronic diseases (USDA, 
2005). The key recommendation about the types and amounts of foods to eat is to 
make smart choices from every food group, and get the most nutrition out of the 
calories consumed. A healthy eating plan from 2005 Dietary Guidelines for Americans 
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emphasizes fruits, vegetables, whole grains, and fat-free or low-fat milk products. 
Fruits and vegetables contain many phytochemicals with positive biological effects, 
including phenolics, flavonoids, isoflavonoids, thiols, carotenoids, ascorbic acid, 
tocopherols, sulforaphane, indoles, isothiocyanates, and glucosinolates, which may 
protect against cancer through a variety of mechanisms. Therefore, the National 
Academy of Sciences of the United States in 1982 had guidelines in their report on 
diet and cancer, strengthening the importance of fruits and vegetables (NAS, 1982). 
The 5-a-Day program launched by National Academy of Sciences in 1989 was 
developed
 as a tool to increase public awareness of the health benefits
 of fruit and 
vegetable consumption and promote adequate intake
 of known vitamins (NAS, 1989). 
However, the median consumption of fruit and vegetables among US adults is
 3.4 
servings/day, and only approximately 23% of US adults consume the recommended
 5 
servings of fruit and vegetables every day (Subar et al., 1995). The majority of adults 
fall well short of meeting the guidelines. Thus, the Dietary Guidelines for Americans 
2005 recommends 9-13 servings of fruits and vegetables daily.  
 
1.2.      Oxidative Stress and Cancer 
1.2.1.  Free radicals: Sources and Reactions 
Normal cellular metabolism is well established as the source of endogenous 
reactive oxygen species (ROS: singlet oxygen, superoxide anion radical, peroxide 
anion, and hydroxyl radical) and reactive nitrogen species (RNS: nitric oxide and 
peroxynitrite), which account for the background levels of oxidative and nitrogen 
damage detected in normal tissue. On the other hand, exposure of normal cells to 
exogenous sources of carcinogens is also known to generate ROS and electrophilic 
stress and has a profound impact on the survival of living organisms. Endogenous 
oxidative events are produced by the Fenton reaction, mitochondrial electron transport, 
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respiratory bursts, oxygenating enzymes, reductive cleavage of peroxides, and 
xenobiotic metabolism. External sources of oxidants include UV radiation, natural 
radioactive gases, environmental pollutants such as automobile and cigarette smoke, 
as well as xenobiotics such as polycyclic aromatic hydrocarbons and phorbol esters. 
Oxidation is a multistage process, and its complexity forms the basis for multiple 
mechanisms of pathogenesis (Ames et al., 1993). Oxidative damage to 
macromolecules such as lipids, DNA, and proteins is an inevitable consequence of 
cellular metabolism, with increased levels following toxic insult.  
 
1.2.2.  Free Radical Defense Systems in Organisms 
Changing the balance between oxidant damage and antioxidant protection 
alters the risks and benefits coming from free radicals. When the level of ROS exceeds 
the antioxidant capacity of the cell, intracellular redox homeostasis is altered and 
oxidative stress ensues (Halliwell, 1999). The crucial issue is to maintain a balance 
between oxidants and antioxidants
 to sustain optimal physiological conditions in the 
body. To prevent
 or slow down the oxidative stress induced by free radicals,
 sufficient 
amounts of antioxidants need to be consumed (Ames et al., 1993). Generally, three 
defense systems exist in the organism to prevent oxidant-caused toxicity and damage, 
including antioxidant enzymes, metal-chelating proteins, and antioxidants (Bourgeois, 
2003). Antioxidant enzymes include superoxide dismutases (SODs), catalase (CAT), 
and glutathione peroxidase (GSH-Px), which are involved in protecting the sites that 
are particularly preventive to oxidative stress. Metal-chelating proteins with 
antioxidant capacity such as transferrin are associated with the Fenton reaction. 
Endogenous antioxidants include vitamin C, vitamin E, and β-carotene. Normally, 
there exists a balance in vivo between the production of ROS and the capacity of the 
endogenous antioxidant defense system. However, endogenous antioxidant defense 
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are usually inadequate to scavenge ROS completely. Disturbance of this balance will 
cause oxidative stress, resulting in cellular damage to macromolecules, which is 
implicated in degenerative diseases (Ames et al., 1993). Dietary phytochemicals have 
been recognized as potentially being involving in the oxidant-antioxidant balance. 
Fruit
 and vegetables contain a wide variety of antioxidants such as phenolics and 
carotenoids that may
 help protect cellular systems from oxidative damage, and thus 
lower
 the risk of chronic diseases.  
 
1.2.3.  Oxidative Stress and Disease 
Overwhelming evidence indicates that oxidative stress can lead to cell, tissue, 
and organ injury, resulting in oxidants- or free radicals-caused diseases such as CVD, 
atherosclerosis, cancer, cataracts, type 2 diabetes, and aging (Ames et al., 1993). Free 
radicals are constantly generated and quenched in our body. In normal metabolism, the 
level of oxidants and antioxidants in humans are maintained in balance, which is 
important for sustaining optimal physiological conditions (Temple, 2000). However, 
in a highly oxidative environment, accumulated long-term damage by free radicals is 
observed. It has been estimated that there are 10,000 damaging hits to DNA per cell 
per day in humans (Ames et al., 1993). It appears that certain phytochemicals such as 
phenolics may chemically retard the pathological processes of chronic diseases caused 
by oxidative stress such as cancer, CVD, autoimmunity, postischemia injury, trauma, 
and aging, which has led to the hypothesis that the consumption of phytochemicals 
may prevent or ameliorate these disease processes.  
 
Much epidemiological data, animal work, and cell culture evidence supports 
the health benefits
 of plant-based foods such as fruit, vegetables, whole grains,
 and 
nuts in the prevention of cancer and cardiovascular disease (CVD) (Block et al., 1992; 
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Joshipura et al., 2001; Hu and Willett, 2002). Updated studies have demonstrated that 
the mechanisms of action of phytochemicals in the prevention of cancer go beyond 
antioxidant activity of scavenging free radicals (Liu 2003). Phytochemicals, especially 
for phenolics, in fruits, vegetables, whole grains, and other plant-based foods can have 
complementary and overlapping mechanisms of action through antioxidant activity 
and scavenging free radicals, chelating metal ions (Liu 2004); inhibition or reduction 
of different enzymes such as telomerase (Naasani et al., 2003), cycloxygenases 
(Laughton et al., 1991), lipoxygenases (Sadik et al., 2003), xanthine oxidase (Van 
Hoorn et al., 2002), and  protein kinases (Agullo et al., 1997); induction of enzyme 
activities in detoxification, oxidation, and reduction; modification
 of platelet activity 
(Dutta-Roy, 2002; Birt et al., 2001), homocysteine concentration (Brattstrom et al., 
1988), and blood pressure (Appel et al., 1997); interaction with signal transduction 
pathways (Wiseman et al., 2001; Spencer et al., 2003), cell receptors (Mueller et al., 
2004), and caspase-dependent pathways (Way et al., 2005); regulation of gene
 
expression in cell proliferation and apoptosis and hormone metabolism; interfering 
with cyclin-dependent regulation of the cell cycle (Fischer and Lane, 2000); inhibition 
of nitrosamine formation; provision of substrate for formation of antineoplastic agents; 
dilution and binding of carcinogens in the digestive tract (Steinmetz and Potter, 1991a); 
and antibacterial and antiviral effects (Dragsted et al., 1993). Convincing evidence 
suggests that a change in dietary
 behavior such as increasing consumption of fruit, 
vegetables,
 and whole grains is a practical strategy for significantly reducing
 the 
incidence of some chronic diseases (Willett 1994). On the other hand, the 
identification of dietary patterns in populations with different disease incidence will be 
useful in understanding the relationship between diet and associated diseases. 
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1.3.  Health Benefits of Fruits and Vegetables 
Epidemiological evidence suggests that dietary phytochemicals present in 
fruits and vegetables can reduce cancer risk. In the first comprehensive review of the 
relation between consumption of fruits and vegetables and cancer, (Steinmetz and 
Potter, 1991a; Steinmetz and Potter, 1991b) concluded that diets rich in fruits and 
vegetables are related consistently to reduced risk for a variety of tumors, especially 
epithelial cancers of the respiratory and gastrointestinal tract (e.g. lung, esophagus, 
stomach, and colon). After investigating approximately 200 studies, (Block et al., 
1992) examined the relationship between
 fruits and vegetables intake and cancers of 
the lung, colon, breast,
 cervix, esophagus, oral cavity, stomach, bladder, pancreas,
 and 
ovary. The consumption of
 fruit and vegetable was found to have a significant 
protective
 effect against different cancers in 128 of 156 dietary studies. The risk of 
cancer for most cancer sites was twice as
 high in persons whose intake of fruit and 
vegetables was low
 compared with those with high intake. Fruit was significantly
 
protective in cancers of the esophagus, oral cavity, and larynx. A protective effect 
from fruits and vegetables was found to be strong for breast cancer. A prospective 
study involving 9959 men and women (age 15–99
 y) in Finland had an inverse 
association between the intake
 of flavonoids and the incidence of all sites of cancer 
(Knekt et al., 1997). Based on the international surveys, World Cancer Research Fund 
(WCRF, 1997) reported that convincing
 evidence supported that high intake of 
vegetables decreases the risk of
 cancers of the mouth and pharynx, esophagus, lung, 
stomach,
 colon, and rectum; that it probably decreases the risk of cancers
 of the larynx, 
pancreas, breast, and bladder; and that it possibly
 decreases the risk of cancers of the 
liver, ovary, endometrium,
 cervix, prostate, thyroid, and kidney. In a cohort study of 
atomic-bomb survivors in Japan, the positive relationship between high consumption 
of vegetables and fruit and lowered risk of bladder cancer was found (Nagano et al., 
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2000). A prospective study performed by (Feskanich et al., 2000) found that higher 
fruit and vegetable intakes were
 associated with lower risks of lung cancer in women 
but not
 in men. A population-based case-control study examined the relationship 
between intake of fruits and vegetables and a reduced risk in breast cancer in woman 
in Shanghai, China (Malin et al., 2003). The pre-menopausal women who ate more 
dark yellow-orange vegetables and more citrus fruits tended to have lower breast 
cancer risk. Increased plasma levels of quercetin
 following a meal of onions were 
accompanied by increased resistance
 to strand breakage by lymphocyte DNA and 
decreased levels of
 some oxidative metabolites in the urine (Boyle et al., 2000). Intake 
of quercetin from onions and apples was found to be negatively correlated with lung 
cancer risk in Hawaii (Le Marchand et al., 2000). Fruit and vegetable consumption 
also appears to have a protective effect against coronary heart disease (CHD) 
(Joshipura et al., 2001). About 84,000 women were followed for 14 years and 42,000 
men were followed for 8 years. It was found that people who ate the highest amount of 
fruits and vegetables had a 20% lower risk for CHD, and the lowest risks were 
observed in people who consumed more green leafy vegetables, and fruits rich in 
vitamin C. In the Zutphen Elderly Study, an approximately 30 mg/day intake of 
flavonoids was associated with around a 50% decreased risk in CHD mortality rate 
compared with individuals who had a less than 19 mg flavonoid/day intake (Hertog et 
al., 1993) In a cohort study of 5,133 men and women aged between 30 and 69 years 
conducted in Finland, onions and apples rich in dietary flavonoids, were related to a 
reduced risk of coronary mortality. People in the highest quartile for apple or onion 
intake showed an approximately 50% reduction in coronary mortality (Knekt et al., 
1996). In a prospective study of 34,492 postmenopausal women in Iowa, flavonoid 
intake was associated with a lowered risk of cardiovascular disease in the group with 
the highest flavonoid intake (Yochum et al., 1999). 
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Compelling support for the involvement of free radicals in chronic disease 
development comes from epidemiological, animal, and cell culture studies showing an 
enhanced antioxidant status is associated with lowered risk for certain diseases. Many 
constituents from fruits and vegetables, including phenolics, flavonoids, vitamins C 
and E, carotenoids, folic acid, and mineral micronutrints, have antioxidant activity, 
contributing to their health promotion properties. The presence of phenolics in fruit 
and vegetables is now being recognized as playing an important role in disease 
prevention, possibly through their effect on oxidative damage beyond antioxidants 
(Heinonen et al., 1998; Record et al., 2001; Liu, 2003). Also, consumption of 
flavonoids in the diet was shown to be inversely associated with morbidity and 
mortality resulted from CHD (Hertog et al., 1993; Knekt et al., 1996). In response to 
oxidative/electrophilic stress, cells initially activate defense mechanisms that lead to 
coordinated
 activation of a battery of defensive genes that protect cells
 against 
oxidative/electrophilic stress. For instance, Induction of phase II enzymes in general 
leads to protection of cells/tissues against exogenous and/or endogenous carcinogenic 
intermediates. Phenolics found in fruits and vegetables are potential phase II enzymes 
inducers.  
A diet high in fruits and vegetables may not only help prevent cancer and heart 
disease, but it may also help protect against a variety of other diseases. For instance, a 
diet high in fruits and vegetables may help protect against Alzheimer disease, 
cataracts, diabetes, and even asthma (Willett, 2002; Woods et al., 2003). It is believed 
that the effect of whole fruits and vegetables tends to be more pronounced than that of 
the individual dietary constituents they provide. This is due mainly to the combination 
of phytochemicals and other dietary constituents in fruits and vegetables.  
 
 
     9
1.4.  Health Benefits of Grapes and Wines 
Grapes, the largest single fruit crop grown in the world, are rich in phenolic 
acids, flavonoids, and resveratrol, which have been suggested to be responsible for the 
health benefits of grapes. At the beginning of the nineties, the ‘French paradox’ 
signified paradigmatically the health benefits due to regular and moderate 
consumption of red wine (Frankel et al., 1993a). That a diet high in saturated fat 
accompanied by regular consumption of red wine is associated with a low risk of CHD 
is called the French paradox (Renaud and Lorgeril, 1992), Lately, it was extensively 
demonstrated that the observed epidemiological relationship between wine intake and 
health benefits was attributable to the red wine phenolics (Kinsella et al., 1993; 
Frankel et al., 1993a). Grapes and wines, especially the skin, seeds, and red wine, are a 
reliable and rich source of phytochemicals, particularly of phenolics, whose individual 
and summated actions are suggested to be responsible for health benefits. 
 
1.4.1. Epidemiological  Evidence 
Epidemiological studies have indicated that red wine protects against many 
diseases including cancer (Kimura et al., 1983; Jang et al., 1997; Clement et al., 1998; 
Das et al., 1999; Pendurthi et al., 1999; Hsieh et al., 1999a; Banerjee et al., 2002). 
Grapes and wines are rich in dietary flavonoids. Consumption of flavonoids was 
shown to be inversely associated with morbidity and mortality resulted from cancers 
and CHD (Hertog et al., 1993; Knekt et al., 1996; Knekt et al., 1997). A case-control 
study showed that increased consumption of grapes is associated with reduced risk of 
cancer (Zheng et al., 1993). In another case-control study, (Freudenheim et al., 1995) 
found that a lowered risk of breast cancer in western New York was associated with 
wine intake.  
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Epidemiological evidence from various populations around the world supports 
the ideas that moderate wine consumption is associated with increased longevity and 
reduced atherosclerotic mortality (St. Leger et al., 1979; Langer et al., 1992; Gronbeak 
and Sorensen, 1996; Rimm, 1996; Gronbeak, 1997; Criqui, 1998; Wannamethee and 
Shaper, 1999). A strong negative association between wine consumption and CHD 
mortality in eighteen developed countries was observed (St. Leger et al., 1979). The 
Danish study examined more than 13,000 men and women with age from 30 to 70 to 
look at the health benefits of wine and other types of alcoholic beverages (Gronbaek et 
al., 1995). It showed that people who drank only wine as an alcohol source had 50% of 
the risk of dying of people who never consumed wine after a 12-year heart study, and 
drinking other types of alcoholic beverages lacked benefits.  
 
 
1.4.2.  In Vitro and In Vivo Studies  
1.4.2.1. Antioxidant Activity 
Grapes and wines, especially grape seeds and red wines, have been found to 
have potent antioxidant activity. The antioxidant effects of grape phenolics were 
determined in a number of different systems (Kanner et al., 1994). It was concluded 
that effective antioxidants were found in all grape varieties, which corresponded to the 
concentration of phenolics in the system. The antioxidant activity of red grapes has 
been correlated with the phenolics and/or flavonoid content (Teissedre et al., 1996; 
Meyer et al., 1997; Mayer et al., 2001). In vitro oxidation positively correlated with 
the content of total phenolics, anthocyanins, and flavonols after investigation of 
phenolic extracts from fourteen different types of fresh grapes. Red wine is a 
concentrated source of dietary phenolic acids and flavonoids. Paganga et al. (1999) 
calculated that the antioxidant activity in 1 glass of red wine (150 mL) was equivalent 
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to that found in 12 glasses of white wine, 2 cups of tea, 5 apples, 5 (100-g) portions of 
onion, 500 mL of beer, or 7 glasses of orange juice.  
 
A positive correlation has been observed between the antioxidant activity of 
wine and RSV level (Alonso et al., 2002). RSV has been shown to possess a stronger 
1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azinobis(3-ethylbenzthiazoline-6-sulfonic 
acid) (ABTS), and hydroxyl radical-scavenging capacity than propyl gallate, vitamin 
E, and vitamin C (Soares et al., 2003).  
 
Anthocyanins possess antioxidant capacity, and this is an important 
physiological function (Rice-Evans et al., 1995; Van Acker et al., 1996; Satué-Gracia 
et al., 1997; Wang et al., 1999; Degenhardt et al., 2000; Espin et al., 2000; Ehlenfeldt 
and Prior, 2001; Kalt et al., 2001; Connor et al., 2002; Moyer et al., 2002). There was 
a positive correlation between anthocyanin content and antioxidant activities of red 
grape extracts (Meyer et al., 1997), grape juices (Frankel et al., 1998), and red wines 
(Burns et al., 2000). Consumption of an anthocyanin-repleted diet in rats significantly 
improved (p < 0.01) plasma antioxidant capacity and decreased (p < 0.001) vitamin E 
deficiency-enhanced hydroperoxides and 8-oxo-deoxyguanosine concentrations in 
liver (Ramirez-Tortosa et al., 2001). Cyanidin 3-O-β-D-glucoside (C3G) functions as 
a potent antioxidant under oxidative stress in rats (Tsuda et al., 2000). Cyanidin-DNA 
copigmentation might be a possible defense mechanism against oxidative damage of 
DNA and may have in vivo physiological function attributable to the antioxidant 
ability of anthocyanins (Sarma and Sharma, 1999). It was found that antioxidant 
capacity of proanthocyanidins from grape seed is 20 times greater than vitamin E and 
50 times greater than vitamin C (Uchida, 1980). 
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1.4.2.2. Antiproliferative Activity 
Grapes and wines are rich source of RSV, being found to inhibit cellular events 
related to initiation, promotion, and progression of carcinogenesis both in vitro and in 
vivo models, including breast cancer (Gehm et al., 1997; Clement et al., 1998; 
Mgbonyebi et al., 1998; Subbaramaiah et al., 1998; Schneider et al., 2000; Ahmad et 
al., 2001; Soleas et al., 2001; Waffo-Teguo et al., 2001; Pozo-Guisado et al., 2002); 
prostate cancer (Hsieh and Wu, 1999; Mitchell et al., 1999; Hsieh and Wu, 2000; 
Kampa et al., 2000; Narayanan et al., 2002); liver cancer (Ciolin et al., 1998; Carbó et 
al., 1999; De Ledinghen et al., 2001; Sun et al., 2002b); Colorectal and intestinal 
cancers (Schneider et al., 2000; Wolter et al., 2001; Delmas et al., 2002; Wolter et al., 
2002); skin cancer (Jang and Pezzuto, 1999; Soleas et al., 2002; Adhami et al., 2003); 
lung cancer (Hecht et al., 1999; Kimura and Okuda, 2001 ); blood cancer (Surh et al., 
1999; Gautam et al., 2000; Dörrie et al., 2001; Gao et al., 2002; Tsan et al., 2002); and 
thyroid cancer (Shih et al., 2002). RSV functions as antiproliferative activities in a 
dose-dependent manner (Jang et al., 1997; Lu and Serrero, 1999).  The 
antiproliferative activity of RSV was observed in a number of cancer cell lines and 
may be due partly to the induction of apoptosis (Surh et al., 1999; Ding and Adrian, 
2002; Joe et al., 2002), and to the arrest of the cell cycle (Wolter et al., 2002; Larrosa 
et al., 2004; Castello and Tessitore, 2005). The molecular mechanisms associated with 
the anti-proliferative effects in cancer cells involve the activation of p53 (Huang et al., 
1999), suppression of nuclear factor-κB (NF-κB) (Banerjee et al., 2002), and activator 
protein-1 (AP-1) (Kundu et al., 2004). The antiproliferative activities of RSV may also 
be explained by the direct inhibition of ribonucleotide
 reductase through efficiently 
scavenging the tyrosyl radical of the small protein, which supplies proliferating cells 
with deoxyribonucleotides required for DNA synthesis (Reichard, 1987; Fontecave et 
al., 1998; Schneider et al., 2000). RSV has
 also been found to inhibit DNA polymerase 
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(Sun et al., 1998), and ornithine
 decarboxylase, a key enzyme of polyamine 
biosynthesis that is
 enhanced in cancer growth (Schneider et al., 2000). The effects of 
RSV in breast cancer cell lines
 are inconsistent. For instance, it was found that RSV 
enhances MCF-7 cell growth (Basly et al., 2000), and induced growth inhibition, S-
phase arrest, apoptosis, and changes in biomarker expression in HL-60, SW-480, 
HCE-7, Seg-1, Bic-1, and MCF-7 human cancer cell lines (Joe et al., 2002). On the 
other hand, RSV was reported to slow down the proliferation of several human 
malignant cell lines (Della Ragione et al., 1998; Hsieh et al., 1999a). RSV induced 
significant dose-dependent inhibition in human oral squamous carcinoma cell (SCC-
25) growth and DNA synthesis, and decreased viability and DNA synthesis capability 
of human promyelocytic leukemia (HL-60) cells through an induction of apoptosis by 
the Bcl-2 pathway (Surh et al., 1999). After investigation of the effect of RSV on 
growth, induction of apoptosis, and modulation of prostate-specific gene expression in 
DU-145, JCA-1 and PC-3 human CaP cells, Hsieh and Wu’s study (1999) suggested 
that RSV negatively modulates CaP cell growth by affecting mitogenesis and inducing 
apoptosis. RSV might be responsible for the growth inhibition of LNCaP cells by 
modulation of multiple signaling pathways (Narayanan et al., 2002). Potter et al. 
(2002) have suggested that the antiproliferative activities of RSV on cancer cells is the 
consequence of its conversion to piceatannol by CYP1B1. After inoculation into mice, 
the trans-RSV-3-O-D-glucoside (piceid) also inhibited the proliferation of Lewis lung 
carcinoma (LLC) cells, but only at a concentration of 1000 μM, while 2,3,5,4'-tetra-
hydroxystilbene-2-O-D-glucoside was more effective with an IC50 of 81 μM. They 
concluded that the antitumor and antimetastatic activity of the stilbene glucosides, 
piceid and 2,3,5,4'-tetra-hydroxystilbene-2-O-D-glucoside might be due to inhibition 
of DNA synthesis in LLC cells and angiogenesis of human umbilical vein endothelial 
cells (Kimura and Okuda, 2001). It was also reported that pterostilbene, a natural 
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methoxylated analog of RSV, suppressed the development of mammary lesions with 
an ED50 of 4.8 μM in a mouse mammary gland organ culture (Rimando et al., 2002). 
 
Cyanidin, pelargonidin, and delphinidin showed antiproliferative activity in 
two estrogen-dependent human breast cancer cell lines (MCF-7 and BG-1), but not in 
the estrogen receptor-negative MDA-MB-231 cell line (Schmitt and Stopper, 2001). 
Cyanidin and delphinidin contribute to the potent inhibitors of the epidermal growth-
factor receptor and were found to inhibit the growth of human vulva carcinoma cell 
line A431 in vitro (Meiers et al., 2001).  
 
1.4.2.3. Inhibition of Lipid Oxidation 
The oxidation of low-density lipoproteins (LDL) is an important event in the 
development of atherosclerosis. Several studies have indicated that grape, wine, and 
grape seed extracts inhibit the LDL oxidation (Mangiapane et al., 1992; Frankel et al., 
1993a; Frankel et al., 1995; Teissedre et al., 1996). Frankel et al. (1993b) were first to 
demonstrate that trans-RSV reduced the copper-catalyzed oxidation of human LDL. In 
vivo, RSV blocked copper-catalyzed LDL oxidation in healthy human subjects by 
70% and 81%, respectively. RSV was demonstrated to inhibit ROS production and 
lower lipid peroxidation, though not to the extent achieved by vitamin C, in blood 
platelets (Olas and Wachowicz, 2002). RSV has been also found to inhibit copper-
initiated and, to a lesser extent, 2,2'-azobis (2-amidinopropane) dihydrochloride 
(AAPH)-initiated oxidation of porcine LDL (Belguendouz et al., 1997; Frémont et al., 
1999). LDL peroxidation was blocked better by RSV than by a phenolic extract from 
red wine. The effect of wine extracts, after 1,000 times dilution, in inhibiting the 
oxidation of isolated human LDL far exceeded that of the vitamin C and E (Frankel et 
al., 1993b). The effects of pretreatment with the anthocyanins (delphinidin, cyanidin, 
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and their glycoside and rutinoside derivatives) on induction of DNA damage were 
evaluated in rat smooth muscle and in rat hepatoma cell lines using the Comet test 
(Lazzé et al., 2003). The results showed that anthocyanins were effective against 
cytotoxicity, DNA single strand breaks formation and lipid peroxidation induced by 
tert-butyl-hydroperoxide. 
 
1.4.2.4. Inhibition of Platelet Aggregation 
The accepted mechanism of cardioprotection by phenolics from grapes and 
wines is inhibition of platelet aggregation. Quercetin, the predominant flavonoid in 
grape, suppressed platelet aggregation in vitro (Chung et al., 1993), and lowered 
thromboxane synthesis in vivo (Tzeng et al., 1991). RSV was also reported to be an 
inhibitor of platelet aggregation (Bhat et al., 2001a). RSV blocks adenosine 
diphosphate (ADP), collagen, and thrombin-stimulated human platelet aggregation in 
vitro (Wang et al., 2002). Pretreatment of platelets with RSV was found to inhibit 
lipopolysaccharide (LPS) and LPS plus thrombin-stimulated platelet adhesion to 
collagen and fibrinogen in a nondose-dependent pattern (Olas and Wachowicz, 2002). 
RSV supplementation decreased rate of platelet aggregation in rabbits when fed with a 
high cholesterol diet (Dobrydneva et al., 1999). The prevention of calcium influx 
through the storage operated calcium channels has been suggested as a target for RSV 
inhibiting thrombin-induced platelet aggregation. RSV was also observed to have 
vasorelaxation properties. RSV might mediate vasorelaxation in endothelium-intact 
and endothelium-independent aortic rings via both nitric oxide-dependent and -
independent mechanisms (Chen and Pace-Asciak, 1996). The release of NO
. has been 
suggested as a mechanism for the reduction of ischemia-reperfusion injury in rat 
hearts after RSV treatments (Bradamante et al., 2003). The effects of extracts of grape 
seed (GSD) and grape skin (GSK) on collagen-induced whole blood platelet 
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aggregation (PA) were examined in vitro (human platelets) and ex vivo (dog platelets) 
(Shanmuganayagam et al., 2002). The results suggest that the components of GSD and 
GSK, when present in combination as in red wine, grape juice or in a commercial 
preparation containing both extracts, have a greater antiplatelet effect than when 
present individually.  
 
The inhibition of platelet aggregation by grapes and wines was also 
demonstrated in animal and human studies. A study (Bagchi et al., 1998) indicated 
that grape seed proanthocyanidin extract showed higher protective effects than vitamin 
E, C, vitamin E plus C, and β-carotene against 12-O-tetradecanoylphorbol-13-acetate-
induced lipid peroxidation and DNA fragmentation in liver and brain tissues, as well 
as against the production of free radicals in peritoneal macrophages of mice. Studies 
(Osman et al., 1998; Folts, 2002) showed that 5 ml/kg of red wine or 5-10 ml/kg of 
purple grape juice but not orange or grapefruit juice inhibited platelet activity, and 
protected against epinephrine activation of platelets in the dog, monkey, and humans. 
In a study of feeding subjects with 7mL/kg body weight/day for 14 days, whole juice 
from purple grapes decreased platelet aggregation, increased platelet-derived nitric 
oxide release, and suppressed superoxide production (Freedman et al., 2001). After 
Concord grape juice was given orally (10 mL/kg/day) to subjects, serum antioxidant 
capacity was increased, and LDL oxidation deceased similarly to that from 400 IU α-
tocopherol per day (O'Byrne et al., 2002). 
 
1.4.2.5. Anti-inflammatory Activity 
The anti-inflammatory activity may be partially responsible for the 
chemopreventive and cardioprotective effects of phenolics present in grapes and 
wines. RSV non-competitively inhibited the activity
 of cyclooxygenase-1 (COX-1) in 
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a dose-dependent manner (Shin et al., 1998). In comparison to non-steroidal anti-
inflammatory drugs such as aspirin
 and piroxicam, RSV also suppressed COX-1 
hydroperoxidase activity
 and, to a lesser extent, cyclooxygenase-2 (COX-2) 
hydroperoxidase activity (Jang et al., 1997). RSV decreased the expression of COX-2 
both in in vitro and in vivo models. It significantly decreased elevated levels of PGD2 
in rats (Martín et al., 2004), while it dose-dependently inhibits induced production of 
PGE2 in human peripheral blood leukocytes in vitro (Richard et al., 2005). It was 
observed that RSV lowered induced-COX-2 activity by inhibiting expression of the 
enzyme via signal transduction pathways (Kundu et al., 2004), and blocked the 
inflammatory actions of cytokines, such as tumor necrosis factor-α (TNF-α) and 
interleukin-1β (IL-1β) (Culpitt et al., 2003). RSV also inhibited induced COX-2 
activity via targeting the protein kinase C (PKC) signal transduction pathway in 
human breast epithelial cells, blocking the translocation of PKC into the membrane 
(Subbaramaiah et al., 1998). Pterostilbene exhibited moderate inhibition of COX-1 
with an IC50 of 19.8 μM, and was weakly active against COX-2 with an IC50 of 83.9 
μM, whereas RSV strongly inhibited both isoforms of the enzyme with IC50 values of 
approximately 1 μM (Rimando et al., 2002). Anthocyanins present in grapes have 
been also reported to be anti-inflammatory (Wang et al., 1999). 
 
1.4.2.6. Phytoestrogenic Activity 
Some phenolics from grapes have a phytoestrogen effect. Typically, RSV has 
been categorized as a phytoestrogen: it is a partial estrogen receptor agonist at low 
levels; it antagonizes the growth-stimulatory effect of E2 at higher doses in the 
presence of 17-β-estradiol (E2) (Lu and Serrero, 1999). The estrogenic properties of 
RSV appear to vary in cell lines. RSV can stimulate estrogen-regulated progesterone 
receptor (PR) expression in MCF-7 cells (Gehm et al., 1997; Lu and Serrero, 1999; 
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Bhat et al., 2001b). It showed a superagonist activity by inducing gene activity 2- to 3-
fold more than estradiol, while it exhibited superagonist activity in MVLN cells, an 
estrogen-dependent MCF-7 cell line (Basly et al., 2000). Conversely, RSV has been 
observed to have no superagonist activity (Bhat et al., 2001b), and demonstrated anti-
estrogenic activity, through estradiol-induced gene expression inhibition, in the MCF-
7 cell line (Lu and Serrero, 1999). In MCF-7, T47D, LY2, and S30 mammary cancer 
cell lines, RSV functioned as an agonist in the MCF-7 and the S30 cell lines, while 
antagonizing estrogen activity in T47D and LY2 cells (Bhat et al., 2001b). Bhat and 
Pezzuto (2001) also reported the anti-estrogenic activity of RSV in human endometrial 
adenocarcinoma (Ishikawa) through the supression of PR expression, estradiol-
induced alkaline phosphatase activity, and an estrogen receptor-mediated reporter 
gene. 
 
1.4.2.7. Effects on the Cell Cycle and Apoptosis 
Inhibition of cell cycle progression is a possible target for chemopreventive 
agents like phenolics. The effect of RSV on the cell cycle in tumor cells occurs at the 
S phase (Bellofernandez et al., 1993; Hsieh et al., 1999a; Schneider et al., 2000; 
Ahmad et al., 2001; Park et al., 2001; Wolter et al., 2001; Joe et al., 2002; 
Kuwajerwala et al., 2002; Estrov et al., 2003). However, a G1 phase arrest could also 
be observed in HepG2 cells (Kuo et al., 2002). RSV arrests stellate cells in G1-phase 
by selectively
 reducing the level of cyclin D1 (Kawada et al., 1998), and induces 
apoptotic cell death in HL-60 cells, particularly in cells arrested in the G0/G1 phase 
(Surh et al., 1999), which was linked
 to a decrease in the expression of the anti-
apoptotic oncoprotein, Bcl-2. However, a RSV-induced arrest of HL-60 cells
 at the 
S/G2 phase transition and a subsequent increase in the
 number of cells in the G1/S 
phases have also been observed (Ragione et al., 1998), which was attributed to an 
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increase in cyclins A
 and E and inactive cdc2, without any modification of p21
WAF/CYP1 
expression. Similar to RSV, piceatannol is also a cell cycle inhibitor that functions in 
the S phase. The suppression effect of RSV on normal cell growth is accompanied by 
the accumulation
 of cells in the S and G2 phases (Hsieh et al., 1999b). 
 
Apoptosis, programmed cell death, is necessary for the maintenance of normal 
tissue homeostasis. Phenolics in grapes and wines are able to induce cell death both in 
vitro and in vivo. RSV has been reported to induce apoptosis in a number of cell lines 
(Carbó et al., 1999; Hsieh et al., 1999a; Adhami et al., 2001; Wolter et al., 2001; Joe et 
al., 2002; Kim et al., 2003; Liontas and Yeger, 2004; Scifo et al., 2004). On the other 
hand, RSV supressed oxidative-induced apoptosis in a variety of cell lines, including 
Swiss 3T3 mouse fibroblasts (Kutuk et al., 2004), rat pheochromocytoma (PC12) 
(Jang and Surh, 2001), human peripheral blood mononuclear (PBM) (Losa, 2003), and 
human retinal pigment epithelium (RPE) cells (King et al., 2005). The apoptosis 
induced by RSV is accompanied by induction of p53, activation of caspase 9, 
upregulation of Bax, and a decrease in Bcl-2 levels (Kim et al., 2004). RSV-induced 
apoptosis coincides with the enhancement of CD95L (Fas L) expression
 and 
preferentially targets CD95 (Fas, APO-1) high-expressing
 cells (Clement et al., 1998). 
RSV-induced cell death
 is consequently tumour-specific and involves the CD95–
CD95L
 system as the apoptotic trigger, suggesting that
 this system could activate a 
series of intracellular events
 culminating in the death cascade. RSV shows anti-
leukaemic activity against some mouse
 and human cell lines by irreversibly inhibiting 
cell proliferation
 and inducing apoptosis (Gautam et al., 2000). In acute lymphoblastic 
leukemia cell lines, depolarization of mitochondrial membranes and activation of 
caspase 9 could be observed after treatment with RSV (Dörrie et al., 2001). In a 
human colon cancer cell line (SW480), Delmas et al. (2003) found that the apoptosis 
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induced by RSV was not mediated directly through modulation of Fas/FasL 
interaction, but was attributable to caspase activation and increased accumulation of 
Bax and Bak. In human prostate carcinoma cells (DU145), RSV upregulated Bax 
protein and mRNA expression in a dose-dependent manner, whereas Bcl-2 and Bcl-xL 
levels were not significantly affected (Kim et al., 2003). The tumor suppressor p53-
deppendent pathway is involved in the induction of apoptosis in HepG2 cells (Kuo et 
al., 2002) and JB6 mouse epidermal cells (Huang et al., 1999) after treatment with 
RSV. In thyroid cancer cells, RSV-induced cell death was blocked by addition of the 
p53 inhibitor pifithrin-α or by transfection of a p53 antisense oligonucleotide (Shih et 
al., 2002). Piceatannol has been also exhibited to be a potent inducer of apoptosis in 
human SK-Mel-28 melanoma cells (Larrosa et al., 2004). 
 
1.4.2.8. Effects on the Signal Transduction 
Phenolics in grapes and wines are able to target signal transduction pathways, 
and further act with different biological effects. Mitogen-activated protein kinase 
(MAPK) pathways, including p38, c-Jun N-terminal protein kinase (JNK), and 
extracellular signal-regulated kinase (ERK), are well-characterized mammalian signal 
transduction pathways (El-Mowafy and White, 1999). MAPKs convert extracellular 
signals into intracellular events. Activator protein-1 (AP-1) is a dimeric transcription 
factor and is responsible for modulating the expression of several tumor-promoting 
genes (Kundu et al., 2004). The interaction between RSV and signal transduction 
pathways may explain many of the beneficial effects of RSV. TNF-α-induced JNK, 
AP-1, and MEK (MAPK kinase) activation were inhibited by pretreatment with RSV 
in U937 lymphoma cells (Manna et al., 2000). The modulation of ERK signaling by 
RSV is suggested to play an important role in angiotensin II (Ang II)–induced 
proliferation and ET-1 gene expression in rat aortic smooth muscle cells (Chao et al., 
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2005). In porcine coronary arteries RSV was found to inhibit the induced activation of 
p38, JNK1, and ERK1/2 by endothelin-1 (ET-1) (El-Mowafy and White, 1999). RSV 
has been reported to target MEK, and ERK activation in the inhibition of cardiac 
fibroblast mitogenic signaling, proliferation, and differentiation into myofibroblasts 
(Olson et al., 2005).  
 
The anticancer properties of RSV are due partly to activation of p53 and 
inhibition of NF-κB and AP-1 through suppressing signaling cascades. RSV could  
induce apoptosis in wild-type p53 mouse fibroblast cells, but was not able to induce 
apoptosis in p53-deficient fibroblast cells (Huang et al., 1999). It was observed that 
RSV-induced apoptosis and p53 activation (via phosphorylation) are mediated by the 
ERK and p38 pathways (She et al., 2001; Lin et al., 2002).  
 
AP-1 is also provided as a potential target for RSV. Induced AP-1 activity in 
human cervical squamous carcinoma (HeLa) cells using 12-myristate 13-acetate 
(PMA), and ultraviolet light-C (UV-C) was reported (Yu et al., 2001). PMA was a 
strong activator of the ERK1/2 pathway, while UV-C activated the MAPK pathways. 
This study showed that RSV suppressed both PMA-induced and UV-C-induced AP-1 
activity. Through the inhibition of AP-1 activity and ERK phosphorylation, topical 
application of RSV to mouse skin was found to be able to inhibit TPA-induced COX-2 
expression (Kundu et al., 2004).  
 
Piceatannol acts as an inhibitor of protein-tyrosine kinase activity of p72
Syk and 
p56
Lck in lymphoid cells (Geahlen and Mclaughlin, 1989), and inhibits the focal 
adhesion kinase and Src in thrombocytes (Law et al., 1999), and the tyrosine kinase 
activity of human placenta (Palmieri et al., 1999). Banerjee et al. (2002) observed that 
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RSV decreased mammary tumor incidence, tumor number, and extended cancer 
latency in female Sprague - Dawley rats by inhibiting the expression of NF-κB, COX-
2, and matrix metalloprotease 9 enzyme. Although the mechanisms by which RSV 
suppresses NF-κB activation remains uncertain, it was found that RSV inhibited TNF-
induced NF-κB activation by blocking phosphorylation and nuclear translocation of 
the NF-κB subunit p65 (Manna et al., 2000), and by preventing NF-κB DNA binding 
and inhibiting IκB kinase (IKK) activity via  an upstream signaling component 
(Holmes-McNary and Baldwin, 2000).  
 
Recently, it was reported that anthocyanidins directly cause human 
promyelocytic leukemia cells (HL-60) to generate intracellular hydrogen peroxide, 
and trigger apoptosis, possibly through an oxidative stress-involved JNK signaling 
pathway. It was observed that delphinidin stimulates JNK pathway activation 
including JNK phosphorylation and c-jun gene expression, and activates caspase-3 
(Hou et al., 2003).  
 
1.4.2.9. Other Health Effects 
Using Tg2576 mice to model Alzheimer's disease (AD)-type amyloid beta-
protein (Abeta) neuropathology, it was tested if moderate consumption of the red 
wine, Cabernet Sauvignon, modulates AD-type neuropathology and cognitive 
deterioration (Wang et al., 2006). The results showed that Cabernet Sauvignon 
significantly attenuated AD-type deterioration of spatial memory function and Abeta 
neuropathology in Tg2576 mice relative to control, supporting epidemiological 
evidence that moderate wine consumption may help reduce the relative risk of AD 
clinical dementia. RSV administrated to male Wistar rats resulted in a significant 
decrease in tumor cell content after inoculated with Yoshida AH-130 ascites hepatoma 
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tumors, which was linked to a G2/M phase arrest and apoptosis (Carbó et al., 1999). 
Recently, it was observed that daily oral administration
 of trans-RSV to adult male rats 
enhanced sperm production
 by stimulating the hypothalamic-pituitary-gonadal axis 
(Juan et al., 2005). The estrogenic activity of RSV may help prevent bone loss in post-
menopausal women. RSV was shown to increase the proliferation of osteoblastic 
MC3T3-E1 cells and induce alkaline phosphatase activity, an enzyme believed to be 
involved in bone mineralization (Mizutani et al., 1998). Ovariectomized rats treated 
with RSV have been ovserved to exhibit significantly greater femur bone length, 
epiphysis bone mineral density, and bone calcium content than ovariectomized rats 
without treatment (Liu et al., 2005). 
 
 
1.5.  Phytochemicals in Grapes and Wines  
Phytochemicals, an array of bioactive nonnutrient compounds
 in fruits, 
vegetables, whole grains, wine, tea, extra virgin olive oil, chocolate and other cocoa 
products, as well as other plant-based foods, have
 been related to reductions in the risk 
of major chronic diseases. It is estimated that over 5,000 phytochemicals have been 
identified (Shahidi and Naczk, 1995), but a large proportion still remain unknown and 
need to be characterized before their health benefits can be completely understood. 
Generally, phytochemicals can be classified as alkaloids, carotenoids, phenolics,
 
nitrogen-containing compounds, and organosulfur compounds (Figure 1.1) (Liu 2004). 
Phenolics constitute one of the largest and most ubiquitous groups of phytochemicals. 
They can be divided into more than ten types based on their chemical structure 
(Strack, 1997). There are thousands of identified phenolic structures that vary from 
simple compounds such as phenolic acids with a C6 ring structure to highly 
polymerized molecules such as tannins. Phenolics share a common chemical structure 
     24
and differ
 in their linkages to other compounds. All phenolics possess an aromatic ring 
bearing one or more hydroxyl groups. The
 majority of phenolics have a sugar residue 
such as a monosaccharide, disaccharide, or oligosaccharide linked to the carbon
 
skeleton.
 Other residues include amines, organic acids, carboxylic
 acids, and lipids. 
 
Grapes contain a large array of bioactive phytochemicals. The main 
phytochemicals in grape (Vitis vinifera) arise from acetyl-CoA and shikimic acids. 
Phenolic acids, flavonoids, stilbenes, and proanthocyanidins are biosynthesized 
through the phenylpropanoid pathway (Kurkin, 2003). Grapes are rich in phenolics; 
most of them are present in the peel. Phenolics in grape are generally classified into 
two groups: the flavonoids and nonflavonoids. The flavonoids include flavan-3-ols, 
flavonols, and anthocyanins. The nonflavonoids encompass phenolic acids and 
stilbenes. In the grape berry, the flavonoids are mainly localized in the skins, such as 
the anthocyanins, while the flavan-3-ols are present both in the skins and seeds. 
However, the composition and concentration of phenolics in grapes vary with variety, 
species, season, and environmental and management factors such as soil conditions, 
climate, and crop load (Jackson and Lombard, 1993).  
 
1.5.1. Phenolic  Acids 
The most common phenolic acids occurring in Vitis are usually divided in two 
main groups (Figure 1.2): benzoic acid derivatives, comprising 7 carbon atoms (C6-
C1) and cinnamic acid derivatives, containing 9 carbon atoms (C6-C3). These 
compounds are present predominantly in the hydroxylated form, therefore being 
generally named hydroxybenzoic and hydroxycinnamic acids, respectively. Natural 
phenolic acids in grapes, either occurring in the free or conjugated forms, generally 
appear as esters or amides (Fiuza et al., 2004). Benzoic acid derivatives are a minor 
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component in new wines. Hydroxycinnamic acid derivatives are the major phenolics 
in grape juice and white wine. Three common hydroxycinnamic acid derivatives in 
grapes and wine are caftaric acid (caffeic acid), coutaric acid (coumaric acid), and 
fertaric acid (ferulic acid).  
 
1.5.2.  Flavonoids 
Flavonoids are present in plants and have been studied extensively in fruits, 
vegetables, whole grains, legumes, nuts, olive oil, tea, and wine. This group contains 
over 8,000 known compounds, and this number is constantly growing due to the great 
structural diversity arising from various hydroxylation, glycosylation, methoxylation, 
and acylation (Rice-Evans and Packer, 2003). The generic structure
 of flavonoids 
consists of two aromatic rings (A and B rings) linked by 3
 carbons that are usually in 
an oxygenated heterocycle ring called C ring (Figure 1.3). Based on differences in the 
heterocycle C ring, flavonoids (Figure 1.4) are categorized as flavonols (quercetin, 
kaempferol, and myricetin), flavones (luteolin and apigenin),
 flavanols (catechins, 
epicatechin,
 epigallocatechin, epicatechin gallate, and epigallocatechin
 gallate), 
flavanones (naringenin), anthocyanidins, and isoflavonoids (genistein, daidzein, 
dihydrodaidzein, and equol) (Liu 2004). For naturally occurring flavonoids, they are 
mostly conjugated
 in glycosylated or esterified forms but can occur as aglycones,
 
especially as a result of the effects of food processing (Hollman and Arts, 2000). 
Anthocyanins, widely distributed throughout the plant kingdom, are natural, nontoxic, 
and water-soluble flavonoid pigments, being particularly common in fruits and 
vegetables where they are responsible for the red, orange, blue, and purple colors. The 
anthocyanins themselves are subdivided into the sugar-free anthocyanidine aglycons 
and and the anthocyanin glycosides. The aglycone is referred to as an anthocyanidin. 
There are 6 commonly occurring anthocyanidin structures (Figure 1.5). However, 
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anthocyanidins are rarely found in plants - rather they are almost always found as the 
more stable glycosylated derivatives, referred to as anthocyanins. These pigments act 
as powerful antioxidants helping to protect the plant from radicals formed by UV light 
and during metabolic processes. Absorption of anthocyanins appears to be much
 less 
than that of the flavonol quercetin, perhaps as little
 as one out of ten (Prior, 2003). 
Catechins are ubiquitous in plant-based foods, being particularly important in a large 
number of fruits, vegetables, and legumes, and occur in beverages such as red wine 
and tea (Arts et al., 2000). It is estimated
 that flavonoids account for nearly 60% of the
 
phenolics in our diet and the remaining 30% are from phenolic
 acids. 
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Figure 1.1. Classification of dietary phytochemicals (modified from Liu, 2004) 
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1) Benzoic  Acid 
 
 
R1
R2
R3
COOH
 
Substitutions  Benzoic acid  
Derivatives  R1 R2 R3
p-Hydroxybenzoic acid  H  OH  H 
Protocatechuic acid  H  OH  OH 
Vanillic acid  OCH3 OH H 
Syringic acid  OCH3 OH OCH3
Gallic acid  OH  OH  OH 
 
 
 
 
 
 
2) Cinnamic  Acid 
 
R1
R2
R3
CH CH COOH
 
 
Substitutions  Cinnamic acid   
Derivatives  R1 R2 R3
p-Coumaric acid  H  OH  H 
Caffeic acid  OH  OH  H 
Ferulic acid  OCH3 OH H 
Sinapic acid  OCH3 OH OCH3
 
 
Figure 1.2. Structures of common phenolic acids: 1) benzoic acid derivatives; 2) 
cinnamic acid derivatives. 
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Flavonoids in grapes and wines are primarily categorized
 into flavonols, 
flavones, flavanols, flavanones, and anthocyanidins. Flavonols are the most abundant 
class of flavonoids in grapes and wine, and they are found in the seed and skin in the 
grape. These are often specifically called the flavan-3-ols to identify the location of 
the hydroxy group on the C ring. Colorless flavanols contain catechin and epicatechin, 
the monomeric units of proanthocyanidins, whereas colored flavanones include 
quercetin, and anthocyanins are pigments responsible for grape and wine color 
(Iwashina, 2000; Shi et al., 2003). Proanthocyanidins, also known as condensed 
tannins, are characterized by a polymerization degree (PD) ranging mainly between 3 
and 11, up to 17 and more (Iriti and Faoro, 2006).  
 
Catechin belongs to flavan-3-ols, which are the most reduced form of the 
flavonoids. Trans and cis forms are found in grapes. The trans from is (2R,3S) (+)-
catechin and the cis form is (2R,3R) (−)-epicatechin. Catechin and epicatechin are 
empimers, with (+)-catechin and (-)-epicatechin being the most common optical 
isomers found in nature (Figure 1.6). Epigallocatechin (EGC) and gallocatechin 
(GC)contain an additional phenolic hydroxyl group when compared to epicatechin and 
catechin, respectively. Catechin gallates are gallic acid esters of the catechins; such as 
epigallocatechin gallate (EGCG), which is commonly the most abundant catechin in 
tea. EGC is found in grape skin, but GC is not found in significant amounts. The 
monomeric catechins are bitter and astringent. 
 
Quercetin is a flavonol, which are always found in a glycoside form in plants 
including in grape berries where it is found in grape skin. There are three forms of the 
simple flavonoid aglycones in grapes: quercetin, myricetin (3'4'5' trihydroxy), and 
kaempferol (4' hydroxy) (Figure 1.6). 
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Anthocyanins provide the red and blue colors found in the skins of red or black 
grapes, and also provide the color in red wine. The five basic anthocyanidins in wine 
are cyanidin, peonidin, delphindin, petunidin and malvidin (Wrolstad, 2000). It is 
estimated that approximately 10,000 tons of anthocyanins from black grapes are 
consumed annually (Walford, 1980). The anthocyanins are a part of the flavonoid 
group of compounds that are characterized by the flavylium nucleus (Figure 1.5). The 
anthocyanin molecule consists of two or three portions: the aglycone base on the 
flavylium nucleus, a group of sugars, and a group of acyl acids. The common 
aglycones are listed in Figure 1.5. V. vinifera may contain up to 17 pigments 
(Riberau-Gayon, 1982). They are the 3-monoglucosides of cyanidin, peonidin, 
malvidin, petunidin, and delphinidin, and the same compounds acylated with acetic, 
coumaric, or caffeic acid. The anthocyanins in V. Labrusca contain the 
monoglucosides and diglucosides acylated with the above acids, in different 
proportions depending on the cultivar. The anthocyanins in grape skins are 
predominately the 3-O-glucosides of malvidin, cyanidin, delphinidin, peonidin, and 
petunidin (Wrolstad, 2000). Malvidin, the reddest of all anthocyanins, is the major one 
in dark red vinifera grape with higher proportions of cyanidin in red grape (Jackson, 
1994). Concord grapes may contain up to 20 pigments with the major aglycones being 
cyanidin and delphinidin. Cyanidin 3-monoglucoside and delphinidin 3-
monoglucoside are major anthocyanins in Concord grapes. Grape anthocyanins play a 
crucial role in the color quality of red wines, and have been increasingly used as food 
colorants and nutraceuticals (Mazza 1995). 
 
Proanthocyanidins, also named condensed tannins, are the second most 
abundant phenolics after lignin (Santos-Buelga and Scalbert, 2000; Gu et al., 2003). 
They are oligomers or polymers of flavan-3-ols subunits. The most common types of 
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proanthocyanidins are shown in Figure 1.7.  An ester bond between C2→C7 resulting 
in linkage of the flavan-3-ol units is named an A-type linkage. Units are linked mainly 
through C4→C8 bond, but the C4→C6 linkage also exists. These linkages are both 
called B-type linkages. The flavan-3-ol subunits may contain acyl or glycosyl 
substituents. The most common acyl substituent is gallic acid, which is bound as an 
ester with the hydroxyl in the C3 position in wine or tea (Santos-Buelga and Scalbert, 
2000). The predominant phenolics in red wine are from the condensation of flavan-3-
ol units to yield the oligomers (proanthocyanidins) and polymers (condensed tannins). 
Epicatechin is the major unit in condensed tannins from grapes and wine, catechin is 
the next most abundant. Grape seeds are waste products of the winery and grape juice 
industry, but they contain 5~8% phenolics depending on the variety (Shi et al., 2003). 
Major phenolics in grape seeds are proanthocyanidins and flavonoids, including gallic 
acid, the monomeric flavan-3-ols catechin, epicatechin, gallocatechin, 
epigallocatechin, and epicatechin 3-O-gallate, procyanidin dimers, trimers, and more 
highly polymerized procyanidins. Among them, the most abundant phenolics isolated 
from grape seed are catechins, epicatechin, procyanidin, and some dimers and trimers. 
In the USA, the daily intake of proanthocyanidins is approximately 57.7 mg/day 
including the monomers(Gu et al., 2004). Apples (32%), chocolate (17.9%), and 
grapes (17.8%) are the major contributors to proanthocyanidin consumption in the 
USA. The other sources of proanthocyanidins in daily diet are pears and wines.  
 
The phenolics in grape seeds are primarily all flavonoids. The presence of 
flavan-3-ol monomers, dimmers, and trimers has been extensively reported (Ricardo 
da Silva et al., 1991; Prieur et al., 1994). Monomers include catechin, epicatechin, and 
epicatech-3-O-gallate. The dimeric procyanidins are referred to as the B-series, while 
the trimeric procyanidins are referred to as the C-series (Figure 1.7). Five different 
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dimers (procyanidin B1, B2, B3, B4, and B5) and two trimers (C1 and C2) were 
identified from grape skin and seeds. Red wine contributes a significant amount of 
proanthocynidins compared to other beverages. The common types of 
proanthocyanidins in grapes and wines are procyanidins, propelargonidin 
(epiafzelechin), and prodelphinidin (epigallocatechin). Due to being specifically 
extracted from the grape seeds and skin during the mash fermentation of red wine, 
proanthocyanidins have been suggested as a potential candidate to cuase the superior 
effect of red wine as compared to white wine and other alcoholic beverage. 
 
1.5.3. Stilbenes 
More than 30 stilbenes and stilbene glycosides have been identified in plants 
(Soleas et al., 1997). Stilbenes (Figure 1.8) are phenolic compounds exhibiting two 
aromatic rings linked by an ethane bridge. Stilbenes usually include resveratrol (RSV: 
3,5,4'-trihydroxystilbene), piceid (a resveratrol glucoside), pterostilbene (a 
dimethylated derivative of resveratrol), and viniferins (resveratrol oligomers) 
(Langcake and Pryce, 1976; Langcake, 1981; Jeandet et al., 1991). RSV is the parent 
molecule of viniferins, a family of phytoalexin that inhibit the progression of fungal 
infection. Another derivative, pterostilbene, has much greater antifungal activity than 
RSV, despite being present in a lower level (Langcake et al., 1979). Stilbenes are 
responsible for the bright blue fluorescence observed under long wavelength UV-light 
on grape leaf surfaces or grape berries following their accumulation within plant 
tissues.  
RSV, one of phytoalexins, is synthesized
 by a wide variety of plant species, 
including grapes, peanuts, and mulberries, in response to pathogenic attack and 
environmental stress such as injury, UV
 irradiation and fungal infection. RSV was 
identified as the bioactive constituent of the dried roots of Polygonum cuspidatum in 
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1963. It has been used in traditional Chinese medicine to fight against favus, 
suppurative dermatitis, gonorrhea, and hyperlipemia. It was first detected in V. vinifera 
grape in 1976 (Langcake and Pryce, 1976), and found in wine in 1992 (Siemann and 
Creasy, 1992). RSV is synthesized
 in the leaf epidermis and the skin of grape berries, 
but not
 in the flesh. RSV exists in two isomers, the cis and trans, as shown in Figure 
1.8. Both forms are found in wine, although it appears that only the trans isomer is 
found in grapes. Direct light (UV-light-induced) can cause its isomerization from 
trans to cis (Trela and Waterhouse, 1996). Grape variety affects RSV concentration, 
with higher concentrations found in red grape varieties compared to white grape 
varieties. In addition, wilting conditions, climate, and amount of fungal infection 
(Botrytis cinerea) also influence the level of RSV in grape skin. Due to its presence in 
grapes, RSV is also found in wines. Other compounds considered as oligomers of 
RSV and termed viniferins have also been found in grapevines as a result of infection 
or stress. The major components of these appear to be ε-viniferin (Figure 1.8), a 
cyclic resveratrol dehydrodimer (Langcake and Pryce, 1977; Jeandet et al., 1997), and 
α-viniferin, a cyclic resveratrol dehydrotrimer (Pryce and Langcake, 1977).  
 
1.5.4. Others 
Carotenoids as representatives of isoprenoid tetraterpens (C40) are produced in 
ripening grapes. Oxidation of carotenoids forms volatile and odoriferous compounds 
such as β-ionone, damascenone, and β-ionol (Baumes et al., 2002). Monoterpenes are 
major components of essential oils, and represent C10 isoprenoids. The presence of 
isoprenoid monoterpens in grape is the primary source of wine aroma (Pisarnitskii, 
2001). Melatonin has been recently found in grape (Iriti and Faoro, 2006). 
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Figure 1.3. The generic structure of flavonoid. 
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Figure 1.4. Structures of main classes of dietary flavonoids. 
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Figure 1.5. Structures of anthocyanidins. 
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Figure 1.6. Chemical structures of common dietary flavonoids. 
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Figure 1.7. Chemical structures of proanthocyanidins in grapes. 
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Figure 1.8. Structures of the main stilbenes found in grape and wine. 
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1.6. Phenolic Levels in Grapes and Wines 
In grapes and wines, phenolics are the third most abundant constituent after 
carbohydrates and acids (Singleton, 1980 ). The total extractable phenolics in grapes 
are 10% or less in pulp, 28-35% in the skin, and 60-70% in the seeds (Shi et al., 2003). 
It is well known that both genetic and agronomic or environmental factors play 
important roles in phenolic composition, concentration, and thus nutritional quality of 
crops. The average number of phenolic compounds for seeded V. vinifera varieties 
from California is about 4,000 and 5,500 mg gallic acid equivalents (GAE)/kg for 
white and red grapes, respectively (Singleton and Esau, 1969). In 2002, Mattivi et al 
studied 25 high-quality red grape cultivars (V. vinifera), and found that the Schiava 
variety contained the lowest phenolic content with 1358 mg/kg, and the Sagrantino 
variety had the highest phenolic content with 4628 mg/kg, resulting in a variability 
factor of 2.7 in the richness of phenolics between the values of the varieties with the 
average concentrations. Kanner et al. (1994) also found a variation in phenolic content 
among Thomson seedless, Flame seedless, and Black seedless grapes, ranging from 
260 to 930 mg/kg of fresh weight. It was estimated that the total phenolics in juice, 
pulp, skins, and seeds are approximately 5%, 1%, 30%, and 64%, respectively 
(Singleton and Esau, 1969; Singleton, 1982). Generally, the total phenolics of red 
grape skins is greatly higher than that of white grapes due to the loss of the ability to 
produce anthocyanins in the skins of white grapes. It was observed that the total 
phenolic content in winemaking grapes is significantly higher than that of table grapes. 
Caftaric acid is the predominant cinnamate in grapes, averaging roughly 170 mg/kg in 
V.  vinifera grapes, while the p-coutaric and fertaric acids have around 20 and 5 
mg/kg, respectively (Singleton et al., 1986). The variability of phenolics is influenced 
largely by genetic factors, environmental conditions, and the stage of development of 
the plant organ.  
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The level of phenolics in wine varies throughout their concentration in the 
grapes, the maturity state of berries, the vinification techniques used, stabilization and 
storage, as well as condensation, polymerization, oxidation and precipitation of 
different molecules. Polymeric condensed tannins and pigmented tannins comprise the 
majority of wine phenolics. Red wine contains phenolics in high concentration up to 4 
g/L, but relatively low levels are present in white and rose wines, approximately a 
tenth of those of red wines (Waterhouse and Teissedre, 1997; Waterhouse, 2002). 
Total hydroxycinnamates’ concentrations are about 130 mg/L in white wines and 60 
mg/L in reds (Waterhouse, 2002). The levels of benzoic acids in white wines are 
around 10 mg/L, while red wines are about 70 mg/L. In red wines, flavonoids usually 
comprise more than 85% of the total phenolic content, whereas in white wines, 
flavonoids typically constitute less than 20% of the total phenolic content (Soleas et 
al., 1997). Total monomeric flavan-3-ols levels in red wine ranges from 40 to 120 
mg/L with the majority frequently being catechin (Ritchey and Waterhouse, 1999). 
The concentrations of total flavonols are about 53 mg/L for Cabernet Sauvignon. The 
amounts of proanthocyanidins and condensed tannins are in the range of 500 – 1500 
mg/L or even higher in some red wines, while in white wine, amounts are between 10 
mg/L and 50 mg/L (Waterhouse, 2002). The levels of total phenolics are 209.5 mg/L 
for young white wine, and 285.5 mg/L for aged white wine; while the amounts of total 
phenolics are 1,732 mg/L for young red wine, and 1,742 for aged red wine.  
 
Grapes are the major dietary sources of anthocyanins, being responsible for the 
coloring of black, red, and purple grapes; however, anthocyanins are lacking in white 
grapes. In particular, anthocyanins mostly accumulate in the skins, whereas 
procyandins are located in the seeds. The study of anthocyanins is important for 
differentiating the quality and health benefits of grapes and red wines derived from 
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grapes. As a characteristic associated with the variety, the level of anthocyanins in 
grapes can be served as a direct estimate of the red pigments, and be useful for the 
classification of grape varieties and of relevant wines (Mattivi and Nicolini, 1997). 
Hence, anthocyanins might be proposed as chemical markers to differentiate grape 
varieties and red wines. The types of anthocyanins occurring in grapes, wines, juices, 
and their distribution were extensively reviewed (Mazza, 1995). It was reported that 
Lomanto and Colobel hybrid grape cultivar had the highest anthocyanin content with 
603 mg/100g; Midsouth cultivar contained the lowest content with 5.5 mg/100g. The 
total anthocyanin content of red grapes is from about 30 to 750 mg/100g of fresh 
weight of ripe berries. The content of anthocyanins in the skin of grapes was estimated 
from 200 ~ 5000 mg/kg of fresh whole grape (Riberau-Gayon, 1982). The average 
content of anthocyanins in red wines is estimated at 26 mg/L (Frankel et al., 1995). 
The content of anthocyanins in skin of three V. vinifera L. grapes was 753-803 mg/kg 
for Pinot Noir, 826-1048 mg/kg for Cabernet Franc, and 981-1043 mg/kg for Merlot 
(Mazza et al., 1999). Muñoz-Espada et al. (2004) reported the total anthocyanin 
contents in skin of three non-Vitis vinifera grapes, which were 258 ± 37 mg/100 g of 
wet weight for Marechal Foch, 888 ± 78 mg/100 g for Norton, and 326 ± 5.9 mg/100 g 
for Concord. As a standard of malvidin 3-monoglucoside chloride, the lowest 
anthocyanin content in Primitivo variety was found to be 250 mg/kg whereas the 
highest amount was found in a Teroldego grape with 2323 mg/kg (Mattivi et al., 2002). 
The concentration and composition of the anthocyains in red grape varies greatly with 
the variety, species, maturity, production area, and climate. In assessing red grape 
varieties for total anthocyanin content, broad variability exists. This is not surprising 
since these secondary metabolites are synthesized under genetic control in different 
varieties.  
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RSV is synthesized particularly in the leaf epidermis and the skin of grape 
berries and only trace amounts are present in the fruit flesh. The RSV levels in grape 
skins and red wines are 50-100 μg/g, and 1.5-3 mg/L, respectively (Joe et al., 2002). 
The RSV concentration in wine is greatly variable, which is affected by grape varieties, 
fungal pressure, skin contact, growing conditions, and vinification. RSV is more 
concentrated in red than
 in white wine due to longer time skin extraction in the red 
wine fermentation process than white wine. It was observed that the concentrations of 
the piceid isomers decreased as fermentation continued, while the RSV isomer 
increased, with trans-RSV having the highest final concentration (Mattivi et al., 1995). 
There was 1.33-7.17 mg RSV/L in Cabernet Sauvignon, 3.14-6.03 mg/L in Merlot, 
and 3.22-5.93 mg/L in Pinot Noir (Mattivi, 1993). Pinot Noir wines were found to 
have the highest concentrations of RSV, while white Bordeaux and Chardonnay wines 
contained the lowest levels in comparison of wines from the north coast of California 
(Lamuela-Raventós and Waterhouse, 1993). Jeandet et al. (1993) exculsively 
examined red wines (Pinot Noir) and white wines (Chardonnay and Aligote) from 
Burgubdy, and quantified the trans- and cis-RSV independently in these samples. It 
was reported that the trans-RSV concentrations were in the range of values previously 
reported for Californian Pinot Noir wines (Lamuela-Raventós and Waterhouse, 1993), 
ranging from 10-15% of the total RSV concentrations (0.34-1.83 mg/L). In a 
comparison of wines made from grapes grown in Japan, results were similar (Sato et 
al. 1997). Siemann and Creasy (1992) reported that RSV level in most white wines 
was less than 0.03 mg/L although some Chardonnays from New York State had up to 
0.1 mg/L. Among the 40 Tuscan wines (mainly Sangiovese grapes), it was found that 
the concentration of trans-RSV ranged from 0.3 to 2.1 mg/mL, while the 
concentration of cis-RSV was between 0.5 and 1.9 mg/mL (Mozzon et al., 1996). 
Generally, the total levels of all RSV derivatives are around 7 mg/L for red wines 
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(Lamuela-Raventós, 1995), 2 mg/L for rosés and 0.5 mg/L for white wines (Ribeiro de 
Lima et al., 1999; Wallerath et al., 2002).  
 
The phenolics in grape seed are also affected by variety, climatic condition, 
site of production, and degree of maturity. Shi et al. (2003) summarized the phenolic 
composition and concentration of grape seeds from the viniferia, hybrid, and labrusca 
type of red and white grape cultivars commonly grown in the Niagara region of 
Ontario, Canada.  It was found that Pinot Noir contained the highest phenolic content 
with 797 mg/100g, followed by Sauvignon with 778 mg/100g, and Vincent with 759 
mg/100g. Among 5 white grapes, Chardonnay had the highest phenolic content with 
293 mg/100g, followed by Niagara with 231 mg/100g, Elvira with 152 mg/100g, 
Riesling with 114 mg/100g, and Seyval with 60 mg/100g. There were trace amount of 
dimer gallates and trimers present in Seyval.   
 
 
1.7. Grape Varieties  
The U.S. grape and grape product industries are primarily concentrated in 
California, accounting for virtually all table grapes and raisins, and approximately 
90% of the nation’s wine production, with New York State and Washington State each 
at about 3% and the rest of the States at 4% combined. Grape juice production is 
mainly focused in Washington State, New York, Pennsylvania and Michigan. Bases 
on a comprehensive study (MKF Research, 2007) unveiled on Capitol Hill by the 
Congressional Wine Caucus on January 17, 2007, the United States wine, grape and 
grape product industries make a contribution more than $162 billion annually to the 
American economy. There are 23,856 grape growers, 934,750 grape bearing acres, 
27.3 million wine-related tourist visits, and $3.5 billion in farm gate grape sales in 
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2005. Grapes rank the highest value fruit crop produced in the US, and the sixth 
highest values among US crops. There were 4,929 US bonded wineries in 2005, with a 
70% increase of wineries compared to that in 2000. Wineries are in all 50 States, 
making $11.4 billion in winery sales revenues. In addition, the economic impact of 
other grapes products include $1.669 billion retail value of grape juice and grape 
product sales, $3 billion retail value of table grape sales, and $560 million retail value 
of raisin sales. This study indicates that all kinds of grape production have increased 
by 5% since 2003, with the total value of the grape increasing by over 15%, mainly 
through rising values for wine grapes and raisins.  
 
1.7.1.  Grape Varieties and Distribution 
The grape is one of the popular fruits and most widely cultivated throughout 
the world. Nearly all Vitis species originate in the Northern Hemisphere. Among them, 
over 70% of Vitis species are native to North America. Early cultivars of Alexander, 
Cape Grape, Catawba, Concord, and Isabella were from native American species 
(Booth, 1911). Hedrick (1907) listed over 1,400 varieties of cultivated American grape 
species. There are about 60 species of Vitis, which are mainly found in the temperate 
zones of the Northern Hemisphere, and almost equally distributed between America 
and Asia (Mullins et al., 1992). Among them, V. aestivalis, V. cinerea, V. labrusca, 
and V. riparia have been used in grape breeding programs. Cythiana or Norton 
selected from V. aestivalis is the most widely grown cultivar in Missouri. V. 
rotundifolia such as muscadine grape has a long history in southern US (Lane, 1997), 
and are exemplified by the Scuppernong variety which is disease resistant, long lived, 
and vigorous. V. labrusca has been applied in interspecific hybrids with various 
cultivated V. vinifera for grape juice, jelly, fresh fruit and wine. As the most widely 
distributed species, V. riparia is very adaptable (Remaily, 1987). Roughly 80% of the 
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total grape is used in winemaking annually, and 13% is consumed as table grapes. The 
main wine-making grape varieties include Cabernet Sauvignon, Chardonnay, Pinot 
Noir, Merlot, and Zinfandel. The major table grape varieties are Perlete, black Ribier, 
Tokay, and Emperor (Mazza, 1995). The V. vinifera grapes are commonly used for 
wine production around the world, principally distributed in Europe. Most studies in 
phenolic composition and related antioxidant activity have been done in grapes and 
wines using V. vinifera species. In the United States, species such as V. labrusca, V. 
riparia, V. aestivalis, V. rupestris, and V. rotundifolia are also used in wine-making. 
Two main grape species in North America are V. labrusca and V. rotundifolia. The 
labrusca grapes are grown mostly in the lower Great Lakes region of the U.S. and 
Canada. The representative grape variety is the large purple berry - Concord. Due to 
its abundance in the United States, this grape is popular in making of juices and jellies. 
The V. rotundifolia or Muscadine grapes are cultivated throughout the southeastern 
United States, from North Carolina to eastern Texas.  
 
1.7.2.  Main Grape Varieties in New York 
In New York State, the grape and wine industry contributes $6 billion annually 
and supports many other businesses, becoming a powerful economic engine (NYGF, 
2007). As the second largest grape juice producer, the third largest total grape acreage, 
and the third wine producer in America, New York State has 962 family-owned 
vineyards covering 33,000 acres, employs about 18,000 people, produces 175,000 tons 
annual harvest with 70% of grape juice, 28% of wine, and 2% of table grapes, totally 
making $45 million annual harvest value (NYGF, 2007). 
 
Back in the mid-1600’s, Dutch settlers made Manhattan the first place in New 
York State to plant grapes for winemaking. Compared to Europe’s wine regions, New 
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York Wine country is huge, spanning some 500 miles (800 km) from eastern Long 
Island to the State’s western border with Pennsylvania. Like the vineyard of Burgundy, 
Champagne, and Germany in Europe, as well as Washington State, New York State is 
considered a cool climate wine area, although New York’s wine country is further 
south than those regions, and on similar latitude to Oregon and parts of northern 
California. The receding glaciers of the Ice Age made New York a unique 
combination of geography and climate. Bodies of water act as natural air conditioning, 
warming in the winter, cooling in the summer, and sheltering the vines from high 
temperature, which result in several major wine regions with temperature gradient 
from 38°C to 43°C, each with specific microclimates. Each with its own unique 
climate, character, scenery, and wine varieties, there are four distinct wine regions in 
New York Sate, including the Long Island area, the Hudson River area between New 
York City and Albany, the Finger lakes area with its thin parallel lakes flanked by 
steep hillsides, and grape juice counties of Niagara, Erie and Cattaraugus. The Finger 
Lakes region is known for its Cabernet Franc and Chardonnay, and specializes in 
Riesling, Pinot Noir, Sparkling, and Ice wines (NYGF, 2007).  
 
Generally, varieties in New York can be categorized as Native American (V. 
labrusca), French-American, and European varieties (V. viniferia). Horticulturists at 
Cornell University have been conducting viticultural research since the 1880s. They 
have released 53 varieties of juice, table and wine grapes since 1906. Native American 
varieties were the only grapes grown in New York until the 1930’s. Like Concord and 
Niagara varieties, these hardy, productive varieties bring in wines with a pronounced 
grapey aroma and taste. The Native American varieties include Catawba, Concord, 
Delaware, Diamond, and Niagara. Catawba can be made into pink (rose or blush) or 
white wines depending on skin contact during fermentation, typically with both high 
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sugar and acid, lending a nice balance of sweetness and tartness. Concord is used to 
make grape juice, and is also used in many kosher wines. Delaware, a white wine, can 
be produced from dry to semi-sweet with a pleasant flowery aroma. Niagara is another 
grape juice variety with unique fruity aroma. Baco Noir and Seyval Blanc are 
examples of French-American varieties, mostly developed by French scientists about 
100 years ago, combining the flavor characteristics of European grapes and the 
hardiness of American grapes together. The Cornell University's Agricultural 
Experiment Station in Geneva, N.Y. has crossbred several popular varieties such as 
Cayuga White and Traminette. Four other varieties in this group are Chancellor, 
Marechal Foch, Vidal Blanc, and Vignoles. Baco Noir, from medium to full-bodied, 
has deep color. When young, it has strong flavors like Cabernet Sauvignon. Cayuga 
White is a highly reliable and productive variety in terms of crop size and quality. 
From Gewürztraminer, Traminette with spicy aroma is a reliable grape to grow and 
yields the same basic aroma and taste characteristics as Gewürztraminer. Vignoles, 
like Riesling, is made from dry to very sweet with a great balance of acidity. European 
varieties such as Riesling and Merlot are also cultivated in New York. Other varieties 
include Cabernet Franc, Cabernet Sauvignon, Chardonnay, Gewürztraminer, Pinot 
Noir, Riesling, and Sauvignon Blanc. Cabernet Sauvignon is a dominant grape in most 
Bordeaux wines, requiring a long growing season. Most New York plantings of 
Cabernet Sauvignon are in the Long Island area. As a very popular varietal wine in 
U.S., New York Chardonnays are generally more like French Chablis (crisp, light, and 
acidic) than California ones (big, round, and oaky). As a signature grape and wine of 
Long Island, Merlot with a rich, full aroma is a blending grape in Bordeaux to add 
softness and velvety texture. As the holy grail of grape and wine, Pinot Noir, most 
commonly associated with France’s Burgundy area, is difficult to grow and vinify. 
Riesling, the signature grape and wine of the Finger Lakes, is versatile in its range of 
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styles. The white wine of Bordeaux, Sauvignon Blanc is mostly grown on Long 
Island, and is typically aromatic, light, and crisp. Taken together, more than 35 grape 
varieties are grown in New York, and make some of the finest wines in the world 
(NYGF, 2007).  
 
 
1.8. Mechanisms of Phytochemicals in the Prevention of Cancer  
Accumulation of ROS and electrophiles under adverse conditions
 are known to 
cause cellular membrane and biomacromolecule damage, mutagenicity, degeneration
 
of tissues, apoptotic cell death, premature aging, cellular
 transformation, and being 
further implicated in chronic diseases such as cancer and CVD (Ames et al., 1993; 
Ward, 1994; Breen and Murphy, 1995). Free radicals react with biological molecules, 
and there is no single defense against all targets of oxidative damage. Therefore, 
organisms have evolved a spectrum of mechanisms to prevent oxidative damage and 
free radicals at multiple steps of oxidation. Exogenous defenses such as dietary 
phytochemicals are demonstrated for the preventive and/or therapeutic intervention of 
ROS disorders. The chemopreventive agents such as dietary phenolics are a very 
promising group of compounds, on account of their safety, low-toxicity, and general 
acceptance. Phenolics may offer an indirect protection by activating endogenous 
defense systems. One of strategies for protecting against ROS or electrophiles injury 
may be through chemically mediated upregulation of endogenous antioxidants and 
phase II enzymes in cells. A connection between exogenous and endogenous 
antioxidants that appear to act in a coordinated fashion are observed (Masella et al., 
2005; Talalay, 2005), which is achieved partly through antioxidant responsive 
elements (AREs) present in the promoter regions of many of the genes inducible by 
oxidative and chemical stress, suggesting dietary phenolics can stimulate antioxidant 
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transcription and detoxification defense systems through ARE. The ARE contains 
AP1/AP1-like
 elements arranged either as inverse or direct repeats followed
 by a GC 
box (Dhakshinamoorthy and Jaiswal, 2000). NF-E2 related
 factors (Nrf1, Nrf2, and 
Nrf3) do not
 bind to the ARE as homodimers or heterodimers and require other leucine 
zipper proteins to form heterodimers
 that bind to the ARE (Chan et al., 1993; Moi et 
al., 1994; Venugopal and Jaiswal, 1996). Nrf2 is a critical transcription factor that 
binds to the ARE in the promoter region of a number of genes, encoding for 
antioxidative and phase II enzymes in animals and human cells and tissues (Kwak et 
al., 2004; Lee and Johnson, 2004; Kobayashi and Yamamoto, 2005; Zhu et al., 2005). 
Nrf2 is more potent than
 Nrf1 in inducing gene expression. It was believed that Nrf1 
and Nrf2 positively and c-Fos, Fra1, small Maf proteins, Nrf3, and Bach 1 
(Dhakshinamoorthy et al., 2005) negatively regulate ARE-mediated NQO1
 and other 
detoxifying enzyme gene expression, as well as antioxidant
 induction (Nguyen et al., 
2000; Dhakshinamoorthy and Jaiswal, 2001). The NF-E2-related factors are in the 
family of basic leucine zipper proteins. The upstream of the leucine zipper in the basic 
region is responsible
 for DNA binding. The acidic region is required for transcriptional
 
activation. Taken together, ARE, Nrf expression, and coordinated induction of genes 
encoding chemopreventive
 proteins provide critical mechanisms for anticancer 
activity.  
 
It is has become increasingly clear that intracellular signaling pathways are 
activated via changes in intracellular metabolic oxidation/reduction (redox) reactions 
associated with ROS in cancer biology (Oberley and Buettner, 1979; Abate et al., 
1990; Sun and Oberley, 1996; Arnold et al., 2001; Nioi and Hayes, 2004; Spitz et al., 
2004; Gius and Spitz, 2006). The mechanism of signal transduction from antioxidants
 
to Nrf2 is the current subject of extensive research. Generally, redox signaling is 
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involved in activation of protein kinases and inhibition of protein phosphatases 
through exposure to oxidants in normal cells (Guyton et al., 1996; Claiborne et al., 
1999; Tonks, 2005). Nrf2 protein binds strongly to the ARE sequence and positively 
regulates its activity. The interaction between Nrf2 and ARE is regulated by several 
inhibiting or activating cofactors. For instance, Kelch-like ECH-associated protein 1 
(Keap1) cofactor which is bound to actin protein and localized in the perinuclear 
space, sequesters Nrf2 in the cytoplasm by forming heterodimers, and inhibits its 
translocation to the nucleus, thus making it unable to activate the ARE sequences (Itoh 
et al., 2003). The modulation of Keap1–Nrf2 binding seems to play a crucial role in 
the cellular response to oxidative stress, although the exact mechanism of dissociation 
of Nrf2 from its inhibitor and the signal transduction pathway from oxidants to Nrf2–
Keap1, remains poorly understood. It was assumed that Nrf2 heterodimerizes with c-
Jun or Small Maf partners, inducing ARE activation and the consequent transcription 
of detoxifying enzyme genes. Phosphorylation, a principal mechanism in Nrf2 
stabilization, is involved in several signal transcription pathways such as the MAPK, 
PKC, and PI3K pathways (Figure 1.9) (Zipper and Mulcahy, 2000; Huang et al., 
2002; Kang et al., 2002; Nakaso et al., 2003). Generally, Nrf2 is retained in the cytosol 
by a cytosolic
 inhibitor Keap1. The signals from phenolic antioxidants lead to 
phosphorylation of Nrf2 and/or redox modulation of Nrf2/Keap1, leading to separation 
of Nrf2 from Nrf2/Keap1. As a result of kinase activation, Nrf2 dissociates from 
Keap1 and translocates in the nucleus. It is therefore possible that the transcriptional 
activity of Nrf2 is regulated by multiple converging signaling pathways. The Nrf2 
accumulates in the nucleus to cause its binding to
 ARE and activation of ARE-
mediated gene expression. A hypothesis could be that, phenolics, through modifying 
the capability of Keap1 in sequestering Nrf2, can react with active sulfhydryl groups, 
therefore modulating several sensor proteins including Keap1 (Levonen et al., 2004). 
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Another possibility could be that phenolics affect ARE-dependent gene expression 
through the activation of MAPK proteins (ERK, JNK and p38), probably involved in 
Nrf2 stabilization through its phosphorylation (Yu et al., 1997).  
 
Dietary phenolics can stimulate the transcription of antioxidant and 
detoxification defense systems through ARE elements by influencing the pathways 
that regulate ARE activation. ARE and nuclear NF-E2 related
 factors mediate the 
basal expression
 and induction of a battery of defensive genes in response to dietary 
antioxidants. For instance, intake of cruciferous vegetables, such as cabbage, broccoli, 
and brussels sprouts, has been demonstrated to induce detoxification enzymes and 
increase clearance of xenobiotics in animals (Wattenberg, 1985; Prochaska et al., 
1992; Zhang et al., 1992), and has been associated with lowered incidence of cancers 
in humans (Graham et al., 1978; Pantuck et al., 1979). Transcriptional regulation
 of 
phase II enzymes by Isothiocyanates (ITCs) is via Keap1–Nrf2–ARE mediated
 
pathways (Dinkova-Kostova et al., 2002; McMahon et al., 2003). ITCs modulate 
carcinogen metabolism by inhibition of phase I carcinogen-activating
 enzymes 
(Talalay and Fahey, 2001), induction of phase
 II detoxification enzymes (Maheo et al., 
1997; Shapiro et al., 1998), and inhibition of cell growth by cell cycle arrest and
 
activation of apoptosis, linked to the
 activation of caspase-8, JNK1 and tyrosine 
phosphorylation (Gamet-Payrastre et al., 2000; Kong et al., 2001; Chiao et al., 2002). 
RSV was found to activate PKB/Akt in MCF-7 cells (Pozo-Guisado et al., 2004), and 
MAPKs in human melanoma (Niles et al., 2003) and mouse epidermal JB6 cells (She 
et al., 2002). RSV was reported to increase the activity of phase II enzymes (Lang et 
al., 1997), suggesting that it may up-regulate phase II antioxidant/detoxifying enzymes 
through Nrf2 activation, probably mediated by PKB/Akt or MAPKs.  
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Figure 1.9. Activation of Nrf2 signaling and induction of phase II detoxifying and 
antioxidant genes (modified from Talalay, 2005) 
 
 
The transcriptional activation of phase II detoxifying and antioxidant enzymes, 
including NQO1, glutathione peroxidase, glutathione reductase, glutathione S-
transferase (GST), γ-glutamylcysteine synthetase, sulfotransferases, epoxide 
hydrolases (EH), and UDP-glucuronosyl transferase (UDPGT), has been related to cis-
acting elements, detected in the promoter region of those genes. NQO1 is a family of 
two-electron reducing enzymes that decrease the oxidative damage resulting from one-
electron reduction of quinines, thus bypassing the semiquinone intermediate. NQO1 
plays a vital role in protecting
 cells against oxidative cycling and GSH depletion by 
quinones (Prochaska et al., 1987) and has provided
 an index for phase II gene status of 
cells (Dhakshinamoorthy et al., 2000). Through a cis-acting ARE located within the 
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regulatory region of the mouse, rat, and human genes, the redox sensitivity of NQO1 
transcription occurs. Expression of NQO1 is induced upon oxidative stress, leading to 
increase in oxidoreductase protein that offers the cell multiple means of protection 
from environmental insults (Nioi and Hayes, 2004), including directly catalyzing the 
reduction and detoxification of highly reactive quinones; decreasing one electron 
reductions and associated redox cycling; acting as an antioxidant enzyme through 
reduction of the oxidized form of vitamin E to a product with antioxidant activity; 
regulating the stability of p53 and apoptosis in mouse and human cells. NQO1 is 
inducible in human cell lines derived from a range of tissues(Nioi and Hayes, 2004), 
including adult retinal pigment epithelial cells, microvascular endothelial cells, the 
MCF-7 and T47D mammary cell lines, the IMR-32 neuroblastoma cell line, the AGS 
and RF-1 stomach cell lines, the NCI-H209 and NCI-H661 lung cells, the HL-60 and 
THP-1 leukemia lines, the HT-29 and LS-174 colon cell lines, and the LNCaP and 
PC3 prostate cell lines. 
 
 
1.9. Additive and Synergistic Effects of Whole Foods and Phytochemicals  
While fruits and vegetables are recommended for prevention of cancer, the 
effect of their bioactive components at the molecular level and their mechanisms of 
action are less well understood. Extensive research has identified and characterized 
various molecular targets that can potentially be used not only for the prevention of 
cancer but also for treatment. However, lack of success with targeted mono-therapy 
resulting from bypass mechanisms has forced researchers to employ combination 
agents that interfere with multiple cell signaling transduction pathways. In general, the 
effect of whole foods is more pronounced than that of the individual micronutrients or 
other bioactive phytochemicals they supply. Dietary phenolics can exert their effects 
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on multiple pathways separately or sequentially; in addition, the occurrence of 
interactions between/among phenolics in different pathways plays an important role. 
Does the single compound and phytochemical mixture have the same health 
benefits in the prevention of cancer? It was observed in some clinical
 trials that dietary 
supplements or individual antioxidants do not appear to possess the consistent 
preventive effects with a diet rich in fruits, vegetables, whole-grains, and other plant-
based foods. Epidemiological evidence for dietary supplements such as vitamin E and 
β-carotene for chronic disease prevention has found no effect on CVD in 
cardiovascular mortality and cancer (Hennekens et al., 1996; Omenn et al., 1996; 
Rapola et al., 1997). The incidence of nonmelanoma skin
 cancer was unchanged in 
patients receiving a β-carotene supplement over a five-year period of treatment 
(Greenberg et al., 1990). Vitamin C supplementation also has been shown not to lower 
the incidence of cancer (Blot et al., 1993) and heart disease (Salonen et al., 2000). 
Since dietary supplements simply cannot offer the
 balanced natural combination of 
phytochemicals present in fruit
 and vegetables, suggesting the health benefits can’t be 
replaced by dietary supplements, we hypothesize that
 the additive and/or synergistic 
effects of phytochemicals in fruit
 and vegetables are responsible for their potential 
biological effects such as antioxidant
 and anticancer activities, and that the benefit of a 
diet rich
 in fruit and vegetables is ascribed to the complex mixture
 of phytochemicals 
present in whole foods (Liu 2004). 
 
1.9.1. Evidence 
Much evidence suggests that foods and diets act synergistically
 to reduce the 
risk of chronic diseases. There is considerable evidence in support of food synergy 
such as whole-grain, Mediterranean diet, DASH diet, and high intake of fruits and 
vegetables diets.  
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1.9.1.1. DASH Diet 
Hypertension is one of the leading causes of heart attack, stroke, and kidney 
disease, and affects about 25% of the population in the United States (Champagne, 
2006). Dietary factors may influence blood pressure since vegetarians
 tend to have 
lower blood pressure than nonvegetarians (Sacks et al., 1974). The Dietary 
Approaches to Stop Hypertension (DASH) trial is a multicenter, randomized feeding 
study that tested the effects
 of dietary patterns on blood pressure. A diet rich in fruits, 
vegetables, and low-fat dairy
 foods and with reduced saturated and total fat can 
substantially
 lower blood pressure, which was shown by a large, randomized feeding 
study of blood pressure reduction,
 the 8-wk DASH study in 459 people (Appel et al., 
1997). This diet offered an additional nutritional
 approach to prevent and treat 
hypertension. It was concluded that the DASH diet with low-sodium intake lowered 
blood pressure in all subgroups studied, including non-hypertensive individuals. The 
combination of the DASH diet and the lowest sodium level tested was superior in 
lowering blood pressure than either dietary intervention alone.  
 
Blood pressure can be lowered by following the DASH eating plan, which 
focuses on increasing intake of foods rich in nutrients that are expected to lower blood 
pressure, mainly minerals (like potassium, calcium, and magnesium), protein, and 
fiber. While each step alone lowers blood pressure, the combination of the eating plan 
and a reduced sodium intake gives the maximum benefit and may help prevent the 
development of high blood pressure. The DASH diet adequately shows that changing 
dietary pattern can alter physiological status. As a trial of dietary
 patterns rather than 
individual nutrients, DASH, which tested the combined
 effects of nutrients that occur 
together in food, has contributed to a lower risk of hypertension.  
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1.9.1.2. Prudent and Western Diets 
Many epidemiological studies have examined dietary patterns
 and those are 
associated with lowered risk of chronic diseases (Hu et al., 2000; Fung et al., 2001; 
Terry et al., 2001; Van Dam et al., 2002). Consumption of a diet high in fruit and 
vegetables,
 whole grains, fish and poultry, and low-fat dairy products presented a 
significant inverse association with the risk of CVD. Conversely, intake of a diet high 
in red and
 processed meats, refined grains, high-fat dairy products, sweets,
 and 
desserts showed a significant positive association with colon
 cancer and CVD (Fung et 
al., 2001; Fung et al., 2003). The concept of prudent and western diets was proposed. 
The prudent dietary pattern was characterized by higher intake
 of fruits, vegetables, 
whole grains, fish/sea foods, legumes, poultry, lean meat, and nuts/vegetable oils, for 
example, the Asian and Mediterranean diets,
 whereas the Western dietary pattern 
involved higher consumption of red meat, processed meat, butter, potatoes, refined 
grains, sweets and dessert, high-fat dairy products, and foods with high saturated fat, 
cholesterol, and trans fats.  
 
Diets in
 the Asian areas are commonly plant-based. Despite containing 
different
 amounts of total fat, these diets include ample amounts of fruit, vegetables,
 
legumes, whole grains, and nuts and smaller amounts of red meat
 and refined grains. It 
is believed that these traditional plant-based
 diets make a greater contribution to 
longevity and a reduced risk
 of CVD in Asian
 countries than in Western countries 
(Willett, 1994). The common Mediterranean dietary pattern is characterized by high 
consumption of fruits, vegetables, bread and other cereals, beans, nuts and seeds, olive 
oil (major monounsaturated fat source), and wine (low to moderate amounts) (De 
Lorgeril et al., 1999). Despite being higher in fat (40%) than the 30% recommended 
by the American Heart Association, the Mediterranean diet is gaining in popularity as 
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a tasty, heart-healthy alternative to low-fat eating. Compared with most Western 
populations, CVD mortality rate is low in the Mediterranean countries
 where olive oil 
rich in oleic acid is the primary
 source of fat, suggesting potential
 beneficial effects of 
monounsaturated fat on CVD. The association between greater longevity and reduced 
mortality and morbidity for CVD in Mediterranean diet has also been observed for 
certain cancers. The people living in the Greek island of Crete and other Greeks are 
20% less likely to die of coronary artery disease than Americans. They also have 
approximately 1/3 less cancer than in the U.S (Visioli et al., 2004). The French 
population consumes similar amounts of saturated fats and has similar risk factors and 
comparable plasma cholesterol to the population in the United States. Renaud and de 
Lorgeril (1992) reported that coronary mortality in the United States is 182/10,000 
population; the overall mortality of the French is 102. This discrepancy is referred as 
the French Paradox mentioned previously, which was believed to be due to the 
consumption of red wine together with the Mediterranean diet rich in vegetables oils. 
Consumption by the French of a diet containing phytochemical antioxidants may 
decrease the perioxidative tendencies and retard processes involved in atherogenesis 
and thrombosis. In general, consumption of nutrient-dense plant-based foods, 
including whole-grain
 foods, fruit and vegetables, is considered to be beneficial
 to 
health. 
 
Cumulative evidence indicates the great potential of diets that
 are primarily 
based on minimally processed plant foods to reduce the risks of chronic diseases. The 
health benefits are due mainly to the large amounts of essential fatty acids, amino 
acids, fiber, minerals, vitamins, and phytochemicals in these diets. The combination of 
these nutrients from various diets has contributed to greater health benefits than those 
from a single diet.  
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1.9.1.3. Pure Compounds and Whole Foods 
Substantial epidemiological evidence concerning the potential role of 
antioxidant nutrients in the prevention of cancers has accumulated over the past few 
decades. However, some studies from intervention and clinic trials do not support a 
preventive effect against cancer for antioxidant supplementation. Performed in 29,133 
male heavy smokers between 50-59 years of age in Finland, the α-Tocopherol and β-
Carotene Lung Cancer Prevention Study (ATBC, 1994) included daily 
supplementation with 50 mg α-tocopherol and 20 mg β-carotene using a 2×2 factorial 
design. There was no benefit found in the β-carotene group; conversely, the incidence 
of lung cancers increased by 16%. In a randomized, double-blind, placebo-controlled 
trial
 of β-carotene (50 mg on alternate days), 22,071
 male physicians, 40 to 84 years of 
age enrolled in the United States. 12 years of supplementation
 with β-carotene 
produced neither benefit nor harm in terms
 of the incidence of malignant neoplasms, 
CVD,
 or death from all causes (Hennekens et al., 1996). A multicenter, randomized, 
double-blind,
 placebo-controlled primary prevention trial - the β-Carotene
 and Retinol 
Efficacy Trial, involving a total of 18,314
 smokers, former smokers, and workers 
exposed to asbestos, was conducted (Omenn et al., 1996). It was found that the 
combination of β-carotene and vitamin A had no benefit
 and might have an adverse 
effect on the incidence of lung
 cancer and on the risk of death from lung cancer, CVD, 
and any cause in smokers and workers after an average of 4 years of supplementation. 
Rapola et al. (1997) found that, in a randomized, double-blind, placebo-controlled 
study, in which 1862 men received dietary supplements of α-tocopherol (50 mg/day), 
β-carotene (20 mg/day), both, or placebo, the percentage of major coronary events in 
men with a previous myocardial infarction who smoke was not decreased with either 
α-tocopherol or β-carotene supplements; the risk of fatal CHD increased in the groups 
that received either β-carotene or the combination of α-tocopherol and β-carotene.  
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The reasons why the above clinical trials showed the nonsignificant or negative 
outcomes between the intake of dietary (antioxidant) supplements and certain chronic 
diseases may be due partially to the antioxidant supplements either losing their 
bioactivity or not behaving the same way as the compound in a phytochemical mixture 
because these compounds differ in molecular size, polarity, and solubility, which may 
affect their bioavailability and distribution in different subcellular organelles, cells, 
and tissues and organs. Another possible explanation of the contradictory results 
between observational studies and randomised trials could be the fact that doses used 
in clinical trials were much higher than the maximum levels offered by the usual 
dietary consumption which were found to be associated with a lower risk of cancer in 
observational epidemiological studies. 
 
Whole-grain
 consumption and the risk of chronic disease is an example of food 
synergy (Chatenoud et al., 1998; Jacobs et al., 1998). Risk of certain chronic diseases 
appears to be lower with consumption of whole grain than
 of refined grain, suggesting 
that health benefit increases when all edible parts
 of the grain (bran, germ, and 
endosperm) are included. A refined-grain food contains only
 the endosperm; therefore, 
most of the grain’s nutritional
 value is lost during milling. The protective effect of 
whole-grain intake on reduced risk of chronic diseases was observed in 
epidemiological studies such as the
 Iowa Women’s Health Study with 10 years of 
follow-up (Jacobs et al., 1999) and the Norwegian Study (Jacobs et al., 2001), and in 
animal studies (Ripsin et al., 1992; Pereira et al., 2002). Frequent Iowa and Norwegian 
whole-grain bread consumers showed a healthier lifestyle
 than did those who ate little 
whole-grain bread. 
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Work previously performed in our lab found that phytochemical extracts from 
fruits and vegetables have strong antioxidant and antiproliferative activities both in 
cell culture (Eberhardt et al., 2000; Yang et al., 2004) and animal studies (Liu et al., 
2005); thus we proposed
 that the combination of phytochemicals in fruits and 
vegetables is critical to their powerful antioxidant and anticancer effects. For example, 
the vitamin C in apples with skin accounts for
 only 0.4% of the total antioxidant 
activity, suggesting that
 most of the antioxidant activity of fruit and vegetables may be 
from phenolics and flavonoids ((Eberhardt et al., 2000). Phytochemical extracts from 
apple skin at a dose of 50 mg/mL (on a wet basis) inhibits HepG2 human liver cancer 
cell proliferation
 by 90%; however, phytochemical extracts in 50 mg/mL apple 
without skin suppress tumor cell proliferation only by 21% (Wolfe et al., 2003). The 
apple extracts
 with skin significantly reduced the tumor cell proliferation
 when 
compared with the apple extracts without skin, indicating phenolic composition and 
concentration from whole apple make a greater contribution than those from a part of 
an apple. 
 
1.9.2.  Additive and Synergistic Research 
Synergism by two or more compounds is defined as therapeutic effects that are 
greater than those expected from addition of the effects of the individual compounds. 
It is believed that chemotherapeutic combination approaches have been used to reduce 
drug toxicity, and delay the development of cancer cells, and to reach a greater effect 
than with one active compound alone. Fruits and vegetables are rich in phenolics and 
other bioactive compounds, the additive and/or synergistic effects have been suggested 
to be responsible for their health benefits (Liu 2003, 2004).  
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1.9.2.1. Antioxidant Activity 
Antioxidant synergism was observed in different experiments such as vitamin 
E and C (Scarpa et al., 1984), vitamin E and β-carotene (Palozza and Krinsky, 1992), 
catechin and malvidin 3-glucoside (Rossetto et al., 2002), flavonoids and urate (Filipe 
et al., 2001), and tea polyphenols and vitamin E (Zhou et al., 2000). Interaction 
between/among various antioxidants would be expected to occur based on the order of 
reactivity of their oxidation-reduction potentials (Buettner, 1993).  
 
Vitamin E reacts with lipid peroxyl radicals to form a relatively stable lipid 
hydroperoxide and vitamin E radical intermediate, which, in turn, may be recycled by 
other reductants. The interaction between the water-soluble antioxidant ascorbic acid 
and the lipid-soluble antioxidant tocopherol has been recognized, and ascorbic acid 
may be involved in the regeneration of the antioxidant capacity of vitamin E (Chen 
and Chang, 1979; Bendich et al., 1986; Chow, 1991). Vitamin C protected against loss 
of vitamin E in cultured rat hepatocytes (Halpner et al., 1998). It was reported that 
lipid-soluble free radical generator (AMVN) reduced by 35% the accumulation of α-
tocopherolquinone, suggesting a recycling rather than an exclusive sparing action of 
vitamin C.  
 
α-Tocoperol can protect β-carotene by the recycling of a α-tocoperol radical. 
A synergistically protective relationship between α-Tocoperol and β-carotene was 
observed (Leibovitz et al., 1990; Palozza and Krinsky, 1992). The authors 
hypothesized that a chain reaction initiating β-carotene peroxyl radical can be formed 
upon oxygen attack. The addition of α-tocoperol and β-carotene substantially facilitate 
the antioxidant activity of the β-carotene by limiting the production or reactivity of β-
carotene peroxyl radical. The added α-tocoperol is consumed as it protects β-carotene 
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from autoxidation. Palozza and Krinsky (1991) observed that α-Tocoperol and β-
carotene have an additive effect in inhibiting radical-initiated lipid oxidation of lipid 
extracts from rat liver microsomes using hexane solutions. It seems that the 
cooperative interaction between ascorbic acid and β-carotene is unlikely at the lipid 
bilayer of membrane or at the core of lipoproteins due to the localization of β-carotene 
(Niki et al., 1995). The inhibiting action of ascorbic acid, α-tocoperol, and β-carotene, 
alone or together, was studied by Böhm et al. (1998). Interestingly, they found a 
synergistic effect of the three antioxidants compared with the individual antioxidants, 
explaining such a synergism by assuming an electron tansfer reaction in which the β-
carotene radical is repaired by vitamin C.  
 
 
1.9.2.2. Antiproliferative and other Biological Effects 
In addition to antioxidant activities, phenolics have demonstrated other specific 
biological activities interfering with cellular mechanisms. Conte et al. (2003) reported 
synergistic protection of PC12 cells from β-amyloid toxicity by reservatrol and 
catechin. Compounds can offer additive or synergistic interaction against different 
biochemical targets. It was found that quercetin could enhance the action of 
carboxyamidotriazole (CAD) in human breast carcinoma MDA-MB-435 cells (Yeh et 
al., 1995). When quercetin and CAD were added to the MDA-MB-435 cells, 
synergism was observed in isobolograms in growth inhibition and clonogenic assays. 
The most effective combination was 20 μM quercetin with 4 μM CAD in growth 
inhibition assay; 30 μM quercetin with 1.2 μM CAD in clonogenic assay. RSV and 
quercetin additively activate caspase 3 in human pancreatic carcinoma cells (Mouria et 
al., 2002), and synergistically induce apoptosis in human leukemia cells (Mertens-
Talcott and Percival, 2005). The effect of a combination of quercetin (25 μM) and 
trans-RSV (25 μM) on mitochondrial cytochrome c release and caspase-3 activity was 
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greater than the expected additive response. The synergistic action with those two 
agents support the concept that the flavonoids (quercetin) and nonflavonoids (trans-
RSV) act on the membrane permeability transition by distinct pathways, suggesting 
that the pathways are interactive (Mouria et al., 2002). Studies in cell cycle kinetics, 
proliferation, and apoptosis (caspase-3 activity) in human leukemia cells (MOLT-4) 
were conducted after incubation with ellagic acid, quercetin, and RSV as single 
compounds and in combination. A synergistic interaction with a CI of 0.64 for the 
combination of ellagic acid and resveratrol, and a CI of 0.68 for quercetin and RSV 
were observed after isobolographic analysis, indicating that the anticarcinogenic 
potential of foods containing phenolics may not be based on the effects of individual 
compounds, but may involve a synergistic enhancement of the anticancer effects 
(Mertens-Talcott and Percival, 2005). Genistein acted in synergism with 
eicosapentaenoic acid (EPA) on MCF-7 cells (genistein > 93.2 μM and EPA > 210.9 
μM) and on MDA-MB-231 cells (genistein > 176.1 μM and EPA > 609.3 μM) 
(Nakagawa et al., 2000). The effects of EPA and an angiogenesis inhibitor (TNP-470) 
on the suppression of breast cancer cell growth were examined in five human breast 
cancer cell lines (MDA-MB-231, T-47D, MCF-7, KPL-1, and MKL-F). A 
combination of EPA and TNP-70 exerts synergistic activity against human breast 
cancer cells by accelerating apoptosis (Yamamoto et al., 1999). In MDA-MB-231 
cells, diallyl disulfide (DADS) antagonized the effect of linoleic acid (LA), and 
synergized the effect of EPA (Nakagawa et al., 2001). 
 
Anticancer activities of grape seed extract (GSE) and doxorubicin (Dox), either 
alone or in combination, in estrogen receptor-positive MCF-7 and receptor-negative 
MDA-MB468 human breast carcinoma cells were examined in order to enhance the 
efficacy of chemotherapy agents against breast cancer treatment (Sharma et al., 2004). 
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It was found that 100 µg/ml GSE in combination with 25–75 nM Dox treatment for 48 
h had a strong synergistic effect (CI < 0.5) in cell growth inhibition, but mostly an 
additive effect (CI ~ 1) in cell death in both MCF-7 and MDA-MB468 cells. 
 
Antioxidant vitamins of β-carotene, ascorbic acid and α-tocopherol, either 
combined or alone, were administered to rabbits with pacing-induced cardiomyopathy 
to assess the progression of congestive heart failure (Shite et al., 2001). It was 
observed that antioxidant vitamins combination decreased the myocardial oxidative 
stress, attenuated cardiac dysfunction, and prevented myocardial β-receptor 
downregulation. Administration of α-tocopherol alone produced similar effects, but 
the effects were less marked than those produced by the three vitamins together. A 
study of supplementing the diet with vitamin E, ginkgo biloba, pycnogenol, and 
ascorbyl palmitate in ApoE-deficient mice resulted in a significant increase in life 
span and a marked reduction of inclusion body histopathology in the hippocampus 
(Veurink et al., 2003). It is suggested that the combined actions of selected 
antioxidants may be therapeutically effective against neurodegenerative diseases such 
as Alzheimer’s disease. Using a balanced combination of several antioxidant nutrients, 
the SU.VI.MAX study (Hercberg et al., 2006) reported that a combination of 
antioxidants at nutritional doses lowered the incidence of cancers in healthy men by 31 
%, without any evident increased cancer risk, where the doses used is similar to a 
healthy diet with high consumption of fruits and vegetables. Carotenoids are involved 
in quenching singlet oxygen and in scavenging reactive oxygen radicals. Experiments 
with zeaxanthin alone and in combination with vitamin E or C were carried out to 
examine their ability to protect cultured human retinal pigment epithelium ARPE-19 
cells against oxidative stress (Wrona et al., 2004). It was concluded that cells with 
added antioxidants showed increased viability and accumulated less lipid 
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hydroperoxides than cells without the antioxidant, suggesting a synergistic action of 
zeaxanthin and vitamin E or C in efficient protection of cell membranes against 
oxidative damage induced by photosensitized reactions. Enhanced oxidative stress 
leads to a situation that favors atherothrombotic processes, thrombogenesis, and 
endothelial dysfunction in diabetes mellitus (Aydin et al., 2001). A recent study found 
that, in diabetic rats, the combination of α-tocopherol and aspirin exhibited a greater 
inhibitory effect on platelet aggregation than in untreated control animals with 
diabetes (Gonzalez-Correa et al., 2006). Also, the combination of the two compounds 
improved the thromboxane/prostacyclin balance in comparison to untreated diabetic 
animals and untreated healthy animals. This combination increased tissue 
concentrations of reduced glutathione; however, it did not potentiate the antioxidant 
effect of either compound alone.  
 
In a recent antioxidant combination study of NNK-induced lung carcinogenesis 
in smoke-exposed ferrets, combined β-carotene, ascorbic acid and α-tocopherol was 
found to maintain normal tissue
 levels of retinoic acid, and inhibit the activation of 
mitogen-activated
 protein kinase pathways, cell proliferation and phosphorylation
 of 
p53 (Kim et al., 2006), suggesting that the combination
 of nutrients, rather than 
individual agents, could be an effective
 chemopreventive strategy against lung cancer 
in smokers. 
 
1.9.2.3.  Induction of Phase II Detoxifying Enzymes 
Phenolics present in fruits and vegetables have numerous other biological 
effects, such as inducing phase II enzymes, that may be totally separate or act in 
concert with antioxidant
 activities. The interactions between sulforaphane and 
apigenin in the regulation
 of UGT and GST expression were examined in 
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undifferentiated CaCo-2 cells (Svehlíková et al., 2004). Sulforaphane in combination 
with apigenin led to a synergism, approximately 12-fold induction
 of UGT1A1 
mRNA, although this interaction was
 not observed for GSTA1, proposing that 
UGT1A1 and GSTA1 are regulated by sulforaphane through
 different signal 
transduction pathways. The combinations of phytochemicals in the whole vegetable 
may provide additional protection through the synergistic induction of 
chemoprotective enzymes, suggesting that the health benefits of whole vegetables may 
be greater than those of the isolated compounds (Jeffery and Stewart, 2004). The 
synergistic upregulation of phase II enzymes by glucosinolate breakdown products in 
cruciferous vegetables has been reported in animal models. Four glucosinolate 
derivatives were examined individually and as a mixture for their effects on NQO1, 
hepatic P4501A (CYP1A), GST, and glutathione reductase (G-Rd) levels (Staack et 
al., 1998). Indole-3-carbinol (I3C, 56 mg/kg) and crambene (50 mg/kg) had a 1.9- and 
2.5-fold increase in NQO1, respectively, in adult male F344 rats. It was observed that 
the I3C and crambene combination produced a synergistic effect on induction of 
NQO1 and GST. Furthermore, this lab tested whether the synergism is at the level of 
transcription. It was found that, after evaluating three subunits, GST Ya2 mRNA had a 
synergistic upregulation by crambene and I3C, while Yc1 and Yc2 showed only an 
additive response in adult male rats (Nho and Jeffery, 2001). Finally, it was concluded 
that a nitrile product of glucosinolate hydrolysis induced NQO1 mRNA levels and 
triggered the ARE, suggesting that synergistic upregulation of NQO1 is due to co-
activation of the ARE and the xenobiotic response element (XRE) by I3C acid 
condensates and crambene (Nho and Jeffery, 2004).  
 
The challenge for our research is to design and implement experimental studies 
to target the development of an understanding of many phytochemical interactions.  
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CHAPTER TWO 
 
PHYTOCHEMICAL PROFILES AND ANTIOXIDANT ACTIVITIES 
OF WINE GRAPES 
 
2.1. Introduction 
A large number of epidemiological studies have revealed that the consumption 
of fruits and vegetables is associated with a lowered risk for developing chronic 
diseases, such as coronary heart disease (CHD), cancer, diabetes, and Alzheimers’s 
disease (Block et al., 1992; Ames et al., 1993; Temple, 2000; Joshipura et al., 2001; 
Willett, 2002). The Caerphilly Study, which looked at 2,112 Welsh men, has shown 
that the consumption of vegetables and fruits could considerably reduce the risk of 
mortality from cancer (Hertog et al., 1996). A cohort study in Finland among 9,959 
men and women aged 15-99 years reported an inverse association between the intake 
of flavonoids and incidence of lung cancer (Knekt et al., 1997). The positive 
relationship between the consumption of fruits and vegetables and a reduced risk for 
CHD was reported by other prospective cohort studies, for examples, the Zutphen 
Elderly Study (Hertog et al., 1993), the Iowa Women’s Health Study (Yochum et al., 
1999), the US Health Professionals Study (Rimm et al., 1996), and a study of 5,000 
men and women in Finland (Knekt et al., 1996). Fruits and vegetables possess many 
bioactive compounds, including phenolics, vitamins, minerals, thiols, carotenoids, and 
glucosinolates. However, phytochemicals in fruits and vegetables, mainly phenolics 
and flavonoids, are suggested to be the major bioactive compounds responsible for 
their health benefits. Therefore, the National Cancer Institute recommends consuming 
five or more servings of fruits and vegetables per day.  
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The disturbance of in vivo ROS production and of the capacity of the 
endogenous antioxidant defense system will cause oxidative stress, resulting in 
cellular damage to DNA, proteins, or lipids, which is implicated in degenerative 
diseases (Ames et al., 1993). The presence of phytochemical compounds in fruits and 
vegetables play an important role in disease prevention, possibly through their effect 
on relieving oxidative damage by acting as antioxidants (Heinonen et al., 1998; 
Record et al., 2001; Liu, 2003; Liu, 2004). The traditional Western diet offers roughly 
1g/day of mixed flavonoids (Kühnau, 1976). Consumption of flavonoids was shown to 
be inversely associated with morbidity and mortality resulted from CHD (Hertog et 
al., 1993; Knekt et al., 1996). Besides antioxidant activity, flavonoids have many 
biological activities such as the inhibition of plasma platelet aggregation and 
cyclooxygenase (COX) activity, the suppression of histamine release and SRS-A 
biosynthesis in vitro (Hope et al., 1983); potent nitric oxide (NO) radical scavenging 
activity (Van Acker et al., 1995), and antibacterial, antiviral, anti-inflammatory, and 
antiallergenic effects (Cook and Samman, 1996). Flavonoids’ antiaging, 
anticarcinogenicity, and antimutagenicity properties originate from these activities, 
thus they potentially play a role in preventing a wide range of degenerative 
physiological processes. Phenolics and other plant antioxidants can scavenge free 
radicals, quench singlet oxygen, and act as chelators, and thus protect biological 
macromolecules from ROS attack. Hence, diet-derived antioxidants may be especially 
important in protecting against chronic diseases. There is an increasing interest in the 
health benefits of naturally occurring antioxidants contained in diets.  
 
Grapes are one of the popular fruits and are widely cultivated throughout the 
world. There are about 60 species of Vitis, which are mainly found in the temperate 
zones of the Northern Hemisphere, and almost equally distributed between America 
   69
and Asia (Mullins et al., 1992). Approximately 80% of the total grapes are used in 
winemaking, and 13% is consumed as table grapes (Mazza, 1995). The main wine-
making grape varieties include Cabernet Sauvignon, Chardonnay, Pinot Noir, Merlot, 
and Zinfandel. The major table grape varieties are Perlete, black Ribier, Tokay, and 
Emperor. V. vinifera grapes are commonly used for wine production around the world, 
principally distributed in Europe. Most studies in phenolic composition and related 
antioxidant activity have been done on grapes and wines using V. vinifera species. In 
the United States, species such as V. labrusca, V. riparia, V. aestivalis, V. rupestris, 
and V. rotundifolia are also used in wine-making. There are two main grape species in 
North America: V. labrusca and V. rotundifolia. The labrusca grapes are grown 
mostly in the lower Great Lakes region of the U.S. and Canada. The representative 
grape variety is the large purple berry - Concord. Due to its abundance in the United 
States, this grape is popular in making of juices and jellies. Grapes are rich in 
phenolics; most of them are present in the peel (Singleton, 1982). Phenolics in grape 
are classified into two groups: the flavonoids and nonflavonoids. The flavonoids 
include flavan-3-ols, flavonols, and anthocyanins. The nonflavonoids encompass 
hydroxybenzoates, hydroxycinnamates, and stilbenes. In the grape berry, the 
flavonoids are mainly localized in the skins, such as the anthocyanins and resveratrol, 
while the flavan-3-ols are presented both in the skins and seeds. However, the 
composition and concentration of phenolics in grapes vary with variety, species, 
season, and environmental and management factors such as soil conditions, climate, 
and crop load (Jackson and Lombard, 1993).  
 
Anthocyanins, widely distributed throughout the plant kingdom, are natural, 
nontoxic, and water-soluble flavonoid pigments, being particularly present in fruits 
and vegetables where they are responsible for the red, orange, blue, and purples colors. 
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Anthocyanins contains in daily diet after consuming certain fruits and vegetables. 
Grapes and berries are the major dietary sources of anthocyanins (Rechkemmer and 
Pool-Zobel, 1996). Anthocyanins are responsible for the coloring of black, red, and 
purple grapes, however, they are lacking in white grapes. In particular, anthocyanins 
mostly accumulate in the skins, whereas procyandins are located in the seeds. It was 
reported that Lomanto and Colobel hybrid grape cultivar had the highest anthocyanin 
content with 603 mg/100g; Midsouth cultivar contained the lowest content with 5.5 
mg/100g (Mazza, 1995). The content of anthocyanins in the skin of grapes was 
estimated from 200 ~ 5000 mg/kg of fresh whole grape (Riberau-Gayon, 1982). The 
average content of anthocyanins in red wines is estimated at 26 mg/L (Frankel et al., 
1995). The anthocyanins in grape skins are predominately the 3-O-glucosides of 
malvidin, cyanidin, delphinidin, peonidin, and petunidin (Wrolstad, 2000). Malvidin, 
the reddest of all anthocyanins (Jackson, 1994), is the major one in dark red vinifera 
grape with higher proportions of cyanidin in red grape. Cyanidin 3-monoglucoside and 
delphinidin 3-monoglucoside are major anthocyanins in Concord grapes. Grape 
anthocyanins play a crucial role in the color quality of red wines, and have been 
increasingly used as food colorants and nutraceuticals. Anthocyanins possess 
antioxidant activity, being considered to be an important physiological function (Wang 
et al., 1997; Ehlenfeldt and Prior, 2001; Kalt et al., 2001; Connor et al., 2002; Moyer 
et al., 2002). Additively, anthocyanins have been reported to have anti-inflammatory 
(Wang et al., 1999), anticancer activity (Kamei et al., 1995; Bomser et al., 1996; Hou, 
2003), apoptotic induction effect (Katsube et al., 2003), α-glucosidase inhibition 
activity (Matsui et al., 2001), vision improvement (Matsumoto et al., 2003), and 
effects on collagen, blood platelet aggregation, and capillary permeability and fragility 
(Kalt and Dufour, 1997). Dietary consumption of anthocyanins has been demonstrated 
to improve overall antioxidant defense status of human plasma (Cao and Prior, 1999). 
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In LPS/IFN-γ-activated RAW 264.7 macrophages, anthocyanins have been 
demonstrated to have significant inhibitory effect on NO production (Wang and 
Mazza, 2002). In 2003, (Katsube et al., 2003) have reported that anthocyanins inhibit 
the growth of HL60 cells through the induction of apoptosis. The growth inhibitory 
effects of anthocyanins in K562 leukemia and HCT-15 carcinoma cells are greater 
than those of other flavonoids, such as flavanons and flavonols (Kamei et al., 1995). 
Thus, anthocyanins as naturally occurring bioactive compounds and pigments present 
in foods have attracted interest due to their safety and health benefits.  
 
Resveratrol (3, 4’, 5-trihydroxystilbene, RSV), synthesized by some plants in 
response to adverse conditions such as pathogenic attack and environmental stress, is 
found in various food products. It is particularly high in grape skins, seeds, and in red 
wine (Langcake and Pryce, 1976). RSV is present in cis and trans isoforms and the 
major trans isomer is the biologically active one (Bhat et al., 2001b). The ‘French 
Paradox’ has been suggested that RSV might be the main active component in red 
wine (Frankel et al., 1993a; Kopp, 1998). Thus, RSV has attracted considerable
 
attention due to its cardioprotective and cancer chemopreventive
 activities (Jang et al., 
1997), which provide great interest in grapes, wines, and dietary products containing 
RSV. The proposed mechanisms related to RSV’s health effects can be summarized as 
scavenging
 intracellular ROS (Manna et al., 2000), inhibiting the oxidation of LDL 
(Frankel et al., 1993b), preventing platelet aggregation (Pace-Asciak et al., 1995), 
suppressing cell proliferation via steps in the signal transduction pathways (Pozo-
Guisado et al., 2002), inducing apoptotic cell death through activation of 
mitochondria-dependent pathways (Huang et al., 1999), exhibiting anti-inflammatory 
activity
 via down-regulation of proinflammatory cytokines (Wadsworth and Koop, 
1999), promoting cellular differentiation (Mizutani et al., 1998), exhibiting 
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antiestrogenic activity (Lu and Serrero, 1999), and inhibiting of CYP1 enzymes 
(Chang et al., 2001).  
 
The beneficial health-related effects of certain phenolics and flavonoids in 
grapes are of importance to consumers, breeders, and the grape industry. There is 
limited knowledge about the phytochemical profiles, antioxidant and antiproliferative 
activities in both Vitis vinifera and non-Vitis vinifera wine grapes grown in Finger 
Lake area in New York State. The objectives for this study were: (1) to determine the 
profiles of total phenolics, total flavonoids, total anthocyanins, and resveratrol in 
selected grapes grown in Finger Lake areas; (2) to measure the total antioxidant 
activity; (3) to determine the antiproliferative activity of grape extracts against human 
colon, liver, and breast cancer cells in vitro.  
 
 
 
2.2. Materials and Methods 
2.2.1. Chemicals 
Sodium nitrite, (+)-catechin, Folin-Ciocalteu reagent (FCR), hydrochloric acid, 
glucagon, hydrocortisone, insulin, α-keto-γ-methiolbutyric acid (KMBA), and tran-
RSV were purchased from Sigma Chemical Co. (St. Louis, MO).  Aluminum chloride, 
sodium hydroxide, methanol, and acetone were purchased from Fisher Scientific 
(Pittsburgh, PA).  Gallic acid was purchased from ICN Biomedical Inc. (Costa Mesa, 
CA).  2,2’-Azobis(amidinopropane) (ABAP) was purchased from Wako Chemicals 
(Richmond, VA). 
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2.2.2. Grapes 
Fourteen wine grape varieties (Baco Noir, Cabernet Franc, Catawba, Cayuga 
White, Chancellor, Chardonnay, Concord, DeChaunac, Marechal Foch, Niagara, Pinot 
Noir, Riesling, Sheridan, and Vidal Blanc) were provided by New York State Wine 
and Grape Foundation. General descriptions of the grape varieties are given in Table 
2.1. Wine grapes were harvested upon ripening in 2003 and 2004. Grapes were 
selected that were free from visible blemish or disease. For quantitative analysis, 
50~70 grape berries randomly selected from each grape variety were collected for 
extraction. All data collected for each grape variety were reported as means ± SD for 
at least three replications.  
 
2.2.3. Extraction of Total Phenolic Compounds 
Total phenolics were extracted from fresh grapes by the modified method 
reported previously in our laboratory (Sun et al., 2002a; Yang et al., 2004). Briefly, 
100 g of grapes were blended for 1 min in 100 g of 80% acetone using a Waring 
blender with medium speed to remove seeds. After removal of seeds and adding 
additional 100 g of 80% acetone, the grapes were blended for 3 min using a Waring 
blender with high speed. The mixture was then homogenized in a Virtis High Speed 
Homogenizer for 3 min and filtered with vacuum under ice bath. The acetone in the 
filtrate was evaporated using a rotary evaporator at 45°C until the weight of the 
evaporated filtrate was less than 10% of the weight of the original filtrate. All extracts 
were stored at –40°C until use. All extractions were performed in triplicate. 
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Table 2.1. Description of grape varieties 
Cultivar Color  Storage Vintage  Growing  Location 
Vinifera        
    Cabernet Franc  Dark purple/blue  - 40°C  2004  Finger Lakes area, NY
    Chardonnay  Green  - 40°C  2004  Finger Lakes area, NY
    Pinot Noir  Dark purple/blue  - 40°C  2004  Finger Lakes area, NY
    Riesling  Green  - 40°C  2004  Finger Lakes area, NY
Hybrid        
    Baco Noir  Dark purple  - 40°C  2004  Finger Lakes area, NY
    Catawba  Pink  - 40°C  2003  Finger Lakes area, NY
    Cayuga White  Green  - 40°C  2004  Finger Lakes area, NY
    Chancellor  Dark purple/blue  - 40°C  2004  Finger Lakes area, NY
    Concord  Red, purple  - 40°C  2004  Finger Lakes area, NY
    DeChaunac  Dark blue  - 40°C  2004  Finger Lakes area, NY
    Marechal Foch  Dark purple  - 40°C  2004  Finger Lakes area, NY
    Niagara  Green  - 40°C  2004  Finger Lakes area, NY
    Sheridan  Red, purple  - 40°C  2003  Finger Lakes area, NY
    Vidal Blanc  Green  - 40°C  2003  Finger Lakes area, NY
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2.2.4. Determination of Total Phenolic Content 
The total phenolic content in grapes was determined using the Folin-Ciocalteu 
colorimetric method (Singleton et al., 1999), which was modified by our laboratory 
(Yang et al., 2004). Briefly, all extracts were diluted 1:10 with distilled water to obtain 
readings within the standard curve ranges of 0.0 - 600.0 µg of gallic acid/mL. The 
grape extracts were oxidized by Folin-Ciocalteu reagent and the reaction was 
neutralized with sodium carbonate. The absorbance was measured at 760 nm after 90 
min at room temperature by a MRX II Dynex plate reader (Dynex Technologies, Inc., 
Chanilly, VA). The absorbance values were then compared with those of standards 
with known gallic acid concentrations. All values were expressed as the mean 
(milligrams of gallic acid equivalents per 100 g of fresh sample) ± SD for three 
replications.  
 
2.2.5. Determination of Total Flavonoid Content 
The total flavonoid content of the grape extract was determined using a 
modified colorimetric method (Jia et al., 1999; Yang et al., 2004). Briefly, 0.25 mL of 
1:10 diluted grape extract was mixed with 1.25 mL of distilled water, and 
subsequently with 0.075mL of 5% sodium nitrite solution, and allowed to react for 5 
min. Then 0.15 mL of 10% aluminum chloride was added and allowed to further react 
for 6 min before 0.5 mL of 1 M sodium hydroxide was added. Distilled water was 
added to bring the final volume of mixture to 3 mL. The absorbance of the mixture 
was immediately measured at 510 nm wavelength against a prepared blank using a 
MRX II DYNEX spectrophotometer. The flavonoid content was determined by a 
catechin standard curve and expressed as mean (milligrams of catechin equivalents per 
100 g of fresh sample) ± SD for the triplicate extracts. 
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2.2.6. Determination of Anthocyanin Content 
Monomeric anthocyanin content of the grape extract was measured using a 
modified pH differential method (Boyles and Wrolstad, 1993; Wolfe et al., 2003). The 
grape extracts were mixed thoroughly with 0.025 M potassium chloride pH 1 buffer in 
1:2 ratio of extract to buffer. The grape extracts were then mixed similarly with 
sodium acetate buffer pH 4.5. A Beckman DU640B spectrophotometer was used to 
measure absorbance at 510 and 700 nm against a buffer blank at pH 1.0 and 4.5. 
Absorbance readings were converted to total milligrams of cyanidin 3-glucoside 
(C3G). The anthocyanin content was calculated as follows:  
 
510 700 1.0 510 700 4.5
Total monomeric anthocyanins (mg/100g) =        1000/( )
() () pH pH
AM W C
AA A A A
ε Δ ×× ×
Δ= − − −
 
where A is absorbance; MW (449.2) is molecular weight for C3G; ε (26,900) is the 
molar absorptivity of C3G; and C is the concentration of the grape extract in 
milligrams per milliliter. Anthocyanin content was expressed as milligrams of C3G 
equivalents per 100 g of fresh grape for the tripicate extracts. 
 
2.2.7. Reverse-Phase HPLC Analysis of Resveratrol 
A 3-mL grape sample was extracted in a test-tube with 5 mL of ethyl ether, 
and then the mixture was put into shaker with 200 rpm for 15 mins. Organic phase was 
transferred into a new test-tube. The residues were extracted with 5 mL of ethyl 
acetate twice using the same condition. The organic solvent in a new test-tube was 
evaporated through flushing with N2. The dry residue was dissolved in 1 mL 
methanol, and the aliquots were than analyzed by RP-HPLC.    
Stock solution containing 14.4 mg/mL of resveratrol in methanol was 
prepared. Solution was stored at -4°C in the darkness after elimination of oxygen with 
   77
a N2 to avoid the oxidation or decomposition of phenolic compounds. Rresveratrol in 
grape extracts was quantified using a RP-HPLC procedure employing a Supelcosil 
LC-18-DB, 150 mm × 4.6 mm, 3 μm column. Samples of 20 μL standard or grape 
methanolic extracts were directly injected into the column. Elution was carried out 
with a mobile phase delivered using a Waters 515 HPLC pump (Waters Corp., 
Milford, MA) at a flow rate of 1.2 mL/min according to the following gradient: the 
initial mixture was acetonitrile – water (9:91) adjusted to pH 2 with triflouroacetic 
acid for 10 mins; linear gradient to (25:75) in 10 mins, hold for 10 mins; linear 
gradient to (70:30) in 1 min, hold for 12 mins. A Waters 2487 wavelength absorbance 
detector (Waters Corp. Milford, MA) was used for UV detection of analytes at 307 
nm. Data signals were acquired and processed on a PC running the Waters Millennium 
software, version 3.2 (1999) (Waters Corp. Milford, MA). Three HPLC injections 
were performed for each extract. Peak heights were used for all calculations. The 
recovery for RSV analyses was 104.78 ± 4.87% (n = 4).  
 
2.2.8. Determination of Total Antioxidant Capacity 
The total antioxidant capacity of grape extracts was measured using a total 
oxyradical scavenging capacity (TOSC) assay (Winston et al., 1998) as modified in 
our laboratory (Yang et al., 2004). In this assay, peroxy radicals produced from 2,2'-
azobis-amidinopropane (ABAP) oxidize α-keto-γ-methiolbutyric acid (KMBA) to 
form ethylene gas, which was measured by gas chromatographic headspace analysis. 
Briefly, antioxidant activity was quantified after 15, 30, 45, and 60 min for four 
different grape extract concentrations and a control. The amount of ethylene generated 
by the reaction was expressed as peak area. The TOSC value corresponding to each 
extract concentration was calculated by integrating the area under the kinetic curve, 
and assessed as the following equation:  , where,    100 ) / ( 100 × ∫ ∫ − = CA SA TOSC SA ∫
   78
is the integrated area from the sample reaction, and   is the integrated areas from 
the control reaction. The median effective dose (EC
CA ∫
50) was determined for each grape 
variety from the dose-response curve of grape concentration versus TOSC value. The 
TOSC value is expressed as µmol of vitamin C equivalents per gram of sample. All 
values were presented as the mean ± SD at least three replicates.  
 
2.2.9. Measurement of Inhibition of Caco-2, HepG2, and MCF-7 Cell Proliferation 
The antiproliferative activity of different grape extracts was assessed by 
measurement of the inhibition of Caco-2, HepG2, and MCF-7 (The American Type 
Culture Collection, ATCC, Rockville, MD) human cancer cell proliferation. 
Antiproliferative activities were determined by the colorimetric MTS assay (MTS-
based cell titer 96 nonradioactivity cell proliferation assay) (Promega, Madison, WI) 
reported previously (Yang et al., 2004). HepG2 - human liver cancer cells were 
cultured in Williams medium E (WME), containing 10 mM Hepes, 5 µg/mL insulin, 
0.05 µg/mL hydrocortisone, 2 µg/mL glucagon, and 5% fetal bovine serum (Gibco, 
Life Technologies, Grand Island, NY), 50 units/mL penicillin, 50 µg/mL 
streptomycin, and 100 µg/mL gentamicin. Caco-2 - human colon cancer cells were 
maintained in DMEM, containing 10 mM Hepes, 5% FBS, 50 units/mL penicillin, 50 
µg/mL streptomycin, and 100 µg/mL gentamicin. MCF-7 human breast cancer cells 
were maintained in Alpha Minimum Essentail Medium (MEM-a), containing 10 mM 
Hepes, 0.01 mg/mL insulin, 50 units/mL penicillin, 50µg/mL streptomycin, 100 
µg/mL gentamicin, and 10% fetal bovine serum (Gibco, Life Technologies, Grand 
Island, NY). HepG2, Caco-2, and MCF-7 cells were maintained in a 5% CO2/37°C 
incubator. A total of 2.5 × 10
4 HepG2 or Caco-2 or MCF-7 cells in growth media were 
placed in each well of a 96-well flat-bottom plate. Cell proliferation was measured by 
the ability of viable cells to reduce 3-(4,5-dimethylthiazol-2-yl)-5-(3-
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carboxymethoxyphenyl)-2-(4-sulfenyl)-2H-tetrazolium (MTS) to formazan. After 4 h 
of incubation, the growth medium was removed and media containing various 
concentrations (2, 5, 10, 20, 30, 40, 50, 75, and 100 mg/mL) of grape extracts were 
added to the cells. Control cultures received the extraction solution minus the grape 
extracts, and blank wells contained 100 µL of growth medium without cells. Cell 
proliferation (percent) was determined at 96 h from the MTS absorbance (490 nm) 
reading for each concentration compared to the control, using at least three 
replications for each sample. The effective median dose (EC50) was determined and 
expressed as milligrams of grape extracts per milliliter ± SD.  
 
2.2.10. Statistical Analysis 
Statistical analysis was performed using Minitab Student Release 12 (Minitab 
Inc., State College, PA) and SigmaStat Version 8.0 (Jandel Corp., San Raphael, CA). 
Results were subjected to ANOVA, and differences between means were located 
using Tukey’s multiple comparison test. Correlations between various parameters 
were also investigated. Significance was determined at p<0.05. All data were reported 
as the mean ± SD of three replications. 
 
 
2.3. Results 
2.3.1. Total Phenolic Content 
Total phenolic content of fourteen wine grapes are presented in Figure 2.1. 
Among all the grape varieties analyzed, Cabernet Franc and Pinot Noir had the highest 
total phenolic content (424.6 ± 3.8 and 396.8 ± 12.4 mg of gallic acid 
equivalents/100g of grape, respectively), followed by Concord (334.0 ± 13.6), 
Sheridan (331.39 ± 8.21), Chancellor (325.8 ± 21.7), Marechal Foch (312.5 ± 10.9), 
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Catawba (311.7 ± 9.1), DeChaunac (293.5 ± 21.6), Riesling (255.8 ± 8.8), Niagara 
(229.6 ± 3.9), Vidal Blanc (230.0 ± 5.5), Baco Noir (217.0 ± 14.1), Cayuga White 
(206.3 ± 8.2), and Chardonnay (201.1 ± 4.9). Significant differences were found in 
total phenolic content in comparisons between Cabernet Franc and Concord, Pinot 
Noir and Sheridan, Chancellor and Riesling, and DeChaunac and Niagara (p<0.05); 
however, significant differences in total phenolic content were not found between 
Cabernet Franc and Pinot Noir, between Riesling and Niagara, among Concord, 
Sheridan, Chancellor, Marechal Foch, and Catawba, and among Vidal Blanc, Baco 
Noir, Cayuga White, and Chardonnay (p>0.05). The results show that the red grape 
varieties except Baco Noir contain high concentrations of total phenolics. In contrast, 
the green grapes have lower phenolic content. There was a 2.1-fold difference in total 
phenolic content between the highest and lowest ranked varieties, Cabernet Franc and 
Chardonnay (p < 0.05).   
 
Total flavonoids of the fourteen grape extracts were measured (Figure 2.2). 
The Pinot Noir showed the highest flavonoid content (301.8 ± 6.2 mg of catechin 
equivalents/100 g of fresh grapes, p<0.05), followed by Catawba (181.0 ± 5.4), 
Cabernet Franc (181.0 ± 15.3), Cayuga White (176.1 ± 10.7), Niagara (173.1 ± 11.3), 
Concord (168.2 ± 6.0), Sheridan (166.8 ± 1.4), Chardonnay (166.4 ± 20.4), Chancellor 
(140.0 ± 18.8), Riesling (133.5 ± 13.7), Marechal Foch (127.0 ± 14.2), DeChaunac 
(114.0 ± 12.0), Vidal Blanc (101.0 ± 9.4), and Baco Noir (98.0 ± 10.0). The flavonoid 
content of Pinot Noir, Catawba, Chancellor, and Baco Noir was significantly different 
from each other (p<0.05). However, significant differences in the total flavonoid 
content were not found in comparisons among Catawba, Cabernet Franc, Cayuga 
White, Niagara, Concord, Sheridan, and Chardonnay, and among Chancellor, 
Riesling, Marechal Foch, DeChaunac, Vidal Blanc, and Baco Noir (p>0.05). An about 
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3.1-fold difference in total flavonoid content was found between the highest and 
lowest ranked varieties, Pinot Noir and Baco Noir (p<0.05). 
 
Total anthocyanin contents of nine red grape extracts were determined (Figure 
2.3). DeChaunac had the highest total anthocyanin content (239.6 ± 25.4 mg of 
cyanidin 3-glucoside equivalents/100g of grapes, p < 0.05), followed by Chancellor, 
Marechal Foch, Baco Noir, Concord, Cabernet Franc, Sheridan, Pinot Noir, and 
Catawba. There was significant difference (p < 0.05) in anthocyanin content between 
DeChaunac, Chancellor, Baco Noir, Cabernet Franc, and Catawba. However, 
significant differences in the anthocyanin content were not observed between 
Chancellor and Marechal Foch, between Baco Noir and Concord, among Cabernet 
Franc, Sheridan, and Pinot Noir (p > 0.05). In addition, anthocyanins were not 
detected for all five green grape varieties.   
 
Resveratrol content of fourteen grape extracts was quantified (Figure 2.4). 
Baco Noir variety contained the highest RSV content (571 ± 30 μg/100g of fresh 
sample), followed by Pinot Noir (421 ± 54), Vidal Blanc (263 ± 16), Marechal Foch 
(130 ± 8), Cabernet Franc (119 ± 8), Chancellor (117 ± 7), Sheridan (112 ± 10), 
Riesling (80 ± 7), DeChaunac (75 ± 6), Chardonnay (73 ± 9), Catawba (72 ± 5), 
Concord (65 ± 8), Niagara (53 ± 4), and Cayuga White (38 ± 2). There were 
significant differences (p < 0.05) in RSV content among Baco Noir, Pinot Noir, Vidal 
Blanc, Marechal Foch, and Chardonnay. However, no significant differences in RSV 
content were found among Marechal Foch, Cabernet Franc, Chancellor, Sheridan, 
DeChaunac, and Riesling, among Chardonnay, Catawba, Concord, Niagara, and 
Cayuga White (p > 0.05).  
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Figure 2.1. Total phenolic content of fourteen grape varieties (mean ± SD, n = 3). Bars 
with no letters in common are significantly different (p < 0.05). 
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Figure 2.2. Total flavonoid content of fourteen grape varieties (mean ± SD, n = 3). 
Bars with no letters in common are significantly different (p < 0.05). 
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Figure 2.3. Total anthocyanin content of nine red grape varieties (mean ± SD, n = 3). 
Bars with no letters in common are significantly different (p < 0.05). 
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Figure 2.4. Resveratrol content of fourteen grape varieties (mean ± SD, n = 3). Bars 
with no letters in common are significantly different (p < 0.05). 
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2.3.2. Total Antioxidant Activity 
Total antioxidant activities of the fourteen grape varieties, expressed as 
micromoles (μmol) of vitamin C equivalents per gram of fresh grape, are shown in 
Figure 2.5. Phytochemical extracts of Cabernet Franc had the highest antioxidant 
activity (149.0 ± 10.0 μmol/g, p < 0.05), followed by Pinot Noir (122.4 ± 5.7), 
Concord (106.0 ± 6.0), Sheridan (106.6 ± 3.6), Chancellor (102.8 ± 6.0), Marechal 
Foch (100.2 ± 6.0), Catawba (98.0 ± 4.6), DeChaunac (96.3 ± 6.1), Riesling (79.8 ± 
4.3), Niagara (65.3 ± 3.8), Vidal Blanc (64.7 ± 2.5), Baco Noir (63.4 ± 4.6), Cayuga 
White (63.3 ± 4.6), and Chardonnay (61.9 ± 6.1). A statistically significant difference 
(p<0.05) was found Among Cabernet Franc, Pinot Noir, Chancellor, Riesling, and 
Chardonnay. The total antioxidant activities of Pinot Noir and Concord were similar (p 
> 0.05) but lower (p < 0.05) than that of Cabernet Franc. No significant difference 
(p>0.05) was found among Concord, Sheridan, Chancellor, Marechal Foch, Catawba, 
and DeChaunac, among Riesling, Niagara, and Vidal Blanc, and among Vidal Blanc, 
Baco Noir, Cayuga White, and Chardonnay grapes. The varieties containing high total 
phenolic content had higher antioxidant activity.  
 
2.3.3. Inhibition of Human Cancer Cell proliferation 
The effect of 14 wine grape varieties on the growth of Caco-2 human colon 
cancer cells, HepG2 human liver cancer cells, and MCF-7 human breast cancer cells in 
vitro are summarized, respectively, in Figure 2.6. Grape extracts had potent 
antiproliferative activity against human colon, liver, and breast cancer cells in a dose-
dependent manner. Among the 14 grape varieties tested, Cabernet Franc, Pinot Noir, 
Chardonnay, Catawba, Concord, Sheridan, Niagara, and Riesling show relatively high 
antiproliferative activities toward both Caco-2 and HepG2 cells.  Cabernet Franc and 
Catawba exhibit relatively strong antiproliferative activities toward MCF-7 cells.   
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Figure 2.7 presents the EC50 of the antiproliferative activity of different grape 
varieties. Lower EC50 values represent higher antiproliferative activities. The 
phytocemical extracts of Pinot Noir and Cabernet Franc possess the greatest 
antiproliferative activity toward Caco-2 cells with the lowest EC50 of 9.5 ± 1.4 and 
10.0 ± 1.0 mg/mL (p<0.05), respectively, followed by Chardonnay, Catawba, Concord, 
Sheridan, Niagara, Riesling, DeChaunac, Cayuga White, Baco Noir, Chancellor, Vidal 
Blanc, and Marechal Foch. The EC50 doses were significantly different among Pinot 
Noir, Concord, Niagara, Baco Noir, and Marechal Foch (p < 0.05). The phytochemical 
extract of Marechal Foch exhibited a weak antiproliferative activity toward Caco-2 
cells at a higher dose with an EC50 of 37.2 ± 1.5 mg/mL.  
 
The antiproliferative activities of grape extracts toward HepG2 human liver 
cancer cells were somewhat different from those toward Caco-2 cells. The 
phytochemical extract of Pinot Noir and Chardonnay varieties exhibit the strongest 
antiproliferative effect toward HepG2 cells with the lowest EC50 of 17.0 ± 0.8 mg/mL 
and 18.1 ± 0.1 mg/mL (p < 0.05), respectively, followed by Cabernet Franc, Sheridan, 
Catawba, Riesling, Niagara, Concord, Cayuga White, Vidal Blanc, and DeChaunac. 
Cabernet Franc and Sheridan had similar EC50 values (p > 0.05). The phytochemical 
extracts of Vidal Blanc and DeChaunac showed a weak antiproliferative activity at 
higher doses with the EC50 of 52.1 ± 2.1 and 52.2 ± 3.0 mg/mL, respectively. 
Although demonstrated HepG2 cell proliferative, the EC50 values of the Baco Noir, 
Chancellor, and Marechal Foch varieties could not be calculated at the maximum 
doses used in this experiment.   
 
The antiproliferative activities of grape extracts on MCF-7 human breast 
cancer cells were different from both HepG2 and Caco-2 cells. The phytochemical 
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extract of Cabernet Franc contained the lowest EC50 at 64.0 ± 3.9 mg/mL, indicating 
the most antiproliferative effect toward MCF-7 cells of the varieties examined (p < 
0.05). There were statistical differences among the EC50 values of Catawba, 
Chardonnay, and Riesling varieties (p<0.05). Although they exhibited inhibition of 
MCF-7 cell proliferation, the EC50 values of the Pinot Noir, Concord, DeChaunac, 
Cayuga White, Baco Noir, Chancellor, Vidal Blanc, and Marechal Foch varieties 
could not be calculated from the maximum doses used in this experiment.   
 
2.3.4. Relationship Between Total Phenolic Content and Antioxidant Activity 
Correlations between total phenolics, total flavonoids, total antioxidant 
activity, and cell proliferation EC50 values were analyzed for the 14 grape varieties. A 
significant linear relationship was found between total phenolic and total antioxidant 
activity in the phytochemical extracts from different grape varieties (R
2 = 0.9775, p < 
0.05, Figure 2.8). The positive correlation indicates that the higher total phenolic 
content resulted in a higher total antioxidant activity. There were no other significant 
relationships observed.  
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Figure 2.5. Total antioxidant activity of phytochemical extracts of fourteen grape 
varieties (mean ± SD, n = 3). Bars with no letters in common are significantly 
different (p < 0.05). 
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Figure 2.6. Percent inhibition of Caco-2 (a), HepG2 (b), and MCF-7 (c) cancer cell 
proliferation by fourteen grape extracts. 
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Figure 2.6 (Continued) 
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Figure 2.7. EC50 of antiproliferative activity of phytochemical extracts of fourteen 
grape varieties (mean ± SD, n = 3). 
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Figure 2.8. Relationship between total phenolic content and total antioxidant activity 
of fourteen grape varieties. 
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2.4. Discussion 
Oxidative stress arising from an imbalance in human antioxidant status 
contributes to the pathology of chronic diseases (Ames et al., 1993; Temple, 2000; 
Record et al., 2001). Besides endogenous defenses, the consumption of dietary 
antioxidants contained in fruits and vegetables plays an important role in protecting 
against those pathological events. Previously, much attention has been paid to the 
antioxidant properties of ascorbic acid, tocopherol, and β-carotene. In recent years, 
phytochemicals, especially phenolics, have attracted increasing attention for their 
antioxidant activities. A study from our group has shown that the vitamin C content in 
whole apples contributes only 0.4% of the total antioxidant activity; suggesting that 
most antioxidant activity is derived largely from phytochemicals such as phenolic 
compounds, flavonoids, and anthocyanins (Eberhardt et al., 2000). This work has 
clearly shown that the phytochemicals present in grapes have potent antioxidant and 
antiproliferative activities, and that antioxidant activity in grapes is positively 
correlated with total phenolic content. 
 
It is well known that both genetic and agronomic or environmental factors play 
important roles in phenolic composition and thus the nutritional quality of crops 
(Tomas-Barberan and Espin, 2001). In our study, the total phenolic contents of 
Cabernet Franc and Pinot Noir were the highest (p < 0.05) at 424.6 ± 3.8 and 396.8 ± 
12.4 mg/100g of fresh sample, respectively. Chardonnay had the lowest (p < 0.05) 
total phenolic content at 201.1 ± 4.9 mg/100g of fresh grape. There exists a 2.1-fold 
difference in total phenolic content between the highest and the lowest ranked 
varieties, Cabernet Franc and Chardonnay (p < 0.05). The total flavonoid content of 
Pinot Noir was around 3.1-fold higher than that of Baco Noir, which had the lowest 
content. The average number of phenolic compounds for seeded Vitis vinifera varieties 
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from California is about 4,000 for white grape and 5,500 mg gallic acid equivalents 
(GAE)/kg for red ones (Singleton and Esau, 1969). In 2002, Mattivi et al have studied 
25 high-quality red grape cultivars (V. vinifera), and found that the Schiava variety 
contained the lowest phenolic content with 1358 mg/kg, and the Sagrantino variety 
had the highest phenolic content with 4628 mg/kg, resulting in a variability factor of 
2.7 in the richness of phenolics between the values of the varieties with the average 
concentrations. (Kanner et al., 1994) (1994) also found a variation in phenolic content 
among Thomson seedless, Flame seedless, and Black seedless grapes, ranging from 
260 to 930 mg/kg of fresh weight. It was estimated that the total phenolics in juice, 
pulp, skins, and seeds are approximately 5%, 1%, 30%, and 64%, respectively 
(Singleton and Esau, 1969; Singleton, 1982). Generally, the total phenolics of red 
grape skins is greatly higher than that of white grapes due to the loss of the ability to 
produce anthocyanins in the skins of white grapes. However, our result showed that 
the phenolic content of different grapes depends mainly on the varietal differences, not 
on grape skin color. For example, Baco Noir variety had lower contents of total 
phenolics and flavonoids than Riesling, Niagara, and Vidal Blanc.  
 
The study of anthocyanins is important for differentiating the quality and 
health benefits of grapes and red wines derived from grapes. As a characteristic 
associated with the variety, the level of anthocyanins in grape can serve as a direct 
estimate of the red pigments, and be useful for the classification of grape varieties and 
of relevant wines (Mattivi and Nicolini, 1997). Hence, anthocyanins have been 
proposed as chemical markers to differentiate grape varieties and red wines (Santos et 
al., 1991; Mattivi and Nicolini, 1997). The concentration and composition of the 
anthocyains in red grapes varies greatly with the variety, species, maturity, production 
area, and climate. In assessing red grape varieties for total anthocyanin content, we 
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found that broad variability exists. This is not surprising since these secondary 
metabolites are synthesized under genetic control in different varieties. In our study, 
DeChaunac variety contained the highest total anthocyanin content at 239.6 ± 25.4 
mg/100 g of sample, whereas Catawba had the lowest one at 8.1 ± 0.8 mg/100g of 
sample, indicating almost 30-fold difference. The total anthocyanin content of red 
grapes is from about 30 to 750 mg/g of fresh weight of ripe berries (Mazza, 1995). 
The content of anthocyanins in skin of three Vitis vinifera L. grapes was 753-803 
mg/kg for Pinot Noir, 826-1048 mg/kg for Cabernet Franc, and 981-1043 mg/kg for 
Merlot (Mazza et al., 1999). (Muñoz-Espada  et al., 2004) reported the total 
anthocyanin contents in skin of three non-Vitis vinifera grapes, which were 258 ± 37 
mg/100 g of wet weight for Marechal Foch, 888 ± 78 mg/100 g for Norton, and 326 ± 
5.9 mg/100 g for Concord. With a standard of malvidin 3-monoglucoside chloride, the 
lowest anthocyanin content in Primitivo variety was found to be 250mg/kg whereas 
the maximum amount was found in a Teroldego grape with 2323 mg/kg (Mattivi et al., 
2002). RSV was first found in grapevines (Vinis vitifera)
 in 1976 (Langcake and 
Pryce, 1976), and then reported in wine in 1992 (Siemann and Creasy, 1992). It is 
synthesized particularly in the leaf epidermis and the skin of grape berries and only 
trace amounts are present in the fruit flesh. Grape skins and red wines contain 50-100 
μg RSV/g, and 1.5-3 mg/L, respectively (Joe et al., 2002). Our study showed that 
Baco Noir grape extract contained the highest RSV content (571 ± 30 μg/100g). The 
reservatrol content in Cayuga White variety was lowest at 38 ± 2 μg/100g.  
 
A positive correlation between total phenolics and total antioxidant activity in 
a number of different fruits has been reported both in our lab and others (Heinonen et 
al., 1998; Prior et al., 1998; Velioglu et al., 1998; Karakaya et al., 2001; Sun et al., 
2002a; Yang et al., 2004). The present study reveals a strong correlation between total 
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antioxidant activity and total phenolics (R
2 = 0.9775, p<0.05). The antioxidant effects 
of grape phenolics were determined by Kanner et al (1994) in a number of different 
systems. It was concluded that effective antioxidants were found in all grape varieties, 
which corresponded to the concentration of phenolics in the system. The antioxidant 
activity of red grapes has been correlated with the phenolics and/or flavonoid content 
(Teissedre et al., 1996; Meyer et al., 1997; Mayer et al., 2001). The antioxidant 
activity was measured by the inhibition of human low-density lipoprotein (LDL) 
oxidation. In vitro oxidation positively correlated with the content of total phenolics, 
anthocyanins, and flavonols after investigation of phenolic extracts from fourteen 
different types of fresh grapes (Meyer et al., 1997). After Concord grape juice was 
given orally (10 mL/kg/day) to subjects, serum antioxidant capacity was increased, 
and LDL oxidation deceased similarly to that obtained with 400 IU α-tocopherol/d 
(O'Byrne et al., 2002). Anthocyanins have been proven to be very efficient 
antioxidants (Rice-Evans et al., 1995; Van Acker et al., 1996; Satué-Gracia et al., 
1997; Wang et al., 1997; Wang et al., 1999; Degenhardt et al., 2000; Espin et al., 
2000). Anthocyanins are potent antioxidants, similar to quercetin because of similar 
structures (Pietta, 2000). There was a positive correlation between anthocyanin 
content and antioxidant activities of red grape extracts (Meyer et al., 1997); grape 
juices (Frankel et al., 1998), and red wines (Burns et al., 2000). Vascular endothelial 
cells enriched with elderberry anthocyanins (1 mg/mL) could incorporate 
anthocyanins into the membrane and cytosol, conferring significant protective effects 
against oxidative damage (Youdim et al., 2000). Consumption of an anthocyanin-
repleted diet in rats significantly improved (p < 0.01) plasma antioxidant capacity and 
decreased (p < 0.001) vitamin E deficiency-enhanced hydroperoxides and 8-Oxo-
deoxyguanosine concentrations in liver (Ramirez-Tortosa et al., 2001). Cyanidin 3-O-
β-D-glucoside (C3G) functions as a potent antioxidant under oxidative stress in rats 
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(Tsuda et al., 2000). (Frankel et al., 1993b) were first to demonstrate that trans-RSV 
reduced the copper-catalyzed oxidation of human LDL. LDL peroxidation was 
inhibited more by RSV than by a phenolic extract from red wine. However, neither 
anthocyanin nor RSV content correlated with total antioxidant activity of grapes in our 
experiment. This could be because individual compounds may act additively or 
synergistically with other compounds and the total expressed antioxidant activity may 
be dependent on the relative proportions of each compound in the system.  
 
The phytochemicals present in all grape variety extracts showed a potent 
inhibitory effect on Caco-2, HepG2, and MCF-7 human cancer cell proliferation. The 
inhibition of cell proliferation was observed in a dose-dependent manner after 
exposure to extracts of Cabernet Franc, Pinot Noir, Chardonnay, Catawba, Concord, 
Sheridan, Niagara, and Riesling; demonstrating that these varieties contained greater 
antiproliferative activity than DeChaunac, Cayuga White, Baco Noir, Chancellor, 
Vidal Blanc, and Marechal Foch grapes. However, there was a significant difference 
among the varieties with respect to antiproliferative activity toward different cell lines. 
Pinot Noir and Cabernet Franc grapes contained the highest level of inhibitory action, 
and Marechal Foch possessed the lowest level toward Caco-2 human colon cancer 
cells. The phytochemical extract of Pinot Noir and Chardonnay varieties exhibited the 
highest antiproliferative effect toward HepG2 human liver cancer cells with the lowest 
EC50, and DeChaunac and Vidal Blanc grapes had the highest EC50 values. The 
antiproliferative activities of grape varieties differed for the Caco-2, HepG2, and MCF-
7 cell lines. Overall, the 14 grape varieties possessed more inhibitory activity for 
Caco-2 colon cancer cell proliferation than for HepG2, and MCF-7 human cancer cell 
proliferation. Also, most grape extracts exhibited higher antiproliferative activity 
against HepG2 than MCF-7. The possible explanation may be that phytochemicals in 
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grape target different organs showing different effects. Since antiproflierative activity 
in cells involves uptake, metabolism, and transcriptional events, it is not surprising 
that different cell types exhibit different degrees of inhibition when presented with the 
same array of phytochemicals.  It was observed that there was direct intestinal uptake 
of red fruit anthocyanins (cyanin 3-glucoside and cyanin 3,5-diglucoside) in human 
and rats, demonstrating that anthocyanins are taken up as structurally intact glycoside 
forms from the digestive tract into the blood circulation system in mammals 
(Miyazawa et al., 1999). The effects of pretreatment with the anthocyanins 
(delphinidin, cyanidin, and their glycoside and rutinoside derivatives) against 
induction of DNA damage were evaluated in rat smooth muscle and in rat hepatoma 
cell lines using the Comet test. The results showed that anthocyanins were effective 
against cytotoxicity, DNA SSB formation and lipid peroxidation induced by tert-
butyl-hydroperoxide (TBHP) (Lazzé et al., 2003). Cyanidin-DNA copigmentation 
might be a possible defense mechanism against oxidative damage of DNA and may 
have an in vivo physiological function attributable to the antioxidant ability of 
anthocyanins (Sarma and Sharma, 1999). Cyanidin, pelargonidin, and delphinidin 
showed an estrogen-inducible cell proliferation effect in two human breast cancer cell 
lines (MCF-7 and BG-1), but not in the receptor-negative line MDA-MB-231 (Schmitt 
and Stopper, 2001). Cyanidin and delphinidin contribute to potent inhibition of the 
epidermal growth-factor receptor and were found to inhibit the growth of a human 
vulva carcinoma cell line A431 in vitro (Meiers et al., 2001). Recently, it was reported 
that anthocyanidins directly cause human promyelocytic leukemia cells (HL-60) to 
generate intracellular hydrogen peroxide, and trigger apoptosis, possibly through an 
oxidative stress JNK signaling pathway. Also, it was shown that delphinidin 
stimulates JNK pathway activation including JNK phosphorylation, c-jun gene 
expression, and activates caspase-3 (Hou et al., 2003). RSV has been reported to have 
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antiproliferative activity
 in different human cancer cell lines, such as MCF-7 
(Mgbonyebi et al., 1998), HL60 promyelocytic leukemia cells (Clement et al., 1998), 
A431 epidermoid carcinoma cells (Ahmad et al., 2001), and Caco-2
 colorectal 
carcinoma (Schneider et al., 2000). The effects of RSV in breast cancer cell lines
 are 
inconsistent. Some researchers found that RSV enhances MCF-7 (Basly et al., 2000) 
cell growth. It was demonstrated that RSV induces growth inhibition, S-phase arrest, 
apoptosis, and changes in biomarker expression in MCF-7, SW480, HCE7, Seg-1, 
Bic-1, and HL60 human cancer cell lines (Joe et al., 2002). On the other hand, RSV 
was reported to slow down the proliferation of several human malignant cell lines 
(Della Ragione et al., 1998; Hsieh et al., 1999a). The suppression effect of RSV in 
normal cell growth is accompanied by the accumulation
 of cells in S and G2 phases 
(Hsieh et al., 1999b). The antiproliferative activities of RSV may be explained by the 
direct inhibition of ribonucleotide
 reductase, which supplies proliferating cells with 
deoxyribonucleotides required for DNA synthesis (Reichard, 1987; Fontecave et al., 
1998). However, a correlation between RSV content and the EC50 value of 
antiproliferative activity for the three human caner cell lines examined was not found 
in our study. A possible reason may be the low dose of RSV in the grape extracts. 
 
No relationships were found between total antioxidant activity and 
antiproliferative activity for Caco-2, HepG2, and MCF-7 cell lines (p > 0.05). 
Additionally, the total phenolic and flavonoid contents of grapes did not correlate with 
antiproliferative activity for all three cell lines (data not shown). Similar results were 
also found in studies of raspberries and strawberries by our group (Liu et al., 2002; 
Meyers et al., 2003), which suggests that phytochemicals other than those tested in 
this experiment are responsible for inhibiting cell proliferation, or that the combination 
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of different phytochemicals functions additively and synergistically or antagonistically 
accounting for the antiproliferative activity of grapes.  
 
Our results have shown that significant differences in phytochemical content 
exist among grape varieties. Phytochemicals in grape extracts have potent antioxidant 
and antiproliferative activities, and that antioxidant activity is well correlated with 
total phenolic content. However, information on the bioavailability and metabolism of 
phenolics in humans is still scarce; therefore, further studies need to be carried out.  
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CHAPTER THREE 
  
INDUCTION OF ANTICARCINOGENIC MARKER ENZYME, 
QUINONE REDUCTASE, IN MURINE HEPATOMA CELLS IN VITRO BY 
GRAPE EXTRACTS AND SELECTED PHYTOCHEMICALS 
 
3.1. Introduction 
Extensive epidemiological evidence has shown that diets rich in fruits
 and 
vegetables are associated with a reduced risk of developing chronic diseases, such as 
cardiovascular disease, cancer, diabetes, and Alzheimers’s disease (Block et al., 1992; 
Ames et al., 1993; Temple, 2000; Joshipura et al., 2001; Willett, 2002). Fruits and 
vegetables contain many antioxidant and anticarcinogenic compounds, including 
phenolics, carotenoids, thiols, tocopherols, and glucosinolates, which may protect 
against cardiovascular diseases and cancer through a variety of mechanisms. These 
findings lead to the USDA Food Guide Pyramid recommendations of 5-9 servings of 
fruits and vegetables every day, and to the guideline of the National 5 a Day for Better 
Health Program which also aims to increase the consumption of fruits and vegetables 
from 5 to 9 servings per day in the United States. 
 
The main carcinogenic agents are exogenous or metabolically generated 
reactive oxygen species (ROS) and electrophiles arising from in vivo normal
 oxidative 
processes and from the environment. For example, insufficient oxygen consumption 
from lipid peroxidation in mitochondria may result in the overproduction of ROS. 
Enhanced ROS levels can initiate DNA damage, are involved in tumor initiation and 
promotion, and may ultimately lead to carcinogenesis (Halliwell et al., 2000). Dietary 
phytochemicals are able to inhibit phase I enzymes and/or induce phase II enzymes, 
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including quinone reductase (QR, DT-diaphorase, NAD[P]H:quinone-acceptor 
oxidoreductase, nicotinamide quinone oxidoreductase 1 (NQO1), EC 1.6.99.2), 
glutathione S-transferase (GST, EC 2.5.1.18), epoxide hydrolase (EH, EC 3.3.2.3), and 
UDP-glucuronosyl transferase (UDPGT, EC 2.4.1.17). The isolated bioactive 
compounds from fruits and vegetables that have shown anticarcinogenic capacity are 
β-carotene (Peto et al., 1981), monoterpenes D-limonene and D-carvone (Wattenberg 
et al., 1989), sulforaphane (Zhang et al., 1992), and pinostrobin and pinocembrin 
(Fahey and Stephenson, 2002). Phytochemicals in fruits and vegetables may inhibit 
carcinogen activation by keeping the balance between carcinogen-activating phase I 
enzymes and phase II detoxifying enzymes, which are likely to play a protective role 
against xenobiotic cellular damage (Prochaska et al., 1992). A number of fruits and 
vegetables contain substantial quantities of compounds that modulate mammalian 
enzymes of xenobiotic metabolism. For example, edible plants belonging to the family 
Cruciferae such as broccoli, cauliflower, and Brussels sprouts contain glucosinolate, 
isothiocyanates, and sulforaphane, some of which are very potent inducers of phase II 
enzymes (Fahey et al., 1997). (Benson et al., 1978) have reported that phenolic 
antioxidants such as 2(3)-tert-Butyl-4-hydroxyanisole (BHA), which blocked tumor 
formation, induced several Phase II enzymes in a variety of animal tissues. The 
elevation of phase II detoxification and antioxidant enzymes by isothiocyanates, 
sulforaphane, carotenoids, flavonoids, and other phytochemicals is documented and 
recognized as one of the mechanisms by which fruits and vegetables exert their 
chemoprotective effects (Talalay and Fahey, 2001). Currently, upregulation of QR is 
thought to be a useful biomarker for anticarcinogenesis (Jaiswal, 2000). 
 
  QR is a flavoprotein that catalyzes the two-electron reduction and 
detoxification of quinones and its derivatives, leading to the protection of cells against 
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redox cycling, oxidative stress, and neoplasia. QR acts as an important regulator of a 
wide variety of biological functions and may play a particularly significant role in 
cancer. The major functions of QR are to lower formation of ROS by decreasing one 
electron reductions and the associated redox cycling (Ernster, 1987), to maintain the 
overall antioxidant functions of the cell by keeping α-tocopherolquinone and 
ubiquinones in their reduced and active states (Siegel et al., 1997), and to act as a 
phase II detoxifying enzyme involved in cancer prevention (Prochaska et al., 1987; 
Ross et al., 1993). Additionally, QR plays an important role in activating some 
anticancer drugs (Workman, 1994) and regulating the stability of p53 and apoptosis in 
mouse cells and human (Asher et al., 2001; De Long et al., 2002). 
 
There exists convincing evidence that induction of phase II enzymes is an 
important mechanism responsible for cancer chemoprevention. The microtiter plate 
assay utilized to determine QR induction has been used extensively to characterize the 
inducer potency of a variety of natural and synthetic compounds as well as crude plant 
extracts (Prochaska and Santamaria, 1988; Dinkova-Kostova and Talalay, 2000; 
Talalay and Fahey, 2001).  This bioassay has provided a rapid and quantitative method 
for detecting inducer activity and determining inducer potency. Induction of QR 
detoxication
 enzyme provides a strategy for achieving protection against ROS and 
carcinogenesis. It is therefore of great interest to see if grapes contain inducing 
compounds. The objective of this study was to determine potential induction of QR 
and antiproliferative activity to Hepa1c1c7 cells by wine grapes widely grown in the 
Finger Lakes region in New York State. The information obtained here suggests a 
novel mechanism of action of wine grapes to provide health benefits.  
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3.2. Materials and Methods 
3.2.1. Chemicals 
Alpha minimal essential medium (α-MEM), fetal calf serum (FBS), hepes, and 
antibiotic-antimycotic solution were purchased from GIBCO (Life Technologies, 
Grand Island, NY). 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfenyl)-2H-tetrazolium (MTS) and phenazinemethosulfate (PMS) were from 
Promega (Madison, WI). Ascorbic acid, caffeic acid (>99% HPLC grade), (+)-
catechin (hydrate, >98%), chlorogenic acid (>95%), ferulic acid, folic acid (~98%), 
genistein (<98% HPLC grade), quercetin (dihydrate), rutin, resveratrol (trans-3,4’,5-
trihydroxystilbene, ~99%), β-naphthoflavone (BNF, 90-95%), digitonin, glucose 6-
phosphate, menadione, nicotinamide adenine dinucleotide phosphate (NADP), flavin 
adenine dinucleotide (FAD), albumin from human serum (≥96%), yeast glucose 6-
phosphate dehydrogenase, 3-(4,5-Dimethylthiazo-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT), sodium dodecyl sulfate (SDS, ~99%), ethylenediamine tetraacetic 
acid (EDTA, anhydrous, ~99%), and dicoumarol were purchased from Sigma (St. 
Louis, MO). Gallic acid was from ICN Biomedicals, Inc. (Aurora, OH). Delphinidin 
chloride and malvidin chloride were from Indofine Chemical Company, Inc. 
(Hillsborough, NJ). L-ergothionenine was obtained from OXIS International, Inc. 
(Portland, OR). Dimethyl sulfoxide (DMSO) and Tween 20 were from Fisher 
Scientific (Fair Lawn, NJ). Tris-base and crystal violet were purchased from 
Mallinckrodt Baker, Inc. (Phillipsburg, NJ). All the other materials used were also 
obtained from Sigma (St. Louis, MO). 
 
3.2.2. Grapes 
Thirteen wine grape varieties (Baco Noir, Cabernet Franc, Catawba, Cayuga 
White, Chancellor, Chardonnay, Concord, DeChaunac, Marechal Foch, Niagara, Pinot 
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Noir, Riesling, and Vidal) were provided by a Grapeyard located in Branchport, N.Y. 
Wine grapes were harvested upon ripening in 2003 and 2004. Grapes free from visible 
blemishes or disease were selected. For quantitative analysis, 50~70 grape berries 
randomly chosen from all samples were collected for each grape variety. All data 
collected for each grape variety were reported as means ± SD for at least three 
replications.  
 
3.2.3. Grape Pytochemical Extraction 
Phytochemicals were extracted from fresh grape by a modified method 
reported previously in our laboratory (Yang et al., 2004). Briefly, 100 g of grape were 
blended for 1 min in 100 g 80% acetone using Waring blender with medium speed in 
order to remove seeds. To get grape samples reflecting the actual phytochemical 
compounds present in grape skin and pulp, the seeds were not crushed. After removal 
of seed, adding another 100 g 80% acetone, the grapes were blended for 3 min using 
Waring blender with high speed. The mixture was then homogenized in a Virtis High 
Speed Homogenizer for 3 min and filtered with vacuum under ice bath.  Water in the 
filtrate was evaporated using a rotary evaporator at 45°C until the weight of the 
evaporated filtrate was less than 10% of the weight of the original filtrate.  All extracts 
were stored at –40°C until use. All extractions were performed in triplicate. 
 
3.2.4. Determination of Quinone Reductase Activity in Hepa1c1c7 Cell Culture 
This bioassay was modified from a previously described method (Prochaska 
and Santamaria, 1988; Zhang et al., 1992). Hepa1c1c7 murine hepatoma cells (The 
American Type Culture Collection, ATCC, Rockville, MD) were grown in α-MEM 
without nucleosides or deoxyribonucleosides, supplemented with 10% FBS, at 37°C in 
an atmosphere of 5% CO  in a humidified incubator. Cultured Hepa1c1c7 cells were  2
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plated at a density of 2 ×10
4 cells/mL in 96-well plates (Costar 3595, Corning Inc. 
Corning, NY), and decanted after a 24 h incubation. The fresh medium and test 
samples dissolved in 10% DMSO were introduced and serially diluted to a 
concentration range of 5 – 200 μM for compounds, and 0.5 – 10 mg/mL for grape 
extracts. The final DMSO concentration in the medium was less than 0.5%. The cells 
were incubated for an additional 48 h. Growth medium and 1 μM BNF were used as 
negative and positive controls, respectively. The medium was removed and the cells 
were lysed with 50 μL 0.8% (w/v) digitonin in 2 mM EDTA at pH 7.6, and incubated 
for 10 min at 37°C. The plates were then agitated on a shaker (120 rpm) for 10 min at 
room temperature. A 200-μL aliquot of reaction mixture (7.5 mL of 0.5 M pH 7.4Tris-
HCl buffer; 100 mg of albumin from human serum; 1 mL of 1.5% Tween-20 solution; 
0.1 mL of 7.5 mM FAD; 1 mL of 150 mM glucose-6-phosphate; 90 μL of 50 mM 
NADP; 300 units of yeast glucose-6-phosphate dehydrogenase; 45 mg of MTT; 150 
μL of 50 mM menadione in acetonitrile; and 140.16 mL distilled water added to total 
150 mL volume) was added to lysed cells. Menadione solution was added just before 
the mixture was dispensed into the microtiter plates. QR activity was measured as the 
reduction of menadione to menadiol, this being coupled to the non-enzymatic 
reduction of MTT to a blue formazan. The reaction generated a blue color, which was 
stopped after 5 min by the addition of 50 μL of a solution containing a 0.3 mM 
dicoumarol in 0.5% DMSO and 5 mM pH 7.4 potassium phosphate. Readings were 
made with triplet for each sample at 590 nm. Total protein concentrations were 
determined in a duplicate set of plates using crystal violet staining, and subsequently 
scanned at 490 nm.  
 
The specific activity of QR is defined as nmol MTT blue formazan reduced per 
min and per mg protein. Induction was expressed as the ratio of the specific activity of 
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QR in the presence and absence of the test sample. The concentration required to 
double specific activity (CD) is determined via a curve of the ratio of QR specific 
activities of sample-treated cells to solvent-treated control cells as a function of 
inducer concentration. The EC50 values of both pure compounds and grape extracts 
(half-maximal inhibitory concentration of cell viability) were examined. 
Chemopreventive Index (CI) values were determined by dividing EC50 values by CD 
values (Gerhäuser et al., 1997). 
 
3.2.5. Measurement of Inhibition of Hepa1c1c7 Cell Proliferation  
The antiproliferative activity of pure compounds (antioxidants) and grape 
extracts was assessed by measurement of the inhibition of Hepa1c1c7 murine 
hepatoma cell proliferation. Antiproliferative activities were determined by the 
colorimetric MTS assay (MTS-based cell titer 96 nonradioactivity cell proliferation 
assay) (Promega, Madison, WI) reported previously (Yang et al., 2004). Hepa1c1c7 
cells were cultured in α-MEM without nucleosides or deoxyribonucleosides, 
containing 10% FBS, 50 units/mL penicillin, 50 µg/mL streptomycin, and 50 µg/mL 
amphotericin B. Hepa1c1c7 cells were maintained in a 5% CO2/37°C incubator. A 
total of 2.5 × 10
4 Hepa1c1c7 cells in growth media were placed in each well of a 96-
well flat-bottom plate (Costar 3595, Corning Inc. Corning, NY). Cell proliferation was 
measured by the ability of viable cells to reduce MTS to formazan. After 4 h of 
incubation, the growth medium was removed, and media containing various 
concentrations of pure compounds or grape extracts were added to the cells. Control 
cultures received the extraction solution minus the grape extracts, and blank wells 
contained 100 µL of growth medium without cells. Cell proliferation (percent) was 
determined at 72 h from the MTS absorbance (490 nm) reading for each concentration 
compared to the control, using at least three replications for each sample. The effective 
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median dose (EC50) was determined and expressed as milligrams of grape extract per 
milliliter ± SD or as micromole of pure compounds ± SD. 
 
3.2.6. Statistical Analysis 
Statistical analysis was performed using Minitab Student Release 12 (Minitab 
Inc., State College, PA) and SigmaStat Version 8.0 (Jandel Corp., San Raphael, CA). 
Correlations between various parameters were also investigated. Significance was 
determined at p < 0.05. All data were reported as the mean ± SD of three replications. 
 
 
3.3. Results 
13 wine grapes and 14 common antioxidants were examined in vitro for their 
potential to induce QR, a representative phase II chemoprotective enzyme. The BNF 
with an induction of 7.5 ± 0.5-fold over solvent control at a concentration of 1 μM and 
with a CD value of 0.027 ± 0.003 μM was used as a positive control. Grape extracts 
which induced QR in Hepa1c1c7 cells are shown in Figure 3.1. Table 3.1 summarizes 
the concentrations of these extracts needed to double the induction. Compared to the 
solvent-treated control cells, at 2 mg/mL concentration, the induction of Cabernet 
Franc and Baco Noir were 3.1 ± 0.3 and 2.3 ± 0.2, respectively. The calculated CD 
values of Cabernet Franc and Baco Noir were 0.6 ± 0.1 and 1.4 ± 0.3 mg/mL, 
respectively. The induction of Pinot Noir and Niagara were 2.5 ± 0.3 and 3.1 ± 0.1 at 
concentration of 3 mg/mL, respectively. The calculated CD values of Pinot Noir and 
Niagara were 2.2 ± 0.2, and 2.4 ± 0.1 mg/mL, respectively. At concentration of 5 
mg/mL, the induction of Concord, Chardonnary, and Vidal Blanc were 4.0 ± 0.4, 2.6 ± 
0.4, and 2.2 ± 0.6, respectively. The generated CD values of Concord, Chardonnary, 
and Vidal Blanc varieties were 3.2 ± 0.1, 4.0 ± 0.4, and 4.6 ± 0.7 mg/mL, respectively. 
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Chancellor, Cayuga White, DeChaunac, and Marechal Foch varieties, at a 
concentration of 8 mg/mL, cause a maximum of 2.0 ± 0.1, 2.6 ± 0.2, 2.2 ± 0.3, 2.1 ± 
0.1-fold induction over control, respectively, in inducing QR activity in Hepa1c1c7 
cells. The calculated CD values of Chancellor, Cayuga White, DeChaunac, and 
Marechal Foch varieties were 8.0 ± 0.1, 6.4 ± 0.3, 7.4 ± 1.1, and 7.7 ± 0.3 mg/mL, 
respectively. However, compared with other grapes, the Catawba and Riesling 
varieties showed very weak induction at concentration ranging from 0.1 to 10 mg/mL. 
The maximum induction of Catawba and Riesling was 1.2  ± 0.1, and 1.6 ± 0.1-fold at 
concentration of 3 mg/mL, respectively. In general, Cabernet Franc and Baco Noir 
were more potent inducers than other grape varieties evaluated. Pinot Noir and 
Niagara also showed strong induction effect. Chancellor, Cayuga White, DeChaunac, 
and Marechal Foch varieties exhibited weak induction activity.  
 
In addition to investigating the QR induction of grape extracts, the induction 
potency of some common antioxidants in fruits and vegetables were also evaluated. 
Among 14 antioxidants examined in this study, only quercetin, genistein, and 
resveratrol exhibited higher induction of QR than other compounds (Figure 3.2 and 
Table 3.2). Quercetin at a concentration of 30 μM resulted in a maximum of 3.5 ± 0.2-
fold induction over control in inducing QR activity in Hepa1c1c7 cells. At a 
concentration of 50 μM, genistein caused a maximum of 2.8 ± 0.2-fold induction over 
control. Resveratrol led to a maximum of 2.2 ± 0.1-fold induction over control at a 
concentration of 50 μM. The generated CD values of quercetin, genistein, and 
resveratrol were 2.5 ± 0.5, 15.0 ± 3.0, and 28.7 ± 2.3 μM, respectively. Although these 
inducers can not double QR activity in the tested concentrations, chlorogenic acid, 
ferulic acid, folic acid, caffeic acid, ascorbic acid need lower concentration to reach  
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Table 3.1. Effects of Grape Extracts on Quinone Reductase Induction 
 
Grape Variety  CD (mg/mL)
a b c EC50 (mg/mL) CI
Baco Noir  52  1.4 ± 0.3  73.3 ± 5.4 
Cabernet Franc  15  0.6 ± 0.1  8.7 ± 2.4 
Cayuga White  9  6.4 ± 0.3  54.7 ± 3.9 
d d Catawba NI ND 40.3 ± 1.6 
Chancellor  8  8.0 ± 0.1  67.4 ± 2.7 
Chardonnay  12  4.0 ± 0.4  49.5 ± 3.7 
Concord  13  3.2 ± 0.1  40.5 ± 2.9 
DeChaunac  9  7.4 ± 1.1  69.3 ± 2.1 
Niagara  15  2.4 ± 0.1  36.4 ± 0.9 
Marechal Foch  10  7.7 ± 0.3  76.9 ± 3.2 
Pinot Noir  12  2.2 ± 0.2  27.0 ± 1.7 
d d Riesling NI ND 39.3 ± 2.9 
Vidal Blanc  9  4.6 ± 0.7  43.0 ± 2.3 
 
 
Table 3.2. Effects of Selected Phytochemicals on Quinone Reductase Induction 
 
c a b Compound   CI CD (μM) EC50 (μM)
d Ascorbic acid   NI > 200  ND
d
Caffeic acid  NI  > 200  ND 
(+)-Catechin NI  >  200  ND 
Chlorogenic acid  NI  > 200  ND 
Delphinidin chloride  NI  > 200  ND 
Ferulic acid  NI  > 200  ND 
Folic acid  NI  > 200  ND 
Gallic acid  NI  > 200  ND 
Genistein  > 125  ND  15.0 ± 3.0 
L-ergothionenine NI  >  200  ND 
Malvidin chloride  NI  > 200  ND 
Quercetin  50  2.5 ± 0.5  123.2 ± 2.7 
Rutin NI  >  200  ND 
Resveratrol  2  28.7 ± 2.3  56.3 ± 3.4 
e > 20  > 740  β-Naphthoflavone 0.027 ± 0.003 
 
          aCD: Concentration to double QR activity in Hepa1c1c7 cells. 
          bEC50: Concentration to inhibit Hepa1c1c7 cell growth by 50%. 
          cCI: Chemopreventive Index (EC50/CD). 
          dNI = no induction; ND = not determined. 
          eQR assay positive control.  
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the maximum induction effect than that of (+)-catechin, delphinidin chloride, gallic 
acid, L-ergothionenine, malvidin chloride, and rutin (Table 3.2).  
 
Figure 3.3 and Figure 3.4 also present the EC50 of the antiproliferative activity 
of both grape varieties and antioxidants. Lower EC50 values represent higher 
antiproliferative activities. The phytocemical extracts of Cabernet Franc possessed the 
greatest antiproliferative activity towards Hepa1c1c7 cells with the lowest EC50 of 8.7 
± 2.4 mg/mL (p < 0.05), followed by Pinot Noir, Niagara, Riesling, Catawba, 
Concord, Vidal Blanc, Chardonnay, Cayuga White, Chancellor, DeChaunac, Baco 
Noir, and Marechal Foch (Table 3.1). The EC50 doses were significantly different 
among Cabernet Franc, Pinot Noir, Niagara, Chardonnary, and Marechal Foch (p < 
0.05). The phytochemical extract of DeChaunac, Baco Noir, and Marechal Foch 
exhibited a weak antiproliferative activity towards Hepa1c1c7 cells at a higher dose. 
The antiproliferativ activity was significantly different among resveratrol, quercetin, 
and genistein (p < 0.05). However, the EC50 values of other antioxidants could not be 
determined since they did not exhibit antiproliferative activity towards Hepa1c1c7 
cells at doses ranging from 0 to 200 μM used in this experiment (Table 3.2).   
 
The induction effect of QR activity observed with 13 grape extracts and 14 
common antioxidants are summarized in Table 3.1 and Table 3.2, respectively. 
Among the grape extracts examined in this study (Table 3.1), Baco Noir, Cabernet 
Franc, Niagara, Concord, Pinot Noir, Chardonnary, Marechal Foch, DeChaunac, 
Cayuga White, Vidal Blanc, and Chancellor varieties were promising inducers of QR 
activity with CI values of 52, 15, 15, 13, 12, 12, 10, 9, 9, 9, and 8, respectively. 
Catawba and Riesling varieties exhibited weak induction of QR. Of the compounds 
tested in this study (Table 3.2), quercetin and resveratrol were potential inducers of 
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QR activity with CI values of 50, and 2, respectively. Caffeic acid, chlorogenic acid, 
ferulic acid, and folic acid exhibited weak induction of QR at concentrations from 0 to 
100 μM. Ascorbic acid, (+)-catechin, delphinidin chloride, gallic acid, L-
ergothionenine, malvidin chloride, and rutin showed very low induction of QR at 
concentrations from 0 to 100 μM.  
 
 
3.4. Discussion  
The potential of grape extracts and some common antioxidants to induce QR 
activity in comparison with the activity of BNF was evaluated. This bioassay measures 
the specific activity of QR in Hepa1c1c7 murine hepatoma cells grown in 96-well 
microtiter plates and exposed to serial concentrations of the tested extracts and 
compounds. Induction of QR activity was calculated from the ratio of specific enzyme 
activities of extract- or compound-treated cells in comparison with solvent-treated 
control cells. In order to investigate the induction of QR and to avoid cytotoxic effects, 
the half-maximal inhibitory concentration of cell viability (EC50) was also determined. 
Ultimately, Chemopreventive indices (CI) were calculated from the ratio between the 
EC50 and CD value, which provided a reasonable index of potency of anticarcinogenic 
activity and cytotoxicity. Our work has clearly shown that the phytochemicals present 
in grapes have potent QR induction and antiproliferative activities towards Hepa1c1c7 
cells.  
 
Carcinogens are metabolized in vivo by phase I enzymes that activate these 
compounds to highly reactive electrophilic metabolites and reactive species capable of 
damaging DNA, and by phase II enzymes that transform these reactive electrophiles to 
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Figure 3.1. Effect of β-naphthoflavone (positive control) and grape extracts (means ± 
SD) on induction of quinone reductase (QR) in Hepa1c1c7 cells. 
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Figure 3.2. Effect of β-naphthoflavone (positive control) and selected phytochemicals 
(means ± SD) on induction of quinone reductase (QR) in Hepa1c1c7 cells. 
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Figure 3.3. Percent inhibition of Hepa1c1c7 cell proliferation by selected grape 
extracts. 
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Figure 3.4. Percent inhibition of Hepa1c1c7 cell proliferation by selected 
phytochemicals. 
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less toxic and more easily excretable products (Talalay et al., 1988; Prestera et al., 
1993). Individuals genetically deficient in QR are more susceptible to hematological 
toxicity and carcinogenicity of benzene exposure, and may be more prone to 
developing a number of malignant tumors (Dinkova-Kostova and Talalay, 2000). In 
addition, QR gene expression is coordinately induced with other detoxifying enzyme 
genes in response to xenobiotics, antioxidants, oxidants, heavy metals, and radiation. 
Deletion mutagenesis in the QR gene promoter have identified several cis-elements 
including antioxidant response element (ARE), a basal element, and AP-2 element 
(Begleiter and Fourie, 2004). The ARE element is essential for basal expression and 
antioxidant-induced QR gene induction. Therefore, inducers of QR such as some 
antioxidants in fruits and vegetables are major protectors of cells against oxidative and 
electrophile stress. QR also plays a role in preventing cells from the toxic and 
neoplastic effects of quinones resulting from their participation in redox cycling. 
 
Theoretically, extracts or compounds with low CD value and high EC50 may be 
promising inducers because at low concentrations they can double QR while having 
little toxic effect on Hepa1c1c7 cells. A maximum of 4.5 ± 0.2- and 4.0 ± 0.4-fold 
induction of QR activity was observed for both Cabernet Franc and Concord, although 
they showed a certain adverse effect upon cell growth at high concentrations. In our 
study, among grape extracts, Cabernet Franc variety required the lowest concentration 
to double QR activity; however, it also showed the maximum antiproliferative activity 
towards Hepa1c1c7 cells. Baco Noir could be considered the most promising inducer 
in terms of inducing potency and low toxicity. Our previous study showed that Baco 
Noir variety possessed the highest reservatrol content among grapes tested, which 
could partially explain its high induction capacity. Pinot Noir with a high content of 
reservatrol also demonstrated lower concentration needed to double QR activity. Both 
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Cabernet Franc and Pinot Noir grape varieties exhibited high induction activity, but 
also high cytotoxicity, resulting in low CI values, which is similar to reservatrol 
(Table 3.2). 
 
The studies conducted by (Fahey and Stephenson, 2002) reported that there 
was a positive correlation between antioxidant capacity and QR induction in honey.  
These authors further reported that dark honey had higher antioxidant capacity with 
better inducers of mammalian phase II enzymes than light colored honey. However, 
(Williamson et al., 1996) have found that the ability to induce QR among quercetin, 
quercetin-4'-glucoside, rutin
 (quercetin-3-rutinoside), quercetin-3,4'- diglucoside,
 and 
isoquercitrin (quercetin- 3-glucoside) did not correlate with antioxidant capacity. 
Similarly, no positive correlation between induction activity and antioxidant capacity 
was found in grape varieties examined in this study. Further, some white grape 
varieties such as Niagara and Chardonnay showed higher induction potency than red 
varieties, and the anthocyanins contents in red grape varieties did not correlate with 
induction activity, which provides evidence that wine grapes have a different 
mechanism of induction that is not associated with their antioxidant activities and 
color. There might exist different mechanisms of action in antioxidant activity and 
induction ability in grapes, although ARE is essentially required for expression and 
coordinated induction of QR and other detoxifying enzyme genes.  
 
Flavonoids are the most common and widely distributed phenolics in plants. 
Based on different structure, flavonoids can be classified into several classes, 
including flavonols, flavonones, flavones, anthocyanins and isoflavones (Harbone, 
1993). Flavonoids are omnipresent in human diet, including fruits, vegetables, tea, and 
wine. Quercetin is a flavonol, and is the predominant flavonoid in the human diet. 
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Based on epidemiological surveys, estimates of human consumption are from 4 to 68 
mg per day (Skibola and Smith, 2000). Quercetin has been shown to be antioxidant, 
anti-inflammatory, antiproliferative, antiviral, and antimicrobial, to enhance phase I 
enzyme transcription activation (Ciolino et al., 1999), and to induce phase II enzymes 
(Williamson et al., 1996; Uda et al., 1997; Yannai et al., 1998). It was demonstrated 
that quercetin was a good inducer of QR, and the concentrations for doubling QR 
activity was around 2.6 μM (De Long et al., 1986; Gerhäuser et al., 2003), which is 
similar to the concentration (2.5 ± 0.5 μM) found to double QR in this study. Also in 
the Hepa1c1c7 cell model, quercetin aglycone was the most effective inducer of QR 
(CD = ~ 13 μM) among quercetin-4'-glucoside, rutin, quercetin-3,4'- diglucoside,
 and 
isoquercitrin.  Rutin, isoquercitrin, and quercetin-3,4'- diglucoside showed a very 
weak induction activity of QR (Williamson et al., 1996). Flavans such as catechin and 
epicatechin have been reported to have no induction of QR at concentrations from 0 to 
100 μM in the Hepa1c1c7 model; while flavonols, such as apigenin, myricetine, 
quercetin, kaempferol, and galangin, were effective QR inducers with a maximal 
induction level from 1.6 to 3.6 (Uda et al., 1997). The structural features in flavonoids 
and related compounds have a decisive influence in promoting QR activity. It has been 
postulated that a 2,3 double bond in the C ring in flavonoid structure is essential for 
QR induction, which was supported by taxifolin, catechin, and epicatechin. In normal 
human Chang liver cells, green tea aqueous extract, green tea polyphenols, and some 
catechins could induce QR activity; however, the studies also showed that EGCG is a 
poor inducer for QR (Steele et al., 2000). Other flavonoids and related compounds, 
such as caffeic acid, gallic acid, and catechin, exhibited much less potent induction of 
QR (Fahey and Stephenson, 2002), which is consistent with our results.   
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Resveratrol was found to act as an antioxidant, antimutagen, inducer of 
apoptotic cell death through activation of mitochondria-dependent pathways (Huang et 
al., 1999), anti-inflammatory activity
 via down-regulation of proinflammatory 
cytokines (Wadsworth and Koop, 1999), as well as inhibitor of phase I enzyme 
(Chang et al., 2001) and inducer of phase II enzymes (Jang et al., 1997). The 
resveratrol concentration in fresh grape skin is about 50 ~ 100 µg/g, and the 
concentration of resveratrol from grape skins required to double QR activity in 
Hepa1c1c7 cells was reported to be 21μM (Jang et al., 1997). Several phytoestrogens 
which induce QR activity in human cancer cells were reported (Wang et al., 1998; 
Bianco et al., 2005). Genistein with phytoestrogenic activity is an isoflavone found 
principally in soybeans. The CD value of genistein is broad from 0.14 to 16.2 μM 
(Wang et al., 1998; Gerhäuser et al., 2003). The CD values of resveratrol and genistein 
in our study are 28.7 ± 2.3 and 15.0 ± 3.0 μM, respectively. Both genistein and 
reservatrol up-regulate QR expression in MCF-7 and MDA-MB-231 breast cancer 
cells, and this kind of regulation occurs at the transcriptional level through ERβ 
(oestrogen receptor β) transactivation at the electrophile response element (EpRE) of 
the QR gene promoter (Bianco et al., 2005). 
 
Only quercetin, genistein, and reservatrol produced strong induction of QR 
among 14 antioxidants examined in this study. Other antioxidant compounds showed 
weak induction activity at different concentrations. Probably, the concentrations of 
other antioxidants used in this study might be too low to cause significant induction 
compared with the solvent control; however, concentration was limited by the 
apparent cytotoxicity on the Hepa1c1c7 cell line, which was observed through EC50 
values.  
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In grapes there might exist other unknown compounds, which have potential 
QR induction ability, further studies needed to be performed to identify those 
compounds. Besides antioxidant activity of wine grapes, our study has shown that 
wine grape varieties can induce QR activity, and have antiproliferative activity toward 
Hepa1c1c7 cells, which would shed new light on the mechanism of action of wine 
grapes to produce health benefits. 
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CHAPTER FOUR 
 
COMBINATION EFFECTS OF COMMON FRUITS ON ANTIOXIDANT 
ACTIVITY AND ANTIPROLIFERATIVE ACTIVITY 
 
 
4.1. Introduction 
Chronic disease such as cancers and cardiovascular diseases (CVD) are the 
mainly leading causes of death in the United States. MyPyramid, which incorporates 
recommendations from the 2005 Dietary Guidelines for Americans released in January 
by the USDA and U.S. Dept. of Health and Human Services, delivers the main 
message: steps to a healthier you. It advises what to eat to promote health and reduce 
the risk of chronic diet-related disease. A healthy eating plan from this guideline 
emphasizes fruits, vegetables, and whole grains. Besides providing the essential 
nutrients for life, their diet also contains bioactive compounds good for disease 
prevention and health maintenance. There is overwhelming evidence indicating that 
increased uptake of fruits and vegetables in the diet reduce the risk of CVD, cancer, as 
well as brain and immune dysfunction (Doll and Peto, 1981; Block et al., 1992; 
Willett, 1994; Temple, 2000; Joshipura et al., 2001). Reactive oxygen species (ROS) 
such as free radicals are byproducts generated during oxidative metabolism in 
organisms. Usually, there exists a balance levels between the oxidants and endogenous 
antioxidants in normal cell metabolism. However, an imbalance could be caused by 
the overproduction of oxidants, leading to oxidative damage to nucleic acids, proteins, 
and lipids. Antioxidants are believed to play a very important role in the body defense 
system against ROS. Fruits and vegetables are important sources of antioxidants. 
Phenolics and other plant antioxidants can scavenge free radicals, and then inhibit 
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their oxidative reactions with macromolecules in the body. The antioxidant activity of 
fruits and vegetables is assumed to be of greatest importance in combating a number 
of chronic diseases.  
 
It is documented that over 5,000 individual
 phytochemicals have been 
identified in fruits, vegetables, and
 grains, but a large proportion still remain unknown 
and need
 to be identified. Phytochemicals can be classified as alkaloids, carotenoids, 
phenolics,
 nitrogen-containing compounds, and organosulfur compounds. Phenolics 
and carotenoids among phytochemicals are mostly studied nowadays. It is estimated
 
that flavonoids account for nearly two out of three of the
 phenolics in our diet and the 
remaining one out of three are from phenolic
 acids. Flavonoids, being phenolic 
compounds with a wide variety of biological activities that have been identified in 
fruits, vegetables, and
 other plant-based foods, have been associated with lowered risk 
of some chronic diseases. The generic structure
 of flavonoids consists of two aromatic 
rings (A and B rings) linked by 3
 carbons that are usually in an oxygenated 
heterocycle ring so-called C ring. Based on differences in the heterocycle the C ring, 
flavonoids are categorized as flavonols, flavones,
 flavanols, flavanones, 
anthocyanidins, and isoflavonoids. For naturally occurring flavonoids, they are mostly 
conjugated
 in glycosylated or esterified forms but can occur as aglycones,
 especially as 
a result of the effects of food processing (Hollman and Arts, 2000). Anthocyanins, 
widely distributed throughout the plant kingdom, are natural, nontoxic, and water-
soluble flavonoid pigments, being particularly present in fruits and vegetables where 
they are responsible for the red, orange, blue, and purple colors. Anthocyanins 
contains in daily diet after consuming certain fruits and vegetables. Catechins are 
ubiquitous in plant-based foods, being particularly important in a large number of 
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fruits, vegetables, and legumes, and occur in beverages such as red wine and tea (Arts 
et al., 2000).   
 
Many constituents from fruits and vegetables, including phenolics, flavonoids, 
vitamins C and E, carotenoids, folic acid, and mineral micronutrints, have antioxidant 
activity, contributing to their health promotion properties. Much attention was paid to 
the dietary antioxidant properties of vitamins C, E, and carotenoids. However, studies 
have shown that some common fruits and vegetables possess high antioxidant activity, 
which cannot be accounted for by their vitamin C content (Wang et al., 1996; 
Eberhardt et al., 2000). Furthermore, some studies have demonstrated that dietary 
phenolics derived from plant are more effective antioxidants in vitro than vitamins C 
or E (Liu, 2004). On the other hand, epidemiological studies of Vitamin E, and β-
carotene supplements for chronic disease prevention have found either no effect on 
CVD or a slight increase in cardiovascular mortality and cancer (Hennekens et al., 
1996; Omenn et al., 1996; Rapola et al., 1997). Phenolics which possess two ortho-
positioned hydroxyl groups are potential antioxidants. In recent years, phenolics and 
flavonoids with powerful antioxidant capacity has been drawing much attention. 
Studies have reported that phytochemicals in fruit and vegetables possess 
complementary and overlapping mechanisms of action, including
 scavenging free 
radicals, chelating metal ions, stimulation of the immune system, modulation of 
detoxification enzymes, regulation of gene
 expression in cell proliferation and 
apoptosis, hormone metabolism,
 and antibacterial and antiviral effects (Dragsted et al., 
1993; Waladkhani and Clemens, 1998).  
 
The synergistic effect of antioxidants such as vitamin E and C (Scarpa et al., 
1984), vitamin E and β-carotene (Palozza and Krinsky, 1992), catechin and malvidin 
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3-glucoside (Rossetto et al., 2002), flavonoids and urate (Filipe et al., 2001), and tea 
polyphenols and vitamin E (Zhou et al., 2000) were observed. Vitamin C can 
regenerate vitamin E from the vitamin E radical, recycling vitamin E. Vitamin E 
becomes a radical in the process, but it can be recycled by interacting with other 
antioxidant systems. It has been postulated that, compared with individual activity, 
combinations have greater antioxidant capacities in different model systems (Teissedre 
et al., 1996; Vivas et al., 1997; Meyer et al., 1998; Filipe et al., 2001; Rossetto et al., 
2002). Antioxidant synergism of tea polyphenols and α-tocopherol against free radical 
induced peroxidation of linoleic acid in homogeneous solutions and in micelles was 
reported, proposing a mechanism involving the recycling of α-tocopherol by the tea 
polyphenol (Zhou et al., 2000). The mixture of phenolic antioxidants found in wine 
and plant foods may interact to yield synergistic protection against LDL oxidation 
(Kinsella et al., 1993). The combinations of phenolics characterized by different free 
radical scavenging efficiency may show an antioxidant activity different from that 
expected on the basis of the sum of their individual activities (Saucier and Waterhouse, 
1999). It was previously reported from our lab that apple extracts exhibit strong 
antioxidant and antiproliferative activities and that the major part of total antioxidant 
activity is from the combination of phytochemicals (Liu, 2004). Beside antioxidant 
activities, phenolics have demonstrated other specific biological activities interfering 
with cellular mechanisms. For example, synergistic protection of PC12 cells from β-
amyloid toxicity by reservatrol and catechin was observed (Conte et al., 2003); 
quercetin and kaempferol were shown to be active on signal transduction pathways in 
cells via inhibiting PI 3-kinase, protein kinase C, and phospholipase A2, and by 
reducing neuronal apoptosis (Gschwendt et al., 1983; Wang et al., 2001).  
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It has been postulated that combinations of fruits have greater antioxidant 
activities than would be expected on the basis of their individual effects. The 
phenolics in fruits and vegetables may act independently or in combination as anti-
tumor or cardioprotective agents. The synergistic effect of pure compound 
combinations has been reported. Only limited knowledge is available about any 
interaction between/among phenolic compounds in inhibiting peroxyl free radical 
production and cell proliferation. Furthermore, there is no literature report related to 
synergistic, additional, and antagonism effects on inhibition of peroxyl radical 
production and cell proliferation in whole foods. Information on antioxidant and 
antiproliferative activities of different phenolics would give us a better understanding 
of the activities of phytochemicals in complex mixtures such as juice cocktails. The 
goal of this study is to seek possible synergies between/among different fruits 
combinations. The objectives for this study were to: (1) determine the phenolic and 
flavonoid contents, the total antioxidant and antiproliferative activity of cranberry, 
apple, and grape extracts on human liver and colon cancer cells in vitro; (2) measure 
the total antioxidant activity with different fruit extract combinations; (3) examine the 
antiproliferative activity of combination of different fruit extracts on human liver and 
colon cancer cells in vitro.  
 
 
4.2. Materials and Methods 
4.2.1. Chemicals 
Sodium nitrite, (+)-catechin, Folin-Ciocalteu reagent (FCR), hydrochloric acid, 
glucagon, hydrocortisone, insulin, and α-keto-γ-methiolbutyric acid (KMBA) were 
purchased from Sigma Chemical Co. (St. Louis, MO).  Aluminum chloride, sodium 
hydroxide, methanol, and acetone were purchased from Fisher Scientific (Pittsburgh, 
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PA).  Gallic acid was purchased from ICN Biomedical Inc. (Costa Mesa, CA).  2,2’-
azobis(amidinopropane) (ABAP) was purchased from Wako Chemicals (Richmond, 
VA). 
 
4.2.2. Sample Preparation 
Cranberry (Early Black variety), Apple (Red Declious variety), and Grape 
(Crimson variety) were purchased from local supermarkets. Samples were cleaned and 
dried before extraction. All data collected for each fruit were reported as means ± SD 
for at least three replications.  
 
4.2.3. Sample Extraction 
Phenolics were extracted from fresh cranberry, apple, or grape by the method 
reported previously in our laboratory (Yang et al., 2004). Briefly, 100 g of fruits were 
blended for 3 min in 200 g 80% acetone using Waring blender. The mixture was then 
homogenized in a Virtis High Speed Homogenizer for 3 min and filtered with vacuum. 
Water in the filtrate was evaporated using a rotary evaporator at 45°C until the weight 
of the evaporated filtrate was less than 10% of the weight of the original filtrate. All 
extracts were stored at –40°C until use. All extractions were performed in triplicate. 
 
4.2.4. Measurement of Total Phenolic Content 
The total phenolic content in fruits was determined using the Folin-Ciocalteu 
colorimetric method (Singleton et al., 1999), which was modified by our laboratory 
(Yang et al., 2004). Briefly, all sample extracts were diluted 1:5 with distilled water to 
obtain readings within the standard curve ranges of 0.0 - 600.0 µg of gallic acid/mL. 
The fruit extracts were oxidized with Folin-Ciocalteu reagent and the reaction was 
neutralized with sodium carbonate. The absorbance was measured at 760 nm after 90 
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min at room temperature by a MRX II Dynex plate reader (Dynex Technologies, Inc., 
Chanilly, VA). The absorbance values were then compared with those of standards 
with known gallic acid concentrations. All values were stated as the mean (milligrams 
of gallic acid equivalents per 100 g of fresh sample) ± SD for three replications.  
 
4.2.5. Measurement of Total Flavonoid Content 
The total flavonoid content of the fruit samples was determined using a 
modified colorimetric method (Jia et al., 1999; Yang et al., 2004). Briefly, 0.25 mL of 
diluted fruit extract was mixed with 1.25 mL of distilled water, and subsequently with 
0.075mL of 5% sodium nitrite solution, and allowed to react for 5 min. Then a 0.15 
mL of 10% aluminum chloride was added and allowed to further react for 6 min 
before 0.5 mL of 1 M sodium hydroxide was added. Distilled water was added to 
bring the final volume of mixture to 3 mL. The absorbance of the mixture was 
immediately measured at 510 nm wavelength against a prepared blank using a MRX II 
DYNEX spectrophotometer. The flavonoid content was determined by a catechin 
standard curve, and expressed as mean (milligrams of catechin equivalents per 100 g 
of fresh sample) ± SD for the triplicate extracts. 
 
4.2.6. Determination of Total Antioxidant Capacity 
The total antioxidant capacity of fruit extracts was measured using a total 
oxyradical scavenging capacity (TOSC) assay (Winston et al., 1998) as modified in 
our laboratory (Jia et al., 1999; Yang et al., 2004). Briefly, antioxidant activity was 
quantified after 15, 30, 45, and 60 min for four different fruit extract concentrations 
and a control. The amount of ethylene generated by the reaction was expressed as peak 
area. The TOSC value corresponding to each extract concentration was calculated by 
integrating the area under the kinetic curve, and assessed as the following equation: 
   130
100 ) / ( 100 × ∫ ∫ − = CA SA TOSC , where,   is the integrated area from the sample 
reaction, and   is the integrated areas from the control reaction. The median 
effective dose (EC
SA ∫
CA ∫
50) was determined for each fruit variety from the dose-response 
curve of fruit concentration versus TOSC value. The TOSC value is expressed as 
µmol of vitamin C equivalents per gram of sample. All values were presented as the 
mean ± SD at least three replicates.  
 
4.2.7. Measurement of Inhibition of HepG2 and Caco-2 Cell Proliferation  
The antiproliferative activity of different fruit extracts was assessed by 
measurement of the inhibition of HepG2 and Caco-2 human cancer cell proliferation. 
Antiproliferative activities were determined by the colorimetric MTS assay (MTS-
based cell titer 96 nonradioactivity cell proliferation assay) (Promega, Madison, WI) 
reported previously (Yang et al., 2004). HepG2 cells were cultured in Williams’ 
medium E (WME), containing 10 mM Hepes, 5 µg/mL insulin, 0.05 µg/mL 
hydrocortisone, 2 µg/mL glucagon, and 5% fetal bovine serum (Gibco, Life 
Technologies, Grand Island, NY), 50 units/mL penicillin, 50 µg/mL streptomycin, and 
100 µg/mL gentamicin. Caco-2 human colon cancer cells were maintained in DMEM, 
containing 10 mM Hepes, 5% FBS, 50 units/mL penicillin, 50 µg/mL streptomycin, 
and 100 µg/mL gentamicin. Both HepG2 and Caco-2 cells were maintained in a 5% 
CO2/37°C incubator. A total of 2.5 × 10
4 HepG2 or Caco-2 cells in growth media were 
placed in each well of a 96-well flat-bottom plate. Cell proliferation was measured by 
the ability of viable cells to reduce 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfenyl)-2H-tetrazolium (MTS) to formazan. After 4 h 
of incubation, the growth medium was removed and media containing various 
concentrations (5, 10, 20, 30, 40, 50, and 60mg/mL) of fruit extracts were added to the 
cells. In the combination test, the concentration were 0.125×EC50, 0.25×EC50, 
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0.5×EC50, 0.75×EC50, 1.0×EC50, 1.25×EC50, and 1.5×EC50. Control cultures received 
the extraction solution minus the fruit extracts, and blank wells contained 100 µL of 
growth medium without cells. Cell proliferation (percent) was determined at 96 h from 
the MTS absorbance (490 nm) reading for each concentration compared to the control, 
using at least three replications for each sample. The effective median dose (EC50) was 
determined and expressed as milligrams of fruit component per milliliter ± SD.  
 
4.2.8. Median-Effect Principle for Dose-Effect Analysis 
The dose-effect analysis was modified from Chou and Talalay (Chou and 
Talalay, 1977; Chou, 1991). The median-effect principle was used to calculate single 
and combined fruit extract effects. Dose-effect curves for each fruit extract and their 
combinations with series diluted concentrations were plotted by using the median-
effect equation as following: 
 
  [ ]
m
m a D D f / ( 1 / 1 + =     (1) 
Where D is the dose, Dm is the dose required for 50% effect, which is equivalent to 
median effect dose (EC50), fa is the fraction affected by dose D, and m is a coefficient 
of the sigmoidicity of the dose-effect curve. 
 
4.2.9. Combination Index for Determining Addition, Synergism and Antagonism  
The combination index (CI) (Chou, 1991; Chou et al., 1994) has been used for 
data analysis of two-way combinations as follow: 
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For three-way combinations, a third term, (D)3/(Dx)3, is added. CI < 1, CI = 1, and CI 
> 1 indicate synergism, additive effect, and antagonism, respectively. (D1) and (D2) 
are the doses of fruit extracts in the combination system; (Dx)1 and (Dx)2 are the doses 
of fruit 1 and fruit 2 alone, respectively. 
 
4.2.10. Experiment Design 
The experiment of different fruit combinations for total antioxidant activity 
and cell proliferation was designed in Table 4.1. Firstly, the EC50 value of each fruit 
extract was determined. Based on each EC50 value, a series of concentrations were 
designed as 0.125×EC50, 0.25×EC50, 0.5×EC50, 0.75×EC50, 1.0×EC50, 1.25×EC50, and 
1.5×EC50. Finally, different dose from fruit extract alone would be combined together 
to inhibit peroxyl free radicals.  The design of combinations in antiproliferative 
activity of three fruit extracts was similar to that of antioxidant activity.  
 
4.2.11. Statistical Analysis 
Statistical analysis was conducted using Minitab Student Release 12 (Minitab 
Inc., State College, PA) and SigmaStat Version 8.0 (Jandel Corp., San Raphael, CA). 
Results were subjected to ANOVA, and differences between means were located 
using Turkey’s multiple comparison test. Significance was determined at p < 0.05.  
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Table 4.1. Experiment design of fruit combination for antioxidant activity and antiproliferative activity. 
 
Fruit 1   
0  0.125×(EC50)1 0.25×(EC50)1
 
0.5×(EC50)1
 
0.75×(EC50)1
 
1.0×(EC50)1 1.25×(EC50)1 1.5×(EC50)1
0  Control (fa)1 (fa)1 (fa)1 (fa)1 (fa)1 (fa)1 (fa)1
0.125×(EC50)2 (fa)2 (fa)1, 2, 3       
0.25×(EC50)2 (fa)2  (fa)1, 2, 3      
0.5×(EC50)2 (fa)2    (fa)1, 2, 3     
0.75×(EC50)2 (fa)2      (fa)1, 2, 3    
1.0×(EC50)2 (fa)2        (fa)1, 2, 3   
1.25×(EC50)2 (fa)2          (fa)1, 2, 3  
 
 
 
Fruit 2 
1.5×(EC50)2 (fa)2            (fa)1, 2, 3
Control (fa)3 (fa)3 (fa)3 (fa)3 (fa)3 (fa)3 (fa)3
0  0.125×(EC50)3 0.25×(EC50)3
 
0.5×(EC50)3
 
0.75×(EC50)3
 
1.0×(EC50)3
 
1.25×(EC50)3 1.5×(EC50)3
 
Fruit 3 
 
 
 
 
1
3
3
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4.3. Results 
4.3.1. Total Phenolic and Flavonoid Content 
The total phenolic and flavonoid contents of the three fresh fruits is shown in 
Figure 4.1. Cranberry was found to have the highest phenolic content (p < 0.05) at 
428.0 ± 23.1mg of gallic acid equivalents/100g sample, followed by apple (221.6 ± 
12.8), and grape (154.5 ± 13.9). Significant differences were found in total phenolic 
content in comparisons among cranberry, apple, and grape (p<0.05). Cranberry had 
the highest flavonoid content (292.2 ± 10.3 mg of catechin equivalents/100g sample, 
p<0.05), followed by apple (171.3 ± 24.5), and grape (93.2 ± 7.1). The flavonoid 
content of cranberry, apple, and gape were significantly different from each other 
(p<0.05).  
 
4.3.2. Total Antioxidant Activity for Single Fruit 
The total antioxidant activities of the three fresh fruits, expressed as µg/mL 
sample, are summarized in Figure 4.2. Cranberry possessed the greatest antioxidant 
activity (228.2 ± 2.8 µg/mL, p<0.05), followed by apple (429.5 ± 6.6), and grape 
(524.1 ± 1.7). A statistically significant difference (p<0.05) was found among 
cranberry, apple, and grape. The dose-effect relationships of three fruit extracts were 
subject to the median-effect plot to determine their potency (EC50), shape (m), and 
conformity (r) in inhibition of peroxyl free radical production. The pooled results are 
summarized in Table 4.2. The EC50 and m values for single fruit extract and for their 
combination mixtures were used for calculating synergism, additive, or antagonism 
based on the CI equation.  
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4.3.3. Antiproliferative Activity for Single Fruit 
The antiproliferative activities of fresh fruits are expressed as the median 
effective dose (EC50), with a lower EC50 value signifying a higher antiproliferative 
activity (Figure 4.3). The extract of cranberry had the highest antiproliferative activity 
toward HepG2 cells with the lowest EC50 of 16.4 ± 3.5 mg/mL (p<0.05), followed by 
apple (32.3 ± 6.4), and grape (54.9 ± 6.4). The antiproliferative activities of three fresh 
fruit extracts on Caco-2 human colon cancer cells were similar to those on HepG2 
cells. The phytochemical extract of cranberry exhibited the highest antiproliferative 
effect toward Caco-2 cells with the lowest EC50 of 14.2 ± 2.2 mg/mL (p<0.05), 
followed by apple (23.1 ± 2.9), and grape (36.7 ± 5.6). Compared with cranberry 
extract, the phytochemical extract of grape exhibited a weak antiproliferative activity 
toward both HepG2 and Caco-2 cells at higher doses. The dose-effect relationships of 
three fruit extracts were subject to the median-effect plot to determine their potency 
(EC50), shape (m), and conformity (r) in inhibition of proliferations of HepG2 and 
Caco-2 human cancer cells in vitro. The pooled results are summarized in Table 4.3. 
The EC50 and m values for single fruit extract and for their combination mixtures were 
used for calculating synergism, additive, or antagonism based on the CI equation.  
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Table 4.2. Dose-effect relationship parameters of fruit extracts in inhibiting peroxyl free radicals*. 
Extract  EC50 (μg/mL)  m r  N 
Apple  429.5 ± 6.6  1.995 ± 0.307  0.960 ± 0.010  3 
Cranberry  228.2 ± 2.8  1.793 ± 0.252  0.948 ± 0.031  3 
Grape  524.1 ± 1.7  1.562 ± 0.183  0.956 ± 0.023  3 
 
 
 
Table 4.3. Dose-effect relationship parameters of fruit extracts combination in inhibiting Caco-2 and HepG2 cell growth in vitro*. 
 Caco-2     HepG2
Extract  EC50 
(mg/mL) 
m r  n  Extract  EC50 
(mg/mL) 
M r  n 
Apple  25.13±1.1 1.856±0.001 0.994±0.002 6  Apple  37.70±0.6 1.980±0.213 0.977±0.013  6 
Cranberry  12.68±0.5 2.430±0.944 0.975±0.001 6  Cranberry 17.46±0.3 2.010±0.196 0.994±0.002  6 
Grape  40.79±0.9 1.966±0.188 0.996±0.004 6  Grape  56.68±1.8 1.816±0.525 0.973±0.001  6 
         
*The parameters EC50, m, and r are antilog of x-intercept, slope, and the linear correlation coefficient of median-effect plot, which 
signifies the potency (EC50), the shape of the dose-effect curve, and conformity of the data to the mass-action law, respectively; n is 
the number of sets of dose-effect relationship experiments tested (Chou et al., 1994).  
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Figure 4.1. Total phenolic and flavonoid content of fresh fruit extracts (mean ± SD, n 
= 3). Bars with no letters in common are significantly different (p < 0.05). 
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Figure 4.2. Total antioxidant activity of phytochemicals from fruit extracts (mean ± 
SD, n = 3). Bars with no letters in common are significantly different (p < 0.05). 
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Figure 4.3. Antiproliferative activity of phytochemicals from fruit extracts (mean ± 
SD, n = 3). 
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4.3.4. Antioxidant Activities of Different Fruit Combinations 
Among three fruits, three pairs of two-way combinations and one pair of three-
way combination were investigated. The average median effect dose (EC50) and CI 
values at 50% induction rate are presented in Table 4.4. The dose-effect curves of 
different combination are plotted out in Figure 4.4. The dose-effect curve of 
antioxidant activity is shifted to the left after the combination. Compared with single 
compound, the EC50 concentration on inhibition of peroxyl free radicals dramatically 
decreases among four pairs of combinations with different magnitude. For example, 
The EC50 of apple and cranberry after combination is 2.3- and 2.4-fold, respectively, 
lower than the EC50 of each fruit alone. The EC50 of apple, cranberry, and grape after 
combination is 3.0-, 3.2-, and 3.1-fold, respectively, lower than the EC50 of each fruit 
alone, suggesting synergistic effect after the combination of the three compounds. 
Apple and grape two-way combinations also resulted in fold reductions of 1.42, and 
1.49, respectively. Both two-way and three-way fruit combinations were examined at 
concentrations ranged from 0 to 1.5 × EC50. The CI at 50% inhibition rate in apple and 
cranberry, in cranberry and grape, and among apple, cranberry, and grape 
combinations are 0.853 ± 0.09, 0.681 ± 0.12, and 0.977 ± 0.02, respectively, indicating 
a synergistic effect in those combinations. However, the two-way combination of 
apple and grape demonstrated an antagonistic effect since the CI value was 1.374 ± 
0.05, which is greater than 1.  
 
4.3.5. Antiproliferative Activities of Various Fruit Combinations 
The median effect dose (EC50) and combination index (CI) values for two-way 
and three-way fruit combinations in antiproliferative activity for human liver and 
colon cancer cells are summarized in Table 4.5, and 4.6, respectively. The dose-effect 
curves of different combination are plotted in Figure 4.5, and 4.6, respectively. For 
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three pairs of two-way and one pair of three-way combination there was a decrease in 
the EC50 dose for all fruits tested both in HepG2 and in Caco-2 cell proliferation.  
 
In HepG2 cell line, compared fruit alone and combination, the fold reduction in 
EC50 of apple and cranberry is 2.42 and 2.62, respectively, in the apple and cranberry 
combination. The fold reduction in EC50 of cranberry and grape is 3.52 and 3.62, 
respectively, in the cranberry and grape combination. The fold reduction in EC50 of 
apple, cranberry, and grape is 3.73, 4.03, and 4.36, respectively, in the apple, 
cranberry and grape combination. However, the fold reduction in EC50 of apple and 
grape is 1.74 and 2.03, respectively, in the apple and grape combination. The CI at 
50% inhibition rate in apple and cranberry, in cranberry and grape, and among apple, 
cranberry, and grape combinations are 0.862 ± 0.11, 0.774 ± 0.12, and 0.899 ± 0.165, 
respectively, indicating a synergistic effect in those combinations. However, the two-
way combination of apple and grape demonstrated an antagonistic effect since the CI 
value was 1.128 ± 0.05, which is greater than 1.  
 
For Caco-2 cell proliferation, in the apple and cranberry combination, the fold 
reduction in EC50 of apple and cranberry is 1.18, and 1.39, respectively; the fold 
reduction in EC50 of apple and grape is 1.20, and 2.07, respectively. Cranberry and 
grape combinations lower the EC50 of cranberry and grape to 2.29-, and 4.38-fold, 
respectively. The 3-way combination also causes the fold reduction in EC50 of apple, 
cranberry, and grape with 2.86, 3.36, and 3.61, respectively. The CI values at 50% 
inhibition of Caco-2 cell proliferation are 1.426 ± 0.04, and 1.295 ± 0.15, respectively, 
in apple and cranberry, and in apple and grape combinations, suggesting an 
antagonism. 0.770 ± 0.03 and 0.927 ± 0.124 of CI values are generated in cranberry 
and grape, and in apple, cranberry, and grape combinations, indicating a synergism.  
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Table 4.4. Summary of medium effect dose based on antioxidant activity from fruit combinations. 
EC50 (µg/mL) [µmol vitamin C equ./g sample] 
 
 EC50   
           
 Fruit  Single Combination 
CI at 50% 
Inhibition rate 
 
Combination 
Effect 
Apple 
Cranberry 
429.5 ± 6.6
228.2 ± 2.8
76.8 ± 1.2 
144.6 ± 1.8
188.1 ± 20.8 
94.05 ± 10.4 
175.4 ± 20.5 
350.8 ± 41.1 
0.853 ± 0.09 
 
Synergism 
 
Apple 
Grape 
429.5 ± 6.6
524.1 ± 1.7
76.8 ± 1.2 
63.0 ± 0.2 
303.3 ± 11.5 
352.7 ± 13.4 
109.1 ± 4.2 
93.5 ± 3.6 
1.374 ± 0.05 
 
Antagonism 
Cranberry 
Grape 
228.2 ± 2.8
524.1 ± 1.7
144.6 ± 1.8
63.0 ± 0.2 
77.0 ± 13.2 
179.6 ± 30.8 
428.6 ± 68.9 
183.7 ± 29.5 
0.681 ± 0.12 
 
Synergism 
 
Apple 
Cranberry 
Grape 
429.5 ± 6.6
228.2 ± 2.8
524.1 ± 1.7
76.8 ± 1.2 
144.6 ± 1.8
63.0 ± 0.2 
144.7 ± 2.8 
72.3 ± 1.4 
168.8 ± 3.3 
228.0 ± 4.4 
456.1 ± 8.9 
195.5 ± 3.8 
 
0.977 ± 0.02 
 
Synergism 
 
Table 4.5. Summary of medium effect dose based on HepG2 cell proliferation from fruit combinations. 
EC50 (mg/mL)  
 
EC50     
             
 Fruit  Single Combination 
CI at 50% 
Inhibition rate 
 
Combination 
Effect 
Apple 
Cranberry 
37.70 ± 0.6 
17.46 ± 0.3 
15.57 ± 0.81 
6.67 ± 0.35 
0.862 ± 0.11 
 
Synergism 
 
Apple 
Grape 
37.70 ± 0.6 
56.68 ± 1.8 
21.68 ± 0.96 
27.87 ± 1.2 
1.128 ± 0.05 
 
Antagonism 
Cranberry 
Grape 
17.46 ± 0.3 
56.68 ± 1.8 
5.37 ± 1.4 
15.66 ± 4.1 
0.774 ± 0.12 
 
Synergism 
 
    Apple  10.11 ± 0.71  37.70 ± 0.6 
Synergism  Cranberry  0.899 ± 0.165  4.33 ± 0.3  17.46 ± 0.3 
  Grape  13.0 ± 0.91  56.68 ± 1.8 
1
4
2
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Table 4.6. Summary of medium effect dose based on Caco-2 cell proliferation from fruit combinations. 
EC50 (mg/mL)  
 
EC50     
             
     Fruit  Single Combination 
CI at 50% 
Inhibition rate 
Combination 
Effect 
 
Apple  Antagonism  25.13 ± 1.1  21.25 ± 0.63  1.426 ± 0.04 
Cranberry      12.68 ± 0.5  9.11 ± 0.27 
Apple  Antagonism  25.13 ± 1.1  20.98 ± 0.98  1.295 ± 0.15 
Grape    40.79 ± 0.9  19.73 ± 5.4 
Cranberry  Synergism  12.68 ± 0.5  5.54 ± 0.19  0.770 ± 0.03 
Grape      56.68 ± 1.8  12.93 ± 0.45 
    Apple  8.79 ± 1.2  25.13 ± 1.1 
Synergism  Cranberry  0.927 ± 0.124  3.77 ± 0.5  12.68 ± 0.5 
  Grape  11.30 ± 0.5  40.79 ± 0.9 
 
 
 
 
 
 
 
 
1
4
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Figure 4.4. The dose-effect curves for fruit combinations in inhibiting peroxyl free 
radicals: (a) apple + cranberry; (b) apple + grape; (c) cranberry + grape; and (d) apple 
+ cranberry + grape. 
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Figure 4.5. The dose-effect curves for fruit combinations in inhibiting HepG2 cell 
proliferation: (a) apple + cranberry; (b) apple + grape; (c) cranberry + grape; and (d) 
apple + cranberry + grape. 
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Figure 4.6. The dose-effect curves for fruit combinations in inhibiting Caco-2 cell 
proliferation: (a) apple + cranberry; (b) apple + grape; (c) cranberry + grape; and (d) 
apple + cranberry + grape. 
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4.4. Discussion 
Compelling evidence indicates that multiple servings of fruits and vegetables 
in the daily diet provide health benefits. Studies conducted by our group and others 
have shown that
 phytochemical extracts in fruits and vegetables exhibit strong 
antioxidant
 and antiproliferative activities and that the major part of
 total antioxidant 
activity is from the combination of phytochemicals. Based on antioxidant and 
antiproliferative activities of the individual fruits, these activities of common fruits 
with different combinations were examined. Our work has clearly shown that the 
phytochemicals from single fruit have potent antioxidant and antiproliferative 
activities, and that antioxidant activity is positively correlated with total phenolic and 
flavonoid contents. Furthermore, the phytochemicals in the two-way and three-way 
combinations of fruits have demonstrated more potent antioxidant and antiproliferative 
activities due to the EC50 decrease. The combinations in apple and cranberry, in 
cranberry and grape, and in cranberry, apple, and grape showed a synergistic effect on 
inhibition of radical production; however, the apple and grape combinations had an 
antagonistic effect on radical production blocking. For the HepG2 and Caco-2 cell 
proliferation, the phytochemicals in apple and cranberry, in apple, cranberry, and 
grape had synergistic effect on antiproliferative activity. The additive and synergistic 
effects of phytochemicals in fruits are responsible for their potent antioxidant
 and 
anticancer activities, and that the benefit of a diet rich
 in fruit is attributed to the 
complex mixture
 of phytochemicals present in whole foods. The evidence suggests 
that antioxidant and antiproliferative activities are
 best acquired through whole-food 
consumption. 
 
The possible reason for protection against chronic disease owing to 
consumption of fruits is the presence of antioxidant vitamins such as vitamin C, 
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vitamin E, and β-carotene. However, some studies doubt on this hypothesis (Vinson et 
al., 1995; Cao et al., 1996; Rapola et al., 1997; Ascherio et al., 1999; Eberhardt et al., 
2000; Leppala et al., 2000; Yusuf et al., 2000). (Vinson et al., 1995) showed that many 
phenolics are stronger antioxidants than the vitamin antioxidants with a model of the 
oxidation of the lower density lipoproteins. There were no benefits of vitamin C or E 
for reducing the risk of stroke for an 8-year prospective study of more than 44,000 
healthy men in the Health Professionals Follow-up Study (Ascherio et al., 1999). 
(Yusuf et al., 2000) reported that a 4-year vitamin E supplementation to over 9000 
patients with high risk for cardiovascular events led to no significant benefit. Studies 
from (Leppala et al., 2000) showed that a 6-year daily vitamin E or β-carotene 
supplementation to cigarette smokers had a decreased risk of cerebral infarction but an 
increased risk of hemorrhage. Our group found that the vitamin C in apples with skin 
accounts for
 only 0.4% of the total antioxidant activity. It has been proposed that the 
majority of antioxidant activity of fruits may come from phytochemicals such as 
phenolics and flavonoids. Phenolic compounds widely distributed in fruits scavenge 
ROS and free radicals as antioxidant. In addition, phenolics can chelate transition 
metal ions, influence specifically the cell at a transcriptional level, affect signal 
transduction pathways in the cells, down-regulate pathways leading to cell death, and 
affect cell redox systems (Spencer et al., 2001; Wang et al., 2001). More than 5,000 
individual
 phytochemicals have been identified in fruits, vegetables, and
 grains, and 
each phytochemical has been proven to have unique biological activities. For example, 
quercetin blocks phospholipase A2, PI 3-kinase, and protein kinase C, and kaempferol 
inhibits the activation of caspase-2, -3, -8, and -9 and reduces neuronal apoptosis 
(Gschwendt et al., 1983; Wang et al., 2001). The studies from Kuroda and Hara (1999) 
and Chung et al. (2001) have shown that catechins inhibit tumors and induce 
apoptosis. Resveratrol arrests the cell cycle at S/G2 phase. Resveratrol may contribute 
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to inhibit cell proliferation by the suppressing the activities of cyclooxigenase-2 
(COX-2), nuclear transition factors NF-κB, AP-1, c-fos, and inducing the activities of 
CD95L, p21, and p53 (Manna et al., 2000).  
 
Based on the principle of the mass-action law via mathematical induction and 
deduction in enzyme kinetic models, the median-effect equation and the CI method 
have been extensively applied in drug combinations (Chou and Talalay, 1977; Chou, 
1991; Chou et al., 1994). Our study was carried out by quantitative analysis of 
synergism or antagonism at different fruit doses and different effect levels. Here three 
methods are used to express additive, synergistic, and antagonistic effects. One way is 
to compare the fold EC50 reduction between single fruit and combined fruit system. 
Another way is to compare generated CI value with 1. The last way is to examine 
inhibition fraction in each fruit system on the basis of the sum of their individual 
activity by using the dose (EC50) produced in combined fruit system. If the results 
from above 3 methods are consistent, conclusions could be drawn. For example, in 
apple, cranberry, and grape combinations, the reduction fold of EC50 of apple, 
cranberry, and grape after combination is 3.0, 3.2, and 3.1, respectively, suggesting 
synergistic effect after the combination of the three compounds. Secondly, the CI at 
50% inhibition rate among apple, cranberry, and grape combinations is 0.977 ± 0.02, 
which is less than 1, indicating a synergistic effect.  
 
From single fruit effect, it was found that cranberry showed the highest 
antioxidant and antiproliferative activities (p < 0.05), followed by apple, and grape. 
Theoretically, it is extrapolated that cranberry would make the maximal contribution 
of synergism among apple, cranberry, and grape combination. However, it was not 
consistent with the observed results. For example, cranberry made a minimal 
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contribution of 3-way combination in antioxidant model (Figure 4.5 (d)). We 
postulated that the activity of certain bioactive compounds from cranberry has 
changed in the combined matrix. Particular bioactive compounds may act additively 
and antagonistically with some compounds in the combined matrix and the overall 
expressed activity may be dependent upon relative proportions of each and/or 
presence/absence of particular compounds. In this study, 2-way combinations of apple 
plus cranberry, cranberry plus grape, and 3-way combination of apple plus grape plus 
cranberry exhibited the synergistic action in inhibiting peroxyl free radicals. However, 
the 2-way combination of apple plus grape showed antagonistic action in suppressing 
peroxyl free radicals. The observed antagonism between catechin and quercetin 
(cyanidin, caffeic acid, and ellagic acid) was also found in inhibiting LDL oxidation 
(Meyer et al., 1998). 
 
Many of the phytochemicals in whole foods have been found to provide a 
much stronger antioxidant activity than single supplement such as vitamin C, E, and β-
carotene. This may be explained by the combination of different phytochemicals 
functioning synergistically or additively. (Bentsath et al., 1936) have found that 
Hungarian red pepper extracts possessed an ascorbate-protective factor, identified as a 
mixture of flavonoids, and demonstrated that the interaction between flavonoids and 
other antioxidants. The synergy between flavonoids and ascorbate has been also 
reported by other experiments (Harper et al., 1969; Kandaswami et al., 1993). Urate is 
an important plasma antioxidant. 12 different flavonoids based on the number and 
position of hydroxylations in the A and B rings, availability, and prevalence in the 
human diet were analyzed for their antioxidant effects on copper-induced lipid 
peroxidation in diluted human whole plasma (Filipe et al., 2001). It has been 
suggested that catechin, quercetin, luteolin, and rutin with concentrations range from 
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5.0 to 7.5 μM showed a synergistic antiperoxidant effect with urate. In terms of 
mechanism, the reduction potential of the urate radical/urate pair is higher than that of 
the ascorbyl radical/ascorbate, which permits the reaction of the latter with the urate 
radical, recycling urate (Maples and Mason, 1988). Due to redox potential similar to 
ascrobate (Hendrickson et al., 1994), it was postulated that some flavonoids could 
recycle urate from its radical. Generally, combination of phytochemicals such as 
phenolics and flavonoid from fruits and vegetables contain more potential antioxidant 
activity and anticancer activity. The antioxidant synergy between (+)-catechin and 
other antioxidants (SO2, Trolox, ascorbate, and uric acid) was evaluated in vitro using 
the Folin-Ciocalteu and metmyoglobin assays (Saucier and Waterhouse, 1999). The 
results showed that the mixture of (+)-catechin and SO2 resulted in a synergistic effect 
of their antioxidant activities, the interaction between (+)-catechin and Trolox, 
ascorbate and uric acid led to an additive effect of their antioxidant activities. Catechin 
is relatively inefficient at inhibiting linoleic acid oxidation in micellar systems 
mimicking LDL (Rossetto et al., 2002). However, a strong synergistic effect between 
catechin and malvidin 3-glucoside was observed, indicating a recycling of malvidin 3-
glucoside by catechin. The chemical structure and antioxidant activity of 
phytochemicals was evaluated by measuring inhibition of copper-catalyzed human 
LDL oxidation in vitro (Meyer et al., 1998). 20 different combinations of two/three of 
catechin, cyanidin, caffeic acid, quercetin, and ellagic acid were examined to 
investigate the potential synergistic or antagonistic effects on measuring the 
antioxidant activities on LDL. It was found that antioxidant effects of the 
hydroxyphenols were additive in both the two- and three-compound combinations 
except combination of ellagic acid with catechin, where ellagic acid had a significant 
antagonistic effect on the antioxidant activity of catechin, it was proposed that the 
effect is due to hydrogen bonding between carbonyls in ellagic acid and o-dihydroxyl 
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  groups in catechin. Neitherof which showed effect on platelet function when used 
alone,
 the combination
 of 25 µmol catechin/L and 5 µmol quercetin/L significantly 
inhibited collagen-induced platelet aggregation and platelet adhesion to collagen, 
suggesting a synergistic effect (Pignatelli et al., 2000). With 50 μM catechin and 10 
μM resveratrol or 25 μM resveratrol and 10 μM catechin, the toxicity determined by 
10
−7 M β-Amyloid peptide (1–41) in PC12 cells is almost completely abolished, 
suggesting a synergistic protective effect (Conte et al., 2003). 
 
The observed additive and synergistic effects may be important in human 
health since oxidative processes are involved in many diseases. Here, the greatest 
challenge is how to decide the concentration range of individual fruits in the 
combination. If the designed concentrations were too low, the combination would not 
function. On the other hand, if the doses were too high, the combination would cause 
cytotoxicity toward cell lines. Here, based on individual fruit’s EC50, series 
concentrations designed were lower or higher than EC50 both in antioxidant and 
antiproliferative activities models. The above method was proven to work well in our 
study. Our current study clearly demonstrated that there existed synergistic and 
antagonistic effects in fruits in inhibition of peroxyl free radical production and HepG2 
and Caco-2 cell proliferation. However, the studies strengthen the quantitative analysis 
of fruit combinations rather than the mechanism of synergistic and antagonistic 
interactions. It is worthwhile to investigate synergistic and antagonistic effects of the 
main bioactive compounds from fruits, and conduct research on the mechanism of 
actions related to these interactions.  
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CHAPTER FIVE 
 
COMBINATION EFFECTS OF SELECTED PHYTOCHEMICALS AND 
FRUITS ON QUINONE REDUCTASE ACTIVITY 
 
 
5.1. Introduction 
Numerous epidemiological studies have consistently shown that a high
 dietary 
consumption of fruits and vegetables is strongly associated with lowered risk for 
developing chronic
 diseases, such as cardiovascular disease (CVD) and cancer, which
 
are the top two leading killers in the United States. From Heart Disease and Stroke 
Statistics—2006 Update (Thom et al., 2006), preliminary mortality data show that 
CVD is the underlying cause of death accounting for 37.3% of all 2,440,000 deaths or 
1 out of every 2.7 deaths, while cancers accounted for 554,643 in 2003 in the United 
States. Scientific evidence suggests that about one-third of the 564,830 cancer deaths 
expected to occur in 2006 will be related to nutrition, physical activity, and being 
overweight, and thus could also be prevented (American Cancer Society, 2006). The 
National Academy of Sciences of the United States in 1982 issued guidelines on diet 
and cancer, strengthening the importance of fruits and vegetables. The Food Pyramid 
developed by the US Department of Agriculture in 2005 recommends fruits and 
vegetables consumption of 5 to 9 servings per day.  
 
Besides providing the essential nutrients for life, diet also supplies bioactive 
compounds which are important for disease prevention and health maintenance. There 
is overwhelming evidence indicating that increased uptake of fruits and vegetables in 
the diet reduce the risk of heart disease, cancer, stoke, as well as brain and immune 
dysfunction (Doll and Peto, 1981; Block et al., 1992; Willett, 1994; Temple, 2000; 
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Joshipura et al., 2001). A number of epidemiological studies have examined the 
relation between consumption of fruits and vegetables and chronic diseases, and most 
of these studies found protective effects for fruits and vegetables. Study from (Knekt 
et al., 1994) indicated an
 inverse relationship between intake of vegetables and the risk
 
of coronary artery disease (CAD) in 5,133 Finnish men and women. A significant 
inverse
 association between flavonoid intake from apple, berries, and onions and CAD 
death has been documented (Knekt et al., 1996). In pooled analyses of the Nurses’ 
Health Study
 and the Health Professionals’ Follow-up Study, including
 2190 cases of 
CAD and 570 cases of ischemic stroke, (Joshipura et al., 2001) have found that there 
existed an inverse
 association between intake of fruits and vegetables and CAD in a 
dose-dependent manner, and that consumption of at least
 8 servings/day is associated 
with the lowest risk. Diets rich in fruit and vegetables have been suggested for 
preventing cancer. In 1997, World Cancer Research Fund and American Institute
 for 
Cancer Research made a conclusion that there was convincing
 evidence that high 
consumption of vegetables lowers the risk of
 the colon, lung, stomach,
 mouth and 
pharynx, esophagus, and rectum cancers; that it probably decreases the risk of the 
larynx, pancreas, breast, and bladder cancers; and that it possibly lowers the risk of the 
liver, ovary, endometrium,
 cervix, prostate, thyroid, and kidney cancers. High intake 
of fruits has been associated with a decreased risk of most of the cancers mentioned 
above (WCRF, 1997). After examining the epidemiological
 evidence from case-
control and cohort studies on fruit
 and vegetable consumption at different cancer sites 
by summarizing
 it quantitatively with a meta-analytic approach, (Riboli and Norat, 
2003) concluded that case-control studies overall show a significant
 reduction in the 
risks of esophagus, lung, stomach,
 and colorectum cancers related to consumption of 
fruits and vegetables; prospective studies provide weaker evidence than
 do case-
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control studies of the association of fruit and vegetable intake with lowered cancer 
risk. 
 
The protective effects of fruits and vegetables are probably mediated by 
multiple beneficial nutrients and/or non-nutrients present in fruits and vegetables, 
including phenolics, folate, antioxidant vitamins, carotenoids, thiols, and 
glucosinolates. Reactive oxygen species (ROS) such as free radicals are the 
byproducts generated during oxidative metabolism in organisms. Antioxidants are 
believed to play a very important role in the body defense system against ROS. 
Endogenous antioxidants with dietary antioxidants may be particularly important in 
diminishing the cumulative effects of oxidatively damaged molecules. Fruits and 
vegetables are the important sources of antioxidants. Phenolics and other plant 
antioxidants can scavenge the free radicals, and then inhibit their oxidative reactions 
with macromolecules in the body. Previously much attention was paid to the dietary 
antioxidant properties of vitamins C, E, and carotenoids. However, studies have shown 
that some common fruits and vegetables possess high antioxidant activity, which 
cannot be accounted for by their vitamin C content (Wang et al., 1996; Eberhardt et 
al., 2000). Furthermore, some studies have demonstrated that dietary phenolics 
derived from plant are more effective antioxidants in vitro than vitamins C or E (Liu, 
2003; Liu, 2004). On the other hand, epidemiological studies of Vitamin E, and β-
carotene supplements for chronic disease prevention have found either no effect on 
CVD or a slight increase in cardiovascular mortality and cancer (Hennekens et al., 
1996; Omenn et al., 1996; Rapola et al., 1997). Phenolics and flavonoids with the 
powerful antioxidant capacity have been drawing much attention recently. Fruits and 
vegetables consumed by human diets contain thousands of phytochemicals. 
Flavonoids are the largest class of phenolic compounds, and more than 5,000 
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compounds have been identified. In particularly, anthocyanins, hydroxybenzoic and 
hydroxycinnamic acid derivatives, flavones, flavanols (catechins), flavonols, 
flavanones, isoflavones, and tannins are frequently present. Phenolics which possess 
two ortho-positioned hydroxyl groups are good antioxidants. The possible effects of 
synergism and antagonism in complex mixtures of these phytochemicals need to be 
considered. It is believed that phytochemicals in fruits and vegetables possess 
complementary and overlapping mechanisms of action, including
 scavenging free 
radicals, chelating metal ions, modulation of detoxification enzymes, stimulation of 
the immune system, regulation of gene
 expression in cell proliferation and apoptosis, 
hormone metabolism,
 and antibacterial and antiviral effects (Dragsted et al., 1993; 
Waladkhani and Clemens, 1998).  
 
Quercetin (3,3',4',5-7-pentahydroxyflavone) belongs to an extensive class of 
polyphenolic flavonoid compounds almost ubiquitous in plant food sources. Quercetin 
is the major bioflavonoid in the human diet. The estimated average daily dietary intake 
of quercetin by an individual in the United States is about 25mg (Davis et al., 2000; 
Davis et al., 2005). The biological functions of quercetin can be summarized as free 
radical scavenger and inhibitor of ROS production (Pietta, 2000); binding in the ATP-
binding pocket of the kinase as protein kinase inhibitor (Walker et al., 2000); 
inhibiting the religation of the DNA double strands as topoisomerase inhibitor 
(Constantinou et al., 1995); and regulating NF-κB transcription factors and AP-1 
which regulate gene expression (Muraoka et al., 2002; Moon et al., 2003).  
 
Genistein (4′,5,7-trihydroxyisoflavone) is a phytoestrogen with a wide variety 
of pharmacological effects in animal cells, and with a range of potential health 
beneficial effects from epidemiological and animal model studies, including 
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chemoprevention of breast and prostate cancers, cardiovascular disease, and post-
menopausal ailments (Adlercreutz et al., 1995; Dixon and Daneel, 2002). In several 
clinical studies, genistein showed chemoprotective and chemotherapeutic potential 
against tumors, including colon, prostate, and breast cancers via different mechanisms 
of action such as modulation of cell cycle activity by arresting cell cycle at the G2-M 
stage (Matsukawa et al., 1993); apoptosis induction; competitive inhibition of ATP 
binding to the catalytic domain of tyrosine kinase; inhibition of DNA topoisomerase-II 
and tyrosine protein kinase (Akiyama et al., 1987); stimulating the production of sex 
hormone-binding globulin, lowering the risk of hormone related cancers by decreasing 
the amount of free and active hormones in the blood (Messina et al., 1994); and 
inhibition of cell growth by modulating transforming growth factor (TGF) β1 
signaling pathways (Kim et al., 1998).  
 
Resveratrol (3, 4’, 5-trihydroxystilbene, RSV) is found in various food 
products, with particularly high abundance in grape skin, seeds, and red wine 
(Langcake and Pryce, 1976). RSV is an active ingredient of the oriental folk medicine 
kojokon which have many therapeutic uses (Kimura et al., 1985). The presence of 
RSV in wine has been suggested as a possible explanation for the French Paradox 
(Siemann and Creasy, 1992; Frankel et al., 1993a). Thus, RSV has attracted 
considerable
 attention due to its cardioprotective and cancer chemopreventive
 
activities (Jang et al., 1997), which provide great interest in grapes, wines, and dietary 
products containing RSV. The proposed mechanisms related to RSV’s health effects 
can be summarized as scavenging
 intracellular ROS (Manna et al., 2000), inhibiting 
the oxidation of LDL (Frankel et al., 1993b), preventing platelet aggregation (Pace-
Asciak et al., 1995), suppressing cell proliferation via steps in the signal transduction 
pathways (Pozo-Guisado et al., 2002), inducing apoptotic cell death through activation 
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of mitochondria-dependent pathways (Huang et al., 1999), exhibiting anti-
inflammatory activity
 via down-regulation of proinflammatory cytokines (Wadsworth 
and Koop, 1999), promoting cellular differentiation (Mizutani et al., 1998), exhibiting 
antiestrogenic activity (Lu and Serrero, 1999), and inhibiting CYP1 enzymes (Chang 
et al., 2001).  
 
Induction of detoxification enzymes by fruits and vegetables is one of 
proposed mechanisms to account for chemoprotective effect through an enhancement 
in excretion of chemical carcinogens (Wattenberg, 1985). For instance, intake of 
cruciferous vegetables, such as cabbage, broccoli, and Brussels sprouts, has been 
demonstrated to induce detoxification enzymes and increase clearance of xenobiotics 
in animals (Prochaska et al., 1992; Zhang et al., 1992), and has been associated with 
lowered incidence of cancers in humans (Graham et al., 1978; Pantuck et al., 1979).  
Quinone reductase (QR) is a family of two-electron reducing enzymes that decrease 
the oxidative damage resulting from one-electron reduction of quinone (Lind et al., 
1982). It is induced coordinately with other phase II detoxifying enzymes, such as the 
glutathione S-transferases (GST), and plays an important role in protecting
 cells 
against oxidative cycling, detoxifying carcinogens, and providing an index for Phase II 
gene status of cells (Dinkova-Kostova and Talalay, 2000). A wide variety of chemical 
compounds, including quinones, Michael reaction acceptors, isothiocyanates, 
oxathiolene oxides, hydroperoxides, trivalent arsenicals, some heavy metals, vicinal 
dimercaptans, carotenoids, and flavanoids has been reported to induce QR in cells 
(Talalay et al., 1988; Prestera et al., 1993; Albena et al., 2004). Compared with the 
corresponding normal tissues, enhanced levels of expression of QR have been reported 
in colon, breast, liver, and lung cancers (Riley and Workman, 1992; Belinsky and 
Jaiswal, 1993).  
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QR is a flavoprotein that catalyzes two-electron reduction and detoxification of 
quinones and its derivatives, leading to the protection of cells against redox cycling, 
oxidative stress, and neoplasia. QR acts as an important regulator of a wide variety of 
biological functions and may play a particularly significant role in cancer. The major 
functions of QR are to catalyze the obligatory single-step two-electron reduction, 
bypassing reactive and toxic semiquinone intermediates (Talalay and Dinkova-
Kostova, 2004); to lower formation of ROS by decreasing one electron reductions and 
the associated redox cycling (Ernster, 1987); to help maintain certain endogenous 
antioxidants in their reduced and active forms such as ubiquinone (Landi et al., 1997) 
and α-tocopherolquinone (Siegel et al., 1997); to negatively regulating Mdm-
2/ubiquitin-independent degradation pathway for stabilization of p53 protein (Asher et 
al., 2001); to play an important role in activating some anticancer drugs (Ross et al., 
1993; Workman, 1994); and to act as a phase II detoxifying enzyme involved in 
cancer prevention (Ross et al., 1993; Workman, 1994).  
 
A complex interplay among the ROS defense systems exists, with various 
antioxidant cycles acting to prevent cell damage and chronic diseases. Synergistic 
effect of antioxidants such as vitamin E and vitamin C (Scarpa et al., 1984), vitamin E 
and β-carotene (Palozza and Krinsky, 1991), catechin and malvidin 3-glucoside 
(Rossetto et al., 2002), flavonoids and urate (Filipe et al., 2001), and tea polyphenols 
and vitamin E (Zhou et al., 2000) were observed. Vitamin C can regenerate vitamin E 
from the vitamin E radical, recycling vitamin E (Buettner, 1993). Vitamin E becomes 
a radical in the process, but it can be recycled by interacting with other antioxidant 
systems. Fruits and vegetables contain an array of phytochemicals and thus provide a 
mixture of unique compounds and their derivatives in the diet. Some phytochemicals 
from fruits and vegetables are linked to induction of both Phase I and Phase II 
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detoxification enzymes, which have been defined as bifunctional inducers, while 
others only induce Phase II enzymes, and they have been designated as 
monofunctional inducers (Prestera et al., 1993). It has been postulated that 
combinations of fruit have greater antioxidant activities than would be expected on the 
basis of their individual effects. The phytochemcials in fruits and vegetables may act 
independently or in combination as anti-tumor or cardioprotective agents. Information 
on inducer interactions of phytochemicals would provide better understanding of the 
QR induction effects in complex mixtures. However, little is known about the relative 
potencies of interaction between/among different compounds present in a single 
fruit/vegetable to induce Phase II enzymes. Furthermore, there is no literature on the 
effect of combinations of fruit extracts on QR induction. Based on our previous 
studies, therefore, it is of great interest to examine combinations of common 
phytochemicals to look at the additive, synergistic, and antagonistic effects in 
induction of Phase II enzymes. The goal of this study therefore was to seek possible 
synergy between/among different phytochemicals and fruit combinations. The 
objectives for this study were to: (1) determine the phytochemical combination effect 
of quercetin, genistein, and resveratrol on QR induction; (2) examine the 
phytochemicals and grape variety combination effect on QR induction; (3) investigate 
the fruit combinations effect on QR induction.  
 
 
5.2. Materials and Methods 
5.2.1. Chemicals 
Alpha minimal essential medium (α-MEM), fetal calf serum (FBS), hepes, and 
antibiotic-antimycotic solution were purchased from GIBCO (Life Technologies, 
Grand Island, NY). 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
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sulfenyl)-2H-tetrazolium (MTS) and phenazinemethosulfate (PMS) were from 
Promega (Madison, WI). Genistein (<98% HPLC grade), quercetin (dihydrate), 
resveratrol (3,4’,5-trihydroxystilbene, ~99%), β-naphthoflavone (BNF, 90-95%), 
digitonin, glucose 6-phosphate, menadione, nicotinamide adenine dinucleotide 
phosphate (NADP), flavin adenine dinucleotide (FAD), albumin from human serum 
(≥96%), yeast glucose 6-phosphate dehydrogenase, 3-(4,5-Dimethylthiazo-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), sodium dodecyl sulfate (SDS, ~99%), 
ethylenediamine tetraacetic acid (EDTA, anhydrous, ~99%), and dicoumarol were 
purchased from Sigma (St. Louis, MO). Dimethyl sulfoxide (DMSO) and Tween 20 
were from Fisher Scientific (Fair Lawn, NJ). Tris-base and crystal violet were 
purchased from Mallinckrodt Baker, Inc. (Phillipsburg, NJ). All the other materials 
used were also obtained from Sigma (St. Louis, MO). 
 
5.2.2. Sample Preparation 
Fresh Cranberry (Early Black variety), Apple (Red Declious variety), and 
Grape (Cabernet Franc variety) were purchased from local supermarkets. Samples 
were cleaned and dried before extraction. All data collected for each fruit were 
reported as means ± SD for at least three replications.  
 
5.2.3. Sample Extraction 
Phytochemicals were extracted from fresh cranberry, apple, or grape by the 
method reported previously in our laboratory (Yang et al., 2004). Briefly, 100 g of 
fruits were blended for 3 min in 200 g 80% acetone using Waring blender. The 
mixture was then homogenized in a Virtis High Speed Homogenizer for 3 min and 
filtered with vacuum.  Water in the filtrate was evaporated using a rotary evaporator at 
45°C until the weight of the evaporated filtrate was less than 10% of the weight of the 
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original filtrate.  All extracts were stored at –40°C until use.  All extractions were 
performed in triplicate. 
 
5.2.4. Determination of Quinone Reductase Activity in Hepa1c1c7 Cell Culture 
This bioassay was modified from a previously described method (Prochaska 
and Santamaria, 1988; Zhang et al., 1992). Hepa1c1c7 murine hepatoma cells (The 
American Type Culture Collection, ATCC, Rockville, MD) were grown in α-MEM 
without nucleosides or deoxyribonucleosides, supplemented with 10% FBS, at 37°C in 
an atmosphere of 5% CO2 in a humidified incubator. Cultured Hepa1c1c7 cells were 
plated at a density of 2 ×10
4 cells/mL in 96-well plates (Costar 3595, Corning Inc. 
Corning, NY), and decanted after a 24 h incubation. Fresh medium and test samples 
dissolved in 10% DMSO were introduced and serially diluted to a concentration range 
of 5 - 200 μM for compounds, and 0.5 - 10 mg/mL for grape extracts. The final 
DMSO concentration in the medium was less than 0.5%. The cells were incubated for 
an additional 48 h. Growth medium and 1 μM BNF were used as negative and positive 
controls, respectively. The medium was removed and the cells were lysed with 50 μL 
0.8% (w/v) digitonin in 2 mM EDTA at pH 7.6, and incubated for 10 min at 37°C. The 
plates were then agitated on a shaker (120 rpm) for 10 min at room temperature. A 
200-μL aliquot of reaction mixture (7.5 mL of 0.5 M pH 7.4Tris-HCl buffer; 100 mg 
of albumin from human serum; 1 mL of 1.5% Tween-20 solution; 0.1 mL of 7.5 mM 
FAD; 1 mL of 150 mM glucose-6-phosphate; 90 μL of 50 mM NADP; 300 units of 
yeast glucose-6-phosphate dehydrogenase; 45 mg of MTT; 150 μL of 50 mM 
menadione in acetonitrile; and 140.16 mL distilled water added to total 150 mL 
volume) was added to lysed cells. Menadione solution was added just before the 
mixture was dispensed into the microtiter plates. QR activity was measured as the 
reduction of menadione to menadiol, this being coupled to the non-enzymatic 
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reduction of MTT to a blue formazan. The reaction generated a blue color, which was 
arrested after 5 min by the addition of 50 μL of a solution containing a 0.3 mM 
dicoumarol in 0.5% DMSO and 5 mM pH 7.4 potassium phosphate. Readings were 
made in triplet for each sample at 590 nm. Total protein concentrations were 
determined in a duplicate set of plates using crystal violet staining, and subsequently 
scanned at 490 nm (Prochaska et al., 1992).  
 
The specific activity of QR is defined as nmol MTT blue formazan reduced per 
min and per mg protein. Induction was expressed as the ratio of the specific activity of 
QR in the presence and absence of the test sample. The concentration required to 
double specific activity (CD) is determined via a curve of the ratio of QR specific 
activities of sample-treated cells to solvent-treated control cells as a function of 
inducer concentration (Kang and Pezzuto, 2004). 
 
Absorbance change of MTT/min   3247 nmol/mg of protein
Specific Activity = 
Absorbance of crystal violet
×
 
Specific Activity of Treated Group
Fold of Induction (ratio) = 
Specific Activity of DMSO Control Group  
 
5.2.5. Median-Effect Principle for Dose-Effect Analysis 
The dose-effect analysis was modified from Chou and Talalay (Chou and 
Talalay, 1977; Chou, 1991). The median-effect principle was used to calculate single 
and combined fruit extract effects. Dose-effect curves for each phytochemical and 
fruit extract and their combinations with series diluted concentrations were plotted by 
using the median-effect equation as follows: 
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Where D is the dose, Dm is the dose required for 50% effect, which is equivalent to 
median effect dose (EC50), fa is the fraction affected by dose D, and m is a coefficient 
of the sigmoidicity of the dose-effect curve.  
 
5.2.6. Combination Index for Determining Addition, Synergism and Antagonism 
The combination index (CI) (Chou, 1991; Chou et al., 1994) has been used for 
data analysis of two-way combinations as following: 
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For three-way combinations, a third term, (D)3/(Dx)3, is added. CI < 1, CI = 1, and CI 
> 1 indicate synergism, additive effect, and antagonism, respectively. (D1) and (D2) 
are the doses of phytochemical/fruit extracts in the combination system; (Dx)1 and 
(Dx)2 are the doses of compound 1 and compound 2 (fruit 1 and fruit 2) alone, 
respectively. 
 
5.2.7. Experiment Design 
The experiment of different phytochemical/fruit combinations for QR 
induction was designed in Table 4.1. Firstly, the CD value of each phytochemical/fruit 
extract was determined. Based on each CD value, a series of concentrations were 
designed as 0.125×CD, 0.25×CD, 0.5×CD, 0.75×CD, 1.0×CD, 1.25×CD, and 1.5×CD. 
Finally, different dose from phytochemical/fruit extract alone would be combined 
together to induce QR activity. The generated CD value was used as EC50 to design 
series of combined concentrations.  
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5.2.8. Statistical Analysis 
Statistical analysis was conducted using Minitab Student Release 12 (Minitab 
Inc., State College, PA) and SigmaStat Version 8.0 (Jandel Corp., San Raphael, CA). 
Results were subjected to ANOVA, and differences between means were located 
using Turkey’s multiple comparison test. Significance was determined at p < 0.05.  
 
 
 
5.3. Results 
5.3.1. QR Induction Capacity for Single Phytochemical and Fruit Extract 
Three phytochemicals commonly present in fruits and vegetables and three 
fruit extracts were in vitro examined for their potential to induce QR, a representative 
phase II chemoprotective enzyme. BNF with an induction of 7.5 ± 0.5-fold over 
solvent control at a concentration of 1 μM and with a CD value of 0.027 ± 0.003 μM 
was used as a positive control. Three phytochemicals and three fresh fruit extracts 
induced QR in Hepa1c1c7 cells are investigated in Figure 5.1, and Figure 5.2, 
respectively. Quercetin at a concentration of 30 μM resulted in a maximum of 3.5 ± 
0.2-fold induction over control of QR activity in Hepa1c1c7 cells. At a concentration 
of 50 μM, genistein caused a maximum of 2.8 ± 0.2-fold induction over control. 
Resveratrol led to a maximum of 2.2 ± 0.1-fold induction over control at a 
concentration of 50 μM. The CD values for quercetin, genistein, and resveratrol were 
2.5 ± 0.5, 15.0 ± 3.0, and 28.7 ± 2.3 μM, respectively. The calculated CD values of 
apple, cranberry, and grape were 1.84 ± 0.2, 1.95 ± 0.2, and 1.72 ± 0.1 mg/mL, 
respectively. Compared to the solvent-treated control cells, at 2 mg/mL concentration, 
the induction of apple, cranberry, and grape were 2.3 ± 0.2, 2.0 ± 0.4, and 2.44 ± 0.3, 
respectively.  
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5.3.2. Single Phytochemical and Fruit Extract Parameters 
The dose-effect relationships of three phytochemicals and three fruit extracts 
were subject to the median-effect plot to determine their potency (EC50), shape (m), 
and conformity (r) in induction of Hepa1c1c7 cells in vitro. The pooled results are 
summarized in Table 5.1. The EC50 and m values for single phytochemical/fruit 
extract and for their combination mixtures were used for calculating synergism, 
additive, or antagonism based on the CI equation.  
 
5.3.3. Two- and Three-Way Combinations Among Phytochemicals 
Among three compounds, three pairs of two-way combinations and one pair of 
three-way combination were investigated. The average median effect dose (EC50) and 
CI values at 50% induction rate are presented in Table 5.2. The dose-effect curves of 
different combination are plotted in Figure 5.3. The dose-effect curve of QR induction 
activity is shifted to the left after the combination. Compared with the single 
compound, the EC50 concentration in induction of QR dramatically decreases among 
four pairs of combinations. For example, the EC50 of quercetin and genistein on 
combination is 2.07- and 2.86-fold, respectively, lower than the EC50 of each 
compound alone. The EC50 of quercetin, genistein, and resveratrol after combination is 
3.05-, 4.20-, and 4.77-fold, respectively, lower than the EC50 of each compound alone, 
suggesting synergistic effect for the combination of the three compounds. It has been 
demonstrated that all combinations among three phytochemicals showed moderate 
synergistic effect on induction of QR at 50% induction rate, being indicated by a CI 
value less than 1.  
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Table 5.1. Dose-effect relationship parameters of phytochemicals and fruit extracts in induction of Hepa1c1c7 cells in 
vitro*. 
 Hepa1c1c7      Hepa1c1c7 
Compound  EC50 (μM)  m r  n  Extract  EC50 
(mg/mL) 
m R  n
Quercetin  2.468±0.368 0.381±0.055 0.957±0.023  3  Apple  2.369±0.208 0.510±0.041 0.777±0.081  3
Genistein  20.473±3.109 0.572±0.054 0.886±0.030  3  Cranberry 2.475±0.413 0.541±0.023 0.915±0.019  3
Resveratrol  44.886±2.851 0.541±0.031 0.835±0.029  3  Grape  2.285±0.400 0.616±0.050 0.884±0.058  3
*The parameters EC50, m, and r are antilog of x-intercept, slope, and the linear correlation coefficient of median-effect plot, 
which signifies the potency (EC50), the shape of the dose-effect curve, and conformity of the data to the mass-action law, 
respectively; n is the number of sets of dose-effect relationship experiments tested (Chou et al., 1994).  
 
Table 5.2. Summary of medium effect dose based on induction of quinone reductase by phytochemical combination in 
Hepa1c1c7 cells in vitro. 
EC50 (µmol) 
 
              EC50
 
Phytochemical  Single Combination 
CI at 50% 
Induction Rate 
Combination
Effect 
Quercetin 
Genistein 
2.47 ± 0.37 
20.47 ± 3.11 
1.19 ± 0.01 
7.15 ± 0.55 
0.850 ± 0.07  Synergism 
Quercetin  
Resveratrol 
2.47 ± 0.37 
44.89 ± 2.85 
1.21 ± 0.05 
14.50 ± 0.60 
0.879 ± 0.04  Synergism 
Genistein 
Resveratrol 
20.47 ± 3.11 
44.89 ± 2.85 
6.39 ± 0.90 
12.78 ± 1.80 
0.651 ± 0.10  Synergism 
Quercetin      2.47 ± 0.37  0.81 ± 0.07 
Genistein  Synergism  0.812 ± 0.10  20.47 ± 3.11  4.89 ± 0.44 
Resveratrol  44.89 ± 2.85  9.40 ± 0.28 
1
6
7
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Figure 5.1. Effect of β-naphthoflavone (positive control) and selected phytochemicals 
(mean ± SD) in induction of quinone reductase in Hepa1c1c7 cells. 
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Figure 5.2. Effect of β-naphthoflavone (positive control) and fruit extracts (mean ± 
SD) in induction of quinone reductase in Hepa1c1c7 cells. 
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Figure 5.3. The dose-effect curves for phytochemical combinations: (a) quercetin + 
genistein; (b) quercetin + resveratrol; (c) genistein + resveratrol; (d) quercetin + 
genistein + resveratrol. 
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Figure 5.3 (Continued) 
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5.3.4. Two-, Three-, and Four-Way Combinations of Phytochemicals and Grape 
Extract 
The results of combinations between Cabernet Franc grape variety and three 
phytochemicals are presented in Table 5.3 and Figure 5.4. The combination of 
Cabernet Franc and resveratrol showed superior synergistic effects with the lowest CI 
value (0.310 ± 0.04) among all combinations. Also, Cabernet Franc and quercetin 
combination yielded a synergy at 50% induction rate for QR. However, the 
combination of grape and genistein yielded antagonistic effect with CI value of 1.97 ± 
0.23. The EC50 of Cabernet Franc and genistein after combination is 0.954- and 1.15-
fold, respectively, similar to the EC50 of Cabernet Franc and quercetin alone, 
indicating an antagonistic effect. The three- and four-way combinations had a slight 
synergistic effect with CI values of 0.948 ± 0.03, and 0.933 ± 0.11, respectively. The 
EC50 of Cabernet Franc and quercetin after combination is 3.67- and 3.23-fold, 
respectively, lower than the EC50 of Cabernet Franc and quercetin alone. The EC50 of 
Cabernet Franc, quercetin, genistein, and resveratrol after combination is 4.30-, 3.77-, 
5.22-, and 5.70-fold, respectively, lower than the EC50 of each one alone, suggesting 
synergistic effect after the combination. 
 
5.3.5. Two- and Three-Way Combinations Among Fruit Extracts 
The combinations among three fruit extracts are summarized in Table 5.4 and 
Figure 5.5. With different extent, all combinations of three fruit extracts showed 
synergistic effect at 50% induction rate on QR activity. The EC50 of apple and 
cranberry after combination is 1.48- and 3.44-fold, respectively, lower than the EC50 
of each fruit alone. The EC50 of apple, cranberry, and grape after combination is 2.92-, 
6.70-, and 3.51-fold, respectively, lower than the EC50 of each fruit alone, suggesting 
synergistic effect after the combination of the three fruit extracts. Based on CI value, 
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cranberry and grape combination yielded a synergistic effect. A moderate synergy was 
observed between apple and grape, among apple, cranberry, and grape. Apple and 
cranberry combination showed a slight synergistic effect.  
 
5.4. Discussion  
Compelling evidence has indicated that frequent consumption of fruits and 
vegetables in the daily diet provide health benefits. Previous work from our lab has 
demonstrated that phytochemicals from single fruit have potent antioxidant and 
antiproliferative activities, and that antioxidant activity is positively correlated with 
total phenolic and flavonoid contents (Yang et al., 2004). Research performed by our 
group and others has shown that
 phytochemical extracts from fruits and vegetable 
exhibit strong antioxidant
 and antiproliferative activities and that the major part of
 total 
antioxidant activity is from the combination of phytochemicals (Liu, 2004). Induction 
of detoxification enzymes via phytochemicals is another mechanism proposed for 
anticancer activity in fruits and vegetables. Data in our study clearly showed that three 
compounds and three fruit extracts could induce QR activity. Our results further 
demonstrated that all combinations among three phytochemicals showed synergistic 
effect on induction of QR at 50% induction rate, being indicated by CI of less than 1. 
Among combinations of three phytochemicals and Cabernet Franc grape, except the 2-
way combination of Cabernet Franc and genistein, all other combinations 
demonstrated synergism. It was proven that all combinations of apple, cranberry, and 
grape fruit extracts had synergistic effect at 50% induction rate on QR activity. The 
additive and synergistic effects of phytochemicals in fruits and vegetables are 
responsible for their potent QR induction activity.  
 
    
 
 
 
Table 5.3. Summary of medium effect dose based on induction of quinone reductase by grape extract and phytochemical 
combination in Hepa1c1c7 cells in vitro. 
 
EC50 (mg/mL) 
 
                        EC50
 
Phytochemical  Single Combination 
CI at 50% 
Induction Rate 
Combination
Effect 
Cabernet Franc 
Quercetin 
2.28 ± 0.40 
4.26 ± 0.70 
0.62 ± 0.07 
1.32 ± 0.16 
0.630 ± 0.08  Synergism   
 
Cabernet Franc 
Genistein 
2.28 ± 0.40 
27.67 ± 4.20 
2.39 ± 0.26 
24.15 ± 2.7 
1.97 ± 0.23  Antagonism  2-way 
 
Cabernet Franc  Synergism  2.28 ± 0.40  0.35 ± 0.05  0.310 ± 0.04 
Resveratrol  51.22 ± 3.30  5.98 ± 0.81 
  Cabernet Franc      2.28 ± 0.40  0.67 ± 0.02 
3-way  Quercetin  Synergism  0.948 ± 0.03  4.26 ± 0.70  1.45 ± 0.05 
Resveratrol  51.22 ± 3.30  11.53 ± 0.36 
  Cabernet Franc      2.28 ± 0.40  0.53 ± 0.06 
  Quercetin  Synergism  0.933 ± 0.11  4.26 ± 0.70  1.13 ± 0.13 
4-way  Genistein  27.67 ± 4.20  5.30 ± 0.6 
  Resveratrol  51.22 ± 3.30  8.98 ± 1.0 
 
 
 
 
 
 
 
1
7
4
    
 
 
 
 
 
 
Table 5.4. Summary of medium effect dose based on induction of quinone reductase by apple, cranberry, and grape combinations 
in Hepa1c1c7 cells in vitro. 
 
EC50 (mg/mL) 
 
                            EC50
 
Phytochemical  Single Combination 
CI at 50% 
Induction Rate 
Combination
Effect 
Apple 
Cranberry 
2.37 ± 0.21 
2.48 ± 0.41 
1.60 ± 0.43 
0.72 ± 0.19 
0.930 ± 0.25  Synergism   
 
Apple 
Grape 
2.37 ± 0.21 
2.28 ± 0.40 
0.74 ± 0.08 
0.93 ± 0.10 
0.775 ± 0.09  Synergism  2-way 
 
Cranberry  Synergism  2.48 ± 0.41  0.46 ± 0.04  0.535 ± 0.06 
Grape  2.28 ± 0.40  0.88 ± 0.14 
  Apple      2.37 ± 0.21  0.81 ± 0.05 
3-way  Cranberry  Synergism  0.786 ± 0.05  2.48 ± 0.41  0.37 ± 0.02 
  Grape  2.28 ± 0.40  0.65 ± 0.04 
 
 
 
 
1
7
5
   176
0 2.0 4.0 6.0
0
0.20
0.40
0.60
0.80
1.00
Dose
E
f
f
e
c
t
Quer/C.Franc Quercetin  C. Franc
a 
 
 
0 10 20 30 40
0
0.20
0.40
0.60
0.80
1.00
Dose
E
f
f
e
c
t
Genistein/C.Franc Genistein  C. Franc
b 
 
 
Figure 5.4. The dose-effect curves for phytochemical and grape combinations: (a) 
quercetin + grape; (b) genistein + grape; (c) resveratrol + grape; (d) quercetin + 
resveratrol + grape; (e) quercetin + genistein + resveratrol + grape. 
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Figure 5.4 (Continued) 
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Figure 5.4 (Continued) 
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Figure 5.5. The dose-effect curves for fruit combinations: (a) apple + cranberry; (b) 
apple + grape; (c) cranberry + grape; (d) apple + cranberry + grape. 
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Figure 5.5 (Continued) 
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  Accumulation of ROS and electrophiles under adverse conditionsare known to 
cause cellular membrane, proteins, lipids, and DNA damage (Ames et al., 1993), 
mutagenicity, degeneration
 of tissues, apoptotic cell death, premature aging, cellular
 
transformation, and being further implicated in chronic diseases such as cancer and 
CHD (Ward, 1994; Breen and Murphy, 1995). Exogenous antioxidants from diet have 
been used for the preventive intervention of ROS disorders (Willett, 1994; Temple, 
2000). Another strategy for protecting against ROS injury may be via chemically 
mediated upregulation of endogenous antioxidants and phase II enzymes in cells. The 
latter depends on a understanding of the chemical inducibility of antioxidants and 
phase II enzymes, as well as the underlying signaling transduction mechanisms. The 
initial response of cell to ROS and electrophiles are the activation of endogenous 
defense mechanisms that lead to coordinated
 activation of a battery of defensive genes 
that protect cells
 against oxidative/electrophilic stress (Jaiswal, 2000), which leads to 
neutralizing the adverse effects and cell survival. Nrf2 has been demonstrated to be a 
critical transcription factor that binds to the antioxidant response element (ARE) in the 
promoter region of a number of genes, encoding for antioxidative and phase II 
enzymes in animals and human cells and tissues (Kwak et al., 2004; Lee and Johnson, 
2004; Kobayashi and Yamamoto, 2005; Zhu et al., 2005). Therefore, it is of great 
interest in studying both exogenous antioxidants from fruits and vegetables and 
endogenous antioxidants and phase II enzymes induced by phytochemicals.  
 
  Studies from our lab and others have proposed thatthe additive and synergistic 
effects of phytochemicals in fruits
 and vegetables are responsible for their potent 
antioxidant
    and anticancer activities, and that the benefit of a diet richin fruit and 
vegetables is attributed to the complex mixture
 of phytochemicals present in whole 
foods(Liu, 2003; Liu, 2004). For instance, the vitamin C in apples with skin accounts 
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    foronly 0.4% of the total antioxidant activity, suggesting thatmost of the antioxidant 
activity of fruit and vegetables may
 come from phenolics and flavonoids in apples 
(Eberhardt et al., 2000). Over 5,000 phytochemicals have been
 identified, but a large 
portion still remain unknown (Shahidi and Naczk, 1995)
 and need to be identified 
before their health benefits are fully
 understood. The combinations of phytochemicals 
in the whole vegetable may provide additional protection through the synergistic 
induction of chemoprotective enzymes, suggesting that the health benefits of whole 
vegetables may be greater than those of the isolated compounds (Jeffery and Stewart, 
2004). The synergistic upregulation of phase II enzymes by glucosinolate breakdown 
products in cruciferous vegetables has been reported in animal models. Four 
glucosinolate derivatives were examined individually and as a mixture for their effects 
on QR, hepatic P4501A (CYP1A), GST, and glutathione reductase (G-Rd) levels 
(Staack et al., 1998). Indole-3-carbinol (I3C, 56 mg/kg) and crambene (50 mg/kg) had 
a 1.9- and 2.5-fold increase in QR, respectively, in adult male F344 rats. It was 
observed that I3C and crambene combination produced a synergistic effect on 
induction of QR and GST. Furthermore, this lab tested whether the synergism is at the 
level of transcription. It was found that, after evaluating three subunits, GST Ya2 
mRNA had a synergistic upregulation by crambene and I3C, while Yc1 and Yc2 
showed only an additive response in adult male rats (Nho and Jeffery, 2001). Lastly, it 
was found that a nitrile product of glucosinolate hydrolysis induced QR mRNA levels 
and triggered the ARE, suggesting synergistic upregulation of QR is due to co-
activation of the ARE and the xenobiotic response element (XRE) by I3C acid 
condensates and crambene (Nho and Jeffery, 2004). It was proposed that crambene 
and sulforaphane, considered as a monofunctional inducer to increase phase II enzyme 
activity, transcriptionally upregulate phase II enzymes through triggering the ARE-
mediated mechanism. The two compounds disrupt the interaction between 
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transcription factor Nrf2 and the sequestering protein Keap1; leading to Nrf2 to 
translocate to the nucleus and interact with the ARE, resulting in elevated transcription 
of target genes (Itoh et al., 2003).  
 
Based on the principle of the mass-action law via mathematical induction and 
deduction in enzyme kinetic models, the median-effect equation and the CI method 
have been extensively applied in drug combinations (Chou and Talalay, 1977; Chou, 
1991; Chou et al., 1994). Our study was carried out by quantitative analysis of 
synergism or antagonism at different phytochemical/fruit doses and different effect 
levels. From our previous study, quercetin, genistein, and resveratrol exhibited strong 
induction activity of QR among eighteen tested phytochemicals. Among all thirteen 
grape varieties analyzed, Cabernet Franc contained the highest induction activity of 
QR. The present study proved that Red Delicious apple and Early Black cranberry had 
QR induction capacity. Apple and cranberry had similar CD values (1.84 ± 0.2, 1.95 ± 
0.2 mg/mL, respectively), and grape showed a lower CD value (1.72 ± 0.1 mg/mL) 
than apple and cranberry, suggesting more potential QR induction capacity. One 
question which remains is how to determine a series of combined doses in the 
experiment. Theoretically, the combined concentration of each phytochemical/fruit 
was based on the generated CD value through dose-response curve. After obtaining 
the CD value, a series of doses were designed from 0.125 × CD to 1.5 × CD; then 
these doses were used to treat cells to produce responses. From the new dose-response 
curve the CD value (EC50) was then determined again. However, there were some 
differences in CD values. For example, the former CD values of apple, cranberry, and 
grape were 1.84 ± 0.2, 1.95 ± 0.2, 1.72 ± 0.1 mg/mL, respectively; the latter CD 
values of apple, cranberry, and grape were 2.37 ± 0.21, 2.48 ± 0.41, and 2.28 ± 0.40 
mg/mL, respectively. These differences in potency between treatments in vitro could 
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be due to differences in bioavailability and/or cell variation. Compared with EC50 
values in induction of QR before and after combinations, it was found that there was a 
4.77-fold difference in EC50 value in the quercetin, genistein, and resveratrol 
combination. A 5.70-fold difference in EC50 of resveratrol was found between 
combination and single compound in Cabernet Franc, quercetin, genistein, and 
resveratrol combination. The EC50 of cranberry lowers 6.70-fold, compared with 
single fruit, in apple, cranberry, and grape combination. However, an antagonistic 
effect was observed in Cabernet Franc and genistein combination since the change of 
EC50 values is small before and after combination.  
 
Our study demonstrated that there was a synergistic effect in phytochemicals 
and fruits in the induction of QR. However, the current studies strengthen the 
quantitative results of phytochemical/fruit combinations rather than the mechanism of 
synergistic and antagonistic interactions. Future research should be focused on 
understanding the mechanism of actions related to these interactions.                  
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                                              CHAPTER SIX 
 
COMBINATION EFFECT OF APPLE EXTRACTS AND QUERCETIN 3-β-D-
GLUCOSIDE ON ANTIPROLIFERATIVE ACTIVITY IN MCF-7 HUMAN 
BREAST CANCER CELLS IN VITRO 
 
6.1. Introduction 
Breast cancer is the most frequently diagnosed cancer in women. 
Approximately 1 million women are estimated to be newly diagnosed with breast 
cancer each year worldwide. The updated data in 2007 report that an expected 178,480 
new cases of invasive breast cancer are expected to occur among women in the US. In 
addition to invasive breast cancer, 62,030 new cases in situ breast cancer is expected 
to occur among women in 2007. The estimated women deaths are 40,460 (American 
Cancer Society, 2007). Although a great deal of work has been done in prevention and 
treatment in breast cancer, the results are not satisfied. For example, one drug, 
Tamoxifen, has been shown to be effective in only one-third of the breast cancer 
patient (Forbes, 1997). Therefore, exploring for new approach for the prevention and 
treatment of breast cancer is of great interest. 
 
One alternative strategy to reduce the risk of cancer is through dietary 
modification. It has been estimated that a healthy diet could prevent approximately 
30% of all cancers (Doll and Peto, 1981; Willett, 1995). Numerous epidemiological 
and animal studies revealed what appeared to be a strong link between intake of fruits 
and vegetables and protection against cancer (Block et al., 1992). The Nurses’ Health 
Study reported a significantly reduced risk of premenopausal women with breast 
cancer in their families who consumed high quantities of β- carotene-rich fruit and 
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vegetables (Zhang et al., 1999). The case-control study from Sweden showed a 
significantly lowered breast cancer risk ratio at the highest consumption of brassica 
vegetables (Terry et al., 2001). In another case-control study of women in Shanghai, 
pre-menopausal women who ate more dark yellow-orange vegetables and more citrus 
fruits tended to be associated with lowered risk of breast cancer (Malin et al., 2003). 
Five of the eight cohort studies showed an inverse relationship between intake of fruits 
and vegetables and survival of breast cancer patient, with a 20–90% reduction in death 
risk (Rock and Demark-Wahnefried, 2002).  
 
Apples are widely and commonly consumed and are the main contributors of 
phytochemicals including phenolics and flavonoids in human diet both in the US and 
in Europe (Boyer and Liu, 2004). In the United States, apples are attributed to 22% of 
the total phenolics consumed from fruits, making them the largest source of phenolics 
(Vinson et al., 2001). In Finland, apples and onions are major sources of dietary 
flavonoids, while in the Netherlands apples rank third behind tea and onions as top 
sources of flavonoids (Hertog et al., 1993; Knekt et al., 1997). Apples are rich in 
hydroxycinnamic acids, dihydrochalcones, flavan-3-ols/procyanidins, anthocyanins, 
and flavonols (Oleszek et al., 1988; Pefes-Ilzarbe et al., 1991). The sugar moieties 
involved in glycosylation are galactose, glucose, rhamnose, xylose, arabinose, and 
rutinose (McRae et al., 1990). Quercetin 3-glycosides, chlorogenic acid, catechin, 
epicatechin and their dimers, phloridzin, and cyanidin 3-glycosides are the main 
individual phenolics in apple (Oleszek et al., 1988; McRae et al., 1990; Awad et al., 
2000). However, the amount of quercetin 3-glucodise was reported to be low in apple 
(Tsao et al., 2003; Kahle et al., 2005).  
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The frequent consumption of fruits, including apple, is associated with lowered 
risk of chronic diseases. It appears that apples were linked to lowered risk of cancer 
(Le Marchand et al., 2000), coronary heart disease (Arts et al., 2000), asthma and 
pulmonary function (Tabak et al., 2001), and type II diabetes (Knekt et al., 2002) 
when compared to other fruits and vegetables and other sources of flavonoids. 
Recently, a study focuses on the investigation of apple intake and the risk of different 
cancers in Italy (Gallus et al., 2005). It was found that there is a consistent inverse 
relationship between apples and risk of various cancers such as breast and prostate 
cancers. Animal and in vitro studies have also exhibited that phytochemicals present in 
apples have strong antioxidant activity antioxidant activity (Eberhardt et al., 2000), 
antiproliferative activity (Wolfe et al., 2003), inhibition of lipid oxidation both in 
humans and rats (Mayer et al., 2001), and Cholesterol-lowering effects (Aprikian et al., 
2001). Our group reported that, corresponding to doses in human consumption of one, 
three, and six apples a day, the whole apple extracts prevent mammary cancer in a 
dose-dependent manner in rat model (Liu et al., 2005). 
 
Synergism by two or more compounds is defined as therapeutic effects that are 
greater than those expected from addition of the effects of the individual compounds. 
It is believed that chemotherapeutic combination approaches have been used to reduce 
drug toxicity, and delay the development of cancer cells, and to reach a greater effect 
than with one active drug alone. Fruits and vegetables are rich in phenolics and other 
bioactive compounds, which have been suggested to be responsible for their health 
benefits. The antioxidant synergism was observed in different experiments such as 
vitamin E and C (Scarpa et al., 1984), vitamin E and β-carotene (Palozza and Krinsky, 
1992), catechin and malvidin 3-glucoside (Rossetto et al., 2002), flavonoids and urate 
(Filipe et al., 2001), and tea polyphenols and vitamin E (Zhou et al., 2000). In addition 
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to antioxidant activities, phenolics have demonstrated other specific biological 
activities interfering with cellular mechanisms. For example, (Conte et al., 2003) 
reported synergistic protection of PC12 cells from β-amyloid toxicity by reservatrol 
and catechin.  
 
The phenolics in fruits and vegetables may act independently or in 
combination as anti-cancer agents. It has been postulated that combinations of fruits 
have greater antioxidant activities than would be expected on the basis of their 
individual effects. We have proposed that the additive and synergistic effects of 
phytochemicals in fruits and vegetables are responsible for their potent antioxidant and 
anticancer activities and that the benefit of a diet rich in fruits and vegetables is 
attributed to the complex mixture of phytochemicals present in whole foods (Liu, 2003; 
Liu, 2004). This hypothesis partially explains why single antioxidant cannot replace 
the combination of natural phytochemicals in fruits and vegetables in achieving health 
benefits. Only limited knowledge is available about any interaction between/among 
phenolics in suppressing MCF-7 cell proliferation. There is no direct evidence linked 
to synergistic, additional, and antagonistic effects on inhibition of cell proliferation in 
apples. In order to elucidate the hypothesis that the combination of phytochemicals is 
responsible for the health benefit in apples, two-way combination of apple extracts 
plus Q3G was designed. The objective for this study was to determine whether the 
apple extracts in combination with Q3G has additive and/or synergistic effect on 
MCF-7 human breast cancer cell proliferation.  
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6.2. Materials and Methods 
6.2.1. Chemicals and Reagents 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfenyl)-2H-
tetrazolium (MTS), Quercetin 3-β-D-glucoside (Q3G), and other chemicals were 
purchased from Sigma Chemical Co. (St. Louis, MO). Dimethyl sulfoxide (DMSO) 
was purchased from Fisher Scientific (Fair Lawn, NJ). All chemicals used in this study 
were of analytical grade.  
 
6.2.2. Apple Preparation 
Apples of Red Delicious variety were obtained from Cornell Orchard (Cornell 
University, Ithaca, NY). Fruits were cleaned and dried before extraction of 
phytochemicals. All data collected were reported as means ± SD for at least three 
replications.  
 
6.2.3. Apple Extraction 
Apple phenolics were extracted using a method reported previously in our 
laboratory (Sun et al., 2002; Yang et al., 2004). Briefly, 100 g of apples were blended 
for 3 min in 80% acetone (1:2 w/v) using a chilled Waring blender. The sample was 
then homogenized in a Virtis High Speed Homogenizer for 3 min and filtered with 
vacuum through a No. 2 Whatman filter paper. The filtrate was evaporated using a 
rotary evaporator at 45°C until approximately 90% of the filtrate had been evaporated. 
The sample was then recovered with water to a final volume of 50 mL, and stored at –
40°C until use. 
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6.2.4. Measurement of Cytotoxicity 
Cell cytotoxicity was assessed by methylene blue assay. Briefly, MCF-7 
human breast cancer cells (The American Type Culture Collection, ATCC, Rockville, 
MD) were plated at a density of 4 x 10
4 cells/well into 96-well plate for 24 hours. 
Then cells were treated with different concentrations of tested apple extracts / 
phytochemicals for 24 hours. The growth media was removed, and the wells were 
rinsed with PBS. 50 μL of Hanks Balanced Salt Solution (HBSS: 1.25% 
glutaraldehyde and 0.6% methylene blue) was added into each well to fix and stain the 
cells for one hour. The 96-well plate was rinsed several times by immersion in Milli-Q 
water after removing HBSS. At the end of treatment, 100 μL of elution solution (PBS 
plus 50% of ethanol and 1% of acetic acid) was added, and cells were incubated for a 
further half hour with gentle rotation at room temperature. Cytotoxicity was obtained 
by scanning at 570 nm using a MRX Microplate Reader (Dynex Technologies, 
Chantilly, VA). 
 
6.2.5. Measurement of Inhibition of MCF-7 Cell Proliferation 
The antiproliferative activity of apple extracts/phytochemicals was assessed by 
measurement of the inhibition of MCF-7 cell proliferation. Antiproliferative activities 
were determined by the colorimetric MTS assay (MTS-based cell titer 96 
nonradioactivity cell proliferation assay) (Promega, Madison, WI) reported previously 
(Yang et al., 2004). MCF-7 cells were maintained in Alpha Minimum Essentail 
Medium (MEM-a), containing 10 mM Hepes, 0.01 mg/mL insulin, 50 units/mL 
penicillin, 50µg/mL streptomycin, 100 µg/mL gentamicin, and 10% fetal bovine 
serum (Gibco, Life Technologies, Grand Island, NY). MCF-7 cells were maintained in 
a 5% CO2/37°C incubator. A total of 2.5 × 10
4 MCF-7 cells in growth media were 
placed in each well of a 96-well flat-bottom plate. Cell proliferation was measured by 
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the ability of viable cells to reduce MTS to formazan. After 4 h of incubation, the 
growth medium was removed and media containing various concentrations of apple 
extracts (10, 30, 50, 75, 100, and 125 mg/mL) or Q3G (10, 20, 30, 40, 50, 60, and 70 
μM) were added to the cells. Control cultures received the extraction solution minus 
the apple extracts, and blank wells contained 100 µL of growth medium without cells. 
Cell proliferation (percent) was determined at 96 h from the MTS absorbance (490 
nm) reading for each concentration compared to the control, using at least three 
replications for each sample. The effective median dose (EC50) was determined and 
expressed as milligrams of apple per milliliter ± SD or micromole of phytochemical ± 
SD.  
 
6.2.6. Experiment Design 
The two-way combination of apple extracts and Q3G for cell proliferation was 
designed. The EC50 value of apple extracts and phytochemical were determined firstly. 
The EC50 value of apple extracts was 70.69 ± 5.73 mg/mL. The EC50 value of Q3G 
was 46.43 ± 1.28 μM, respectively. Based on each EC50 value, a series of 
concentrations were designed. For apple extracts, the combined concentrations are 
0.125×EC50, 0.25×EC50, 0.5×EC50, 0.75×EC50, 1.0×EC50, and 1.25×EC50. For Q3G, 
the combined concentrations are 0.125×(EC50)/2, 0.25×(EC50)/2, 0.5×(EC50)/2, 
0.75×(EC50)/2, 1.0×(EC50)/2, and 1.25×(EC50)/2. The different apple and 
phytochemical concentrations were combined together to generate the dose-response 
curve in MCF-7 cell proliferation model.  
 
6.2.7. Median-Effect Principle for Dose-Effect Analysis 
The dose-effect analysis was modified from Chou and Talalay (Chou, 1976; 
Chou and Talalay, 1984; Chou, 1991). The median-effect principle was used to 
   192
calculate individual and combined apple extracts/phytochemicals effects. Dose-effect 
curves for apple extracts/phytochemcials and their combinations with series diluted 
concentrations were plotted by using the median-effect equation as follow: 
 
        ( 1 )   1/ 1 ( / )
m
am fD =+ ⎡ ⎣ D ⎤ ⎦
Where D is the dose, Dm is the dose required for 50% inhibition effect, which is 
equivalent to median effect dose (EC50), fa is the fraction affected by dose D, and m is 
a coefficient of the sigmoidicity of the dose-effect curve. 
 
The Medium-Effect Plot. The medium-effect plot is based on the logarithmic form of 
Chou’s median-effect equation (Chou, 1976; Chou, 1980):  
 
log( / ) log( ) log( ) au m f fmD mD = −   (2) 
Where fu is the fraction unaffected,  1 ua f f = − . 
 
6.2.8. Combination Index for Determining Addition, Synergism and Antagonism 
The combination index (CI) (Chou, 1991; Chou et al., 1994) has been used for 
data analysis of two-way combinations as follow: 
 
2
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x x D
D
D
D
CI + =                 (3) 
Where (D)1 and (D)2 are the doses of apple extracts and Q3G, respectively, in the 
combination system; (Dx)1 and (Dx)2 are the doses of apple and Q3G alone, 
respectively. CI < 1, CI = 1, and CI > 1 indicate synergism, additive effect, and 
antagonism, respectively.  
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6.2.9. Statistical Analysis 
Statistical analysis was performed using Minitab Student Release 12 (Minitab 
Inc., State College, PA) and SigmaStat Version 8.0 (Jandel Corp., San Raphael, CA). 
Results were subjected to ANOVA, and differences between means were located 
using Tukey’s multiple comparison test. Significance was determined at p<0.05. All 
data were reported as the mean ± SD of three replications. 
 
 
6.3. Results 
The antiproliferative activities of apple extracts, Q3G, and two-way 
combination of those two agents (apple extracts + Q3G) toward the growth of MCF-7 
human breast cancer cells in vitro are shown in Figures 6.1a. Apple extracts inhibited 
the MCF-7 cell proliferation at the doses of 30-125 mg/mL (p<0.05) in a dose-
dependent manner. No cytotoxicity was found in apple extracts at the concentration 
equal to or lower than 125 mg/mL (Figure 6.1b). The EC50 value of apple extracts 
inhibiting MCF-7 cell proliferation was 70.7 ± 5.7 mg/mL (Table 6.1).  Q3G 
exhibited significant antiproliferative activity against MCF-7 cells at the doses 20-60 
μM (p<0.05) in a dose-dependent manner (Figure 6.1a). The EC50 value of Q3G in 
inhibiting MCF-7 cell growth was 46.4 ± 1.3 μM.  No cytotoxicity was found at the 
doses tested above in MCF-7 cells (Figure 6.1b).   
 
Two-way combination of apple extracts and Q3G significantly increased 
antiproliferative activity toward the growth of MCF-7 human breast cancer cells in 
vitro when compared to the apple extracts and Q3G alone (Figure 6.1a).   The EC50 
values of apple extracts and Q3G in the two-way combination were reduced to 33.8 ± 
2.9 mg/mL and 10.8 ± 2.1 μM, respectively (Table 6.1), which were 2-fold and 4-fold 
   194
lower than that of apple extracts and Q3G alone. No cytotoxicity was observed in the 
two-way combination of apple extracts and Q3G at all concentrations tested in MCF-7 
cells (Figure 6.1b). 
 
In order to quantify the combination effects of apple extracts and Q3G, dose-
reduction index (DRI) and combination index (CI) were calculated based on the 
method reported previously (Chou et al., 1994).  The DRI values at the inhibition of 
50, 75, 90, and 95% of MCF-7 cell growth are presented in Table 6.2.  The DRI value 
of apple extracts and Q3G at the 50% of inhibition of MCF-7 cell growth were 2.03 ± 
0.55 and 4.28 ± 0.39 - fold when compared to the values of apple extracts and Q3G 
alone.  The DRI value of apple extracts and Q3G at the 95% of inhibition of MCF-7 
cell growth were 4.32 ± 1.48 and 6.55 ± 0.66 - fold when compared to the values of 
apple extracts and Q3G alone.  The CI values at the inhibition of 50, 75, 90, and 95% 
of MCF-7 cell growth were calculated based on the median effect plot (Figure 2; 
(Chou, 1991; Chou et al., 1994), and presented in Table 6.2.  CI<1, CI=1, and CI> 1 
indicate synergism, additive effect, and antagonism, respectively, as reported 
previously (Chou et al., 1994). The CI values of the two-way combination of apple 
extracts and Q3G at 50, 75, 90, and 95% inhibition of MCF-7 cell growth were 0.76 ± 
0.16, 0.60 ± 0.12, 0.47 ± 0.10, and 0.42 ± 0.10, respectively, indicating strong 
synergistic effect at all concentrations tested.  
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Table 6.1. EC50 values of apple extracts, Q3G, and apple extracts in combination with Q3G in inhibiting MCF-7 cell growth. 
 
EC50 value  Component 
Single Combined 
Apple Extracts   70.69 ± 5.73 mg/mL  33.75 ± 2.85 mg/mL 
Q3G  46.43 ± 1.28 μM 10.80  ± 2.10 μM 
 
 
 
 
Table 6.2. Computer-stimulated CI and DRI values for apple extracts and Q3G combination at 50%, 75%, 90%, and 95% inhibition 
of MCF-7 cell growth. 
 
DRI* values at inhibition of  CI values at inhibition of  Component 
50% 75% 90%  95%  50%  75% 90% 95% 
Apple Extracts   2.03 ± 0.55  2.69 ± 0.79  3.56 ± 1.15  4.32 ± 1.48 
Q3G  4.28 ± 0.39  5.00 ± 0.22  5.87 ± 0.06  6.55 ± 0.66 
 
0.76 ± 0.16 
 
0.60 ± 0.12 
 
0.47 ± 0.10 
 
0.42 ± 0.10 
 
*DRI (dose-reduction index) represents the order of magnitude (fold) of dose reduction that is allowed in combination for  
a given degree of effect as compared with the dose of each component alone. All DRI values are calculated on the basis  
if the classic isobologram equation and assumptions (Chou et al., 1994).  
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Figure 6.1. Cell proliferation (a) and cytotoxicity (b) of apple extracts, Q3G, and apple 
extracts plus Q3G combination toward MCF-7 cells. “ * ” indicates a significant 
difference from the control (p < 0.05). 
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Figure 6.2. Medium-effect plot for apple extracts and Q3G combination. 
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6.4. Discussion 
Epidemiological studies have consistently shown that the consumption of fruits 
and vegetables is associated with a lowered risk for developing chronic diseases, such 
as coronary heart disease (CHD), cancer, diabetes, and Alzheimers’s disease (Block et 
al., 1992; Ames et al., 1993; Joshipura et al., 2001; Willett, 2002). Breast cancer is the 
most commonly diagnosed invasive cancer in women in the US and is one of the 
leading causes of death due to cancer. Compelling evidence indicates that multiple 
servings of fruits and vegetables in the daily diet provide health benefits. 
Phytochemicals present in fruits and vegetables, including phenolics and flavonoids, 
are suggested to be responsible for those health benefits. Studies conducted by our 
group and others have shown that
 phytochemical extracts in fruits and vegetables 
exhibit strong antioxidant
 and antiproliferative activities and that the major part of
 total 
antioxidant activity is from the combination of phytochemicals (Eberhardt et al., 2000; 
Chu et al., 2002; Sun et al., 2002; Yang et al., 2004). Although there are many 
therapeutic strategies including chemotherapy to treat clinical breast cancer, the result 
is not satisfied. There is an urgent need to develop alternative strategy to prevent and 
treat breast cancer. Dietary modification is a practical approach, applying a 
combination of non-toxic effective phytochemicals from fruit extracts, which could 
enhance the efficacy of chemotherapy and lower toxicity to normal cells. Our data 
here clearly showed that apple extracts in combination with Q3G had a potent 
synergistic effect on MCF-7 cell proliferation in vitro.  
 
Substantial epidemiological evidence concerning the potential role of 
antioxidant nutrients in the prevention of cancers has accumulated over the past few 
decades. However, in some clinical trials, it is observed that antioxidant nutrients 
taken alone do not explain the observed health benefits of diets rich in fruits and 
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vegetables (Liu, 2004). In a randomized, double-blind, and placebo-controlled trial
 of 
β-carotene in 22,071
 male physicians, 12 years of supplementation
 with β-carotene (50 
mg on alternate days) produced neither benefit nor harm in terms
 of the incidence of 
malignant neoplasms, CVD,
 or death from all causes (Hennekens et al., 1996). A 
multicenter, randomized, double-blind,
 placebo-controlled primary prevention trial - 
the β-Carotene
 and Retinol Efficacy Trial, involving a total of 18,314
 smokers, former 
smokers, and workers exposed to asbestos, was conducted (Omenn et al., 1996). It was 
found that the combination of β-carotene and vitamin A had no benefit
 and may have 
had an adverse effect on the incidence of lung
 cancer and on the risk of death from 
lung cancer and CVD in smokers and workers after an average of 4 years of 
supplementation. Why the single antioxidant approach doesn’t work in clinical trials? 
The crucial point is whether a purified phytochemical has the same health benefit as 
does the whole mixture of foods in which the phytochemicals are present. It is 
hypothesized that the additive and synergistic effects of phytochemicals in fruits and 
vegetables are responsible for their potent antioxidant and anticancer activities, and 
that the benefit of a diet rich in fruits and vegetables is attributed to the complex 
mixture of phytochemicals present in whole foods (Liu, 2003; Liu, 2004).  
 
Here we showed that the EC50 values of apple extracts and Q3G in the two-
way combination were dramatically reduced, being 2-fold and 4-fold lower than that 
of apple extracts and Q3G alone, indicating a strong synergistic action. The CI values 
were smaller than 1 at the doses of 50, 75, 90, and 95% inhibition of MCF-7 cell 
growth. The DRI is a measure of how much the dose of each component in a 
synergistic combination may be reduced at a given effect level compared with the 
doses for each component alone. The DRI is important in clinical situations, where 
dose-reduction leads to lowered toxicity toward the host while retaining the 
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therapeutic efficacy. Data here exhibited that the DRI values of apple extracts and 
Q3G at the 50% of inhibition of MCF-7 cell growth were 2.03 ± 0.55 and 4.28 ± 0.39 - 
fold when compared to the values of apple extracts and Q3G alone. The DRI value of 
apple extracts and Q3G at the 95% of inhibition were 4.32 ± 1.48 and 6.55 ± 0.66 - 
fold when compared to the values of apple extracts and Q3G alone.   
 
The identified key bioactive components and mechanisms that contributed to 
the health benefits of fruits and vegetables have been drawn much attentions. However, 
increasing evidence suggested that these components are much more complex in scope, 
interaction, and magnitude. It is estimated that approximately 8,000 phytochemicals 
present in whole foods. Those compounds may act on different targets with different 
mechanisms of action (Liu, 2004). It is believed that phenolics can exert their effects 
on the different signaling pathways such as mitogen-activated protein kinases 
(MAPK), activator protein-1 (AP-1), or nuclear factor-κB (NF-κB) either separately or 
sequentially, as well as possible interaction between/among these pathways, which can 
offer complementary and overlapping mechanisms of action. Apples are rich in 
phenolics and Flavonoids. Some of the extensively studied bioactive compounds in 
apples include catechin, epicatechin, procyanidin, cyanidin-3-galactoside, coumaric 
acid, chlorogenic acid, gallic acid, quercetin-3-galactoside, quercetin-3-glucoside, 
quercetin-3-rhamnoside, and phloridzin. (Tsao et al., 2003) have examined the 
concentrations of the major phenolic compounds in eight apple cultivars. The total 
phenolics ranged from 101.7 to 235.0 mg/100g of fresh weight in the peel. 
Procyanidins were present in both the peel (59.7%) and the flesh (55.7%). Ranging 
from 22.03 to 34.99 mg/100 g in the peels of the eight varieties, Quercetin glycosides 
accounted for 17.9% of the total phenolics; most are quercetin 3-galactoside, 3-
arabinoside, and 3-rhamnoside. The amount of Q3G present in apple is low (Tsao et 
   201
al., 2003; Kahle et al., 2005), which may be not enough to cause antiproliferative 
activity against MCF-7 cells. Our hypothesis is that combination of apple extracts and 
Q3G will have synergistic effect in inhibiting the growth of MCF-7 cells in vitro. The 
results reported here clearly supported our hypothesis and showed that the two-way 
combination of apple extracts and Q3G had strong synergistic effect against MCF-7 
cell growth. The synergistic action of apple extracts and Q3G may be of interest in 
clinical trials for breast carcinoma. 
 
Both synergistic and antagonistic effects against breast cancer cells were 
reported. Compounds can offer additive or synergistic interaction through against 
different biochemical targets. It was found that quercetin could enhance the action of 
carboxyamidotriazole (CAD) in human breast carcinoma MDA-MB-435 cells (Yeh et 
al., 1995). When quercetin and CAD were added to the MDA-MB-435 cells, 
synergism was observed in isobolograms in growth inhibition and clonogenic assays. 
The most effective combination was 20 μM quercetin with 4 μM CAD in growth 
inhibition assay; 30 μM quercetin with 1.2 μM CAD in clonogenic assay. Resveratrol 
and quercetin additively activate the caspase 3 in human pancreatic carcinoma cells 
(Mouria et al., 2002), and synergistically induce apoptosis in human leukemia cells 
(Mertens-Talcott and Percival, 2005). The effect of a combination of quercetin (25 
μM) and trans-resveratrol (25 μM) on mitochondrial cytochrome c release and 
caspase-3 activity was greater than the expected additive response. The synergistic 
action with those two agents support the concept that the flavonoids (quercetin) and 
nonflavonoids (trans-resveratrol) act on the membrane permeability transition by 
distinct pathways, suggesting that the pathways are interactive (Mouria et al., 2002). 
Studies in cell cycle kinetics, proliferation, and apoptosis (caspase-3 activity) in 
human leukemia cells (MOLT-4) were conducted after incubation with ellagic acid, 
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quercetin, and resveratrol as single compounds and in combination. A synergistic 
interaction with a CI of 0.64 for the combination of ellagic acid and resveratrol, and a 
CI of 0.68 for quercetin and resveratrol were observed after an isobolographic 
analysis, indicating that the anticarcinogenic potential of foods containing phenolics 
may not be based on the effects of individual compounds, but may involve a 
synergistic enhancement of the anticancer effects (Mertens-Talcott and Percival, 2005).  
 
Here two methods were applied to evaluate additive, synergistic, and 
antagonistic effects. One way is to examine the shifted pattern of combination in dose-
response curve, and then to compare the EC50 reduction between individual 
component and combined components. Another way is to compare generated CI value 
with 1. For example, in Figure 6.1, the combined concentration was almost saturated 
in dose-effect curve, which didn’t show cytotoxicity in the maximum combined 
concentration. The dose-response curve of antiproliferative activity was shifted to the 
left after combination of apple extracts and Q3G. The EC50 of apple extracts and Q3G 
after combination is 2.03 ± 0.55, and 4.28 ± 0.39 - fold, respectively, lower than the 
EC50 of apple or Q3G alone, suggesting synergistic effect. Secondly, the CI at 50% 
inhibition rate in apple extracts and Q3G combination is 0.755 ± 0.16, which is less 
than 1, indicating a synergistic effect (Chou, 1991). The mechanism of action in apple 
plus Q3G combination might be explained as bioactive compounds in apple extracts 
tend to increase the antiproliferative activity in MCF-7 cells by suppressing one or 
more targets of the signal transduction pathway, by stabilizing the Q3G in the system 
or, by increasing the bioavailability of the Q3G (HemaIswarya and Doble, 2006). In 
this study, based on individual apple extracts or Q3G’s EC25 and/or EC50, series 
concentrations were designed in combination in antiproliferative activities model. This 
method was proven to work well in our study.  
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The health benefits of fruits and vegetables are due to the additive and 
synergistic effects of an array of phytochemicals, rather than to a single compound 
alone. The balanced natural combination of phytochemicals present in fruits and 
vegetables cannot simply be mimicked by dietary supplements. The reasons may be 
due partially to that the purified compounds either loses their bioactivity or may
 not 
behave the same way as the compound in whole food. In addition, these compounds 
differ in molecular size, polarity, and solubility, which may affect their bioavailability 
and distribution in different subcellular organelles, cells, and tissues and organs. 
Another possible explanation of the contradictory results between observational 
studies and randomised trials could be the fact that the doses used in clinical trials 
were much higher than the maximum levels in whole foods through the dietary 
consumption which were found to be associated with the lower risk of cancer in 
observational epidemiological studies. Consumers may gain more significant health 
benefits from whole foods in their balanced diet than from dietary supplements, which 
do not contain the same array of balanced, and complex compounds (Liu, 2003; Liu, 
2004). Our findings have important implications for combinations of phenolics for 
cancer prevention. However, further studies are needed to elucidate the underlying 
mechanisms of combination effects of bioactive components in breast cancer. 
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